Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,KEGG_2021_Human__Shigellosis,-0.43438297625659117,-2.5260776287030535,0.0,0.0,0.0,15/20,28.76%,H3C13;H3C7;FOXO1;PIK3R1;ITGA5;WASF1;CSF2;H3-5;PRKCQ;TLR4;MAPK10;HCLS1;CCL5;AKT3;MYL9
prerank,KEGG_2021_Human__Salmonella infection,-0.33435308402470115,-2.1688117676910648,0.0,0.06624319419237751,0.05,21/23,55.61%,RAB9B;LEF1;RHOH;TLR4;ARHGEF26;TUBA1A;KIF5C;MAPK10;TUBB4A;AKT3;MYL9;RHOJ;LY96;BCL2;NLRP3;FLNC;NCKAP1L;MYL10;KIF5A;PIK3CG;IL6
prerank,KEGG_2021_Human__Epstein-Barr virus infection,-0.32118253177254386,-2.1275231196821256,0.0,0.061826981246219,0.07,22/23,60.71%,PIK3R1;RUNX3;HLA-DPB1;HLA-DRA;MAPK10;HLA-DPA1;HLA-DQA2;CXCL10;CD3D;AKT3;CCNA1;HLA-DOA;CD19;HLA-DQA1;ENTPD1;BCL2;ITGAL;CD3E;BTK;IL6;FCER2;CD3G
prerank,KEGG_2021_Human__Lipid and atherosclerosis,-0.32684706597750074,-2.120503928983251,0.0,0.046370235934664245,0.07,25/25,67.59%,FASLG;PIK3R1;NCF2;TLR4;LBP;MAPK10;NFATC1;CCL5;CYP1A1;AKT3;VCAM1;LY96;IL12B;BCL2;NLRP3;CD36;SELP;CCL2;CYBB;CAMK2A;CD40LG;IL6;RXRG;OLR1;SELE
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,-0.3793161421216956,-2.033472449688022,0.0,0.079491833030853,0.12,22/23,56.52%,CLDN22;FASLG;CLDN2;WASF1;TLR4;TUBA1A;MAPK10;TUBB4A;HCLS1;MYO5A;LPAR1;WIPF1;MYH10;CLDN10;F2R;NLRP3;FCGR2A;NCKAP1L;CLDN11;LPAR4;IL6;IL1R1
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.30154371282852854,-1.9497524076609862,0.0,0.16339987900786448,0.25,20/23,51.87%,H2BC3;ASB9;RNF144A;ASB11;SPSB1;KLHL13;FBXL22;KBTBD8;RNF112;UBE2E2;MARCHF1;SPSB4;PDZRN3;CAND2;BCL2;MEFV;FBXL7;HECW1;ASB2;TRIM61
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,-0.22792698825585422,-1.9477177654739979,0.0,0.14005703914959813,0.25,26/38,38.41%,FASLG;PIK3R1;ITGA5;ZNF667;ZNF471;HLA-DPB1;ZNF677;ZNF418;ZIK1;ZFP92;HLA-DRA;HLA-DPA1;ZFP82;HLA-DQA2;ZNF382;CCL5;ITGB3;AKT3;LTA;HLA-DOA;HLA-DQA1;ZNF354C;IL12B;ZNF135;ZNF154;BCL2
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,-0.3785995756289785,-1.9038348205454214,0.0,0.17554446460980036,0.34,15/15,62.34%,NLRP12;TLR4;CASP12;MAPK10;CCL5;P2RX7;GBP5;BCL2;MEFV;NLRP3;CASR;CCL2;CYBB;IL6;ANTXR1
prerank,KEGG_2021_Human__Osteoclast differentiation,-0.24390167703065227,-1.8845375308138106,0.0,0.17959265981044567,0.37,33/34,71.67%,PIK3R1;TREM2;LILRB1;SIRPB1;NCF2;CAMK4;MAPK10;SIRPG;LILRA5;NFATC1;LCP2;ITGB3;LILRB4;AKT3;LILRB2;TGFB2;LILRA2;FCGR3A;MITF;FCGR2C;LILRA6;FCGR2A;CSF1R;BTK;LILRA1;IL1R1;FCGR2B;FCGR3B;CALCR;FOSB;IFNG;CTSK;LILRB5
prerank,KEGG_2021_Human__Influenza A,-0.26646848986395255,-1.8770109461394375,0.0,0.1642831215970962,0.37,17/25,35.76%,CPSF4L;FASLG;PIK3R1;HLA-DPB1;TLR4;HLA-DRA;HLA-DPA1;RSAD2;HLA-DQA2;CXCL10;CCL5;AKT3;TPSAB1;HLA-DOA;HLA-DQA1;TPSB2;IL12B
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.3295868370754682,-1.869848606792657,0.0,0.15416597921135128,0.37,16/18,53.20%,SLC8A3;TRPC6;TRPC4;ATP2B3;TRPC1;P2RX7;NALCN;GRIN2B;MICU3;TRPC3;CACNA1G;PKD2;SLC24A2;SLC24A4;CACNA2D1;TRPM3
prerank,KEGG_2021_Human__Protein digestion and absorption,0.3426900895426365,1.8061485421442827,0.0,1.0,0.94,24/31,49.28%,ATP1A4;COL8A1;COL10A1;COL6A6;COL19A1;COL14A1;COL24A1;XPNPEP2;COL11A1;COL3A1;COL6A5;SLC8A1;ATP1A2;CPA3;COL6A3;COL5A2;ELN;COL21A1;COL1A2;COL1A1;COL4A6;COL5A1;COL8A2;COL12A1
prerank,KEGG_2021_Human__Insulin secretion,0.43469255247460725,1.7995456961487877,0.012658227848101266,1.0,0.94,16/18,47.95%,ATP1A4;CCKAR;ADCYAP1;GPR119;GCG;FFAR1;ATP1A2;PRKCB;ADCYAP1R1;KCNMB2;GIP;ADCY2;ADCY5;GLP1R;RIMS2;CAMK2A
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,-0.3020500278042457,-1.7445042664803938,0.0,0.28484573502722327,0.6,16/22,35.76%,RUNX3;IL2RB;HLA-DPB1;ZAP70;PRKCQ;TBX21;HLA-DRA;MAPK10;HLA-DPA1;CD4;HLA-DQA2;NFATC1;CD3D;HLA-DOA;HLA-DQA1;IL12B
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,-0.2794623313109355,-1.7410595181864132,0.05555555555555555,0.26701102889850625,0.6,13/17,43.42%,PIK3R1;TLR4;LBP;MAPK10;CD80;CXCL10;CCL5;AKT3;CCL4;LY96;IL12B;CXCL9;CD86
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.08744721214629105,-1.7355835344196453,0.0,0.2536168006222453,0.6,91/97,81.35%,AHSG;ST8SIA5;PEAK3;SIK1;MEX3B;RUNX3;SERPINA10;ASB9;MXRA8;FGFR1;FAM20A;ENAM;ZAP70;PLOD2;CPE;ASB11;SPSB1;PTPRO;IGFBP7;DUSP26;KLHL13;FBXL22;KBTBD8;CAMK4;FN1;NUAK1;DUSP1;KRT2;CHGB;UBE2E2;MAPK10;SDC2;PLAT;CDK14;BMPR1B;ST8SIA3;SPSB4;WNK3;NTRK1;AKT3;TGFB2;FLG;PRSS23;ST8SIA1;FCGR3A;CCDC8;CHST4;PRKD1;ERG;RET;ST8SIA4;PRKG1;CDH2;PTPN5;GPC3;PTPRD;FBXL7;ST8SIA6;LRRK2;ASB2;BTK;CCL2;CCN1;CAMK2A;SCG3;LTBP1;IL6;ST8SIA2;SCG2;CD3G;PTPRT;FSTL1;SPARCL1;CCL11;PRKCB;LOX;IGFBP5;TNC;DCLK1;CDK15;PADI4;PSMA8;ART4;ART1;COL3A1;FBN1;MATN3;AMTN;PTPRC;KRT1;VCAN
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.3816070973484156,1.7166753264647099,0.011764705882352941,1.0,0.98,12/21,28.97%,CCL19;FGF10;FGF7;FGF19;FGF16;FGF5;NEXN;CCL21;SST;FBLN1;CCR7;PLXNA4
prerank,KEGG_2021_Human__Tuberculosis,-0.23143724876277247,-1.6998740037653972,0.07692307692307693,0.30383545069570483,0.68,31/32,72.60%,LSP1;HLA-DPB1;CLEC4E;FCER1G;TLR4;MRC2;LBP;HLA-DRA;MAPK10;HLA-DPA1;HLA-DQA2;IL10RA;AKT3;TGFB2;HLA-DOA;FCGR3A;HLA-DQA1;FCGR2C;IL12B;BCL2;FCGR2A;CLEC7A;CAMK2A;IL6;FCGR2B;FCGR3B;IL10;MRC1;CD209;IFNG;TGFB3
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,-0.2469854890363481,-1.6763706143591606,0.0,0.3063747731397459,0.7,27/30,61.44%,PIK3R1;IL2RB;EGR1;CSF2;HLA-DPB1;HLA-DRA;MAPK10;HLA-DPA1;CD4;HLA-DQA2;NFATC1;CD3D;AKT3;LTA;CCNA1;TGFB2;HLA-DOA;HLA-DQA1;MMP7;ITGAL;CD3E;ADCY5;IL6;IL1R1;EGR2;CD3G;ADCY2
prerank,KEGG_2021_Human__Type I diabetes mellitus,-0.305630339611695,-1.6566505677895251,0.0,0.32576064908722113,0.74,13/16,43.42%,FASLG;HLA-DPB1;CPE;HLA-DRA;HLA-DPA1;CD80;HLA-DQA2;LTA;HLA-DOA;HLA-DQA1;IL12B;GAD2;CD86
prerank,KEGG_2021_Human__Prion disease,-0.24599122118715167,-1.655132549876565,0.05,0.3106069772131478,0.75,12/23,20.91%,PIK3R1;C6;EGR1;CAV1;NCF2;CASP12;C1QB;TUBA1A;KIF5C;MAPK10;C1QC;TUBB4A
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.30159035425463687,-1.6455981501132397,0.047619047619047616,0.3040213965039641,0.76,12/16,38.50%,FAM107A;PEAK3;MAPT;RHOH;MAP6;PHLDB2;P2RX7;PDGFRB;DLC1;CORO2B;CLIC4;GPM6B
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.25774134790528236,-1.6320684877974008,0.0625,0.3086932849364792,0.78,20/20,74.41%,CAMK1D;NTRK3;ROR1;WNT5A;ZNF804A;NTRK1;NDNF;PRKD1;RET;ROR2;ZDHHC15;PTN;RELN;BMP5;ALK;DPYSL3;TENM3;PLPPR5;STMN2;EPHA3
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.3724103893518245,1.6297601062075546,0.012987012987012988,1.0,1.0,14/18,46.62%,OGN;OMD;KERA;VCAN;DCN;LUM;CHSY3;PRELP;GSTM5;ANGPT1;GGTA1;DSEL;HPGDS;CHST9
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.37581011703724554,1.6251163447931676,0.05063291139240506,1.0,1.0,16/19,51.24%,RSPO3;FGF10;SFRP1;SFRP4;RSPO1;RSPO2;DKK2;SFRP2;PSMA8;DAAM2;COL1A1;SULF1;ADGRA2;ZEB2;DACT1;LRRK2
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.2651883353584447,-1.6205296070675508,0.047619047619047616,0.31670555699593816,0.8,22/22,73.69%,SEMA5A;CYTIP;DUSP26;NUAK1;DUSP1;PKHD1;SPN;PLXNC1;CCL5;IL12B;RET;AZU1;ADAM22;DSCAM;PIK3CG;ANGPT1;RIPOR2;CXCL12;PLXNA4;CCR7;FBLN1;TNFSF18
prerank,KEGG_2021_Human__Pertussis,-0.3494998484389209,-1.5999083242118135,0.07692307692307693,0.33482923609965354,0.84,15/15,65.24%,CFL2;ITGA5;SERPING1;CXCL6;TLR4;C1QB;MAPK10;C1QC;LY96;IL12B;NLRP3;C1R;IL6;C1S;IL10
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.3210355983125398,1.5938198689524448,0.02564102564102564,1.0,1.0,13/24,31.93%,LGI1;PLP1;MYOC;NPY;ADCYAP1;STMN4;ATCAY;SH3GL2;GPM6A;CCL21;STMN2;CCR7;TSGA10IP
prerank,KEGG_2021_Human__Rheumatoid arthritis,-0.2196573787568405,-1.5907696057205436,0.05263157894736842,0.3294878876351298,0.84,23/24,72.60%,CSF2;HLA-DPB1;CXCL6;TLR4;HLA-DRA;HLA-DPA1;CD80;HLA-DQA2;CCL5;TGFB2;HLA-DOA;HLA-DQA1;TEK;ITGAL;CD86;CTLA4;CCL2;IL6;ANGPT1;CXCL12;IFNG;CTSK;TGFB3
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.19805467358524126,-1.5869439123209532,0.0,0.3223835450695705,0.84,29/35,57.09%,PPBP;LILRB1;CXCL6;TLR4;LBP;CD80;CX3CR1;WNT5A;CXCL10;NUGGC;CCL5;PDE4B;AXL;LILRB2;LY96;TNFSF4;CXCL9;BPI;NLRP3;CD86;SERPINE1;CCL2;CD180;MEF2C;PDCD1LG2;IL6;TNIP3;ANKRD1;STAP1
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.2892886476446133,1.5828777713186664,0.06741573033707865,1.0,1.0,25/35,49.28%,GREM1;COL8A1;COL10A1;COL19A1;DPT;COL14A1;COL24A1;CYP1B1;ADAMTS3;COL11A1;COL3A1;DDR2;COL6A3;LOX;LUM;COL5A2;TLL1;COL21A1;COL1A2;COL1A1;COL4A6;P4HA3;COL5A1;COL8A2;COL12A1
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,-0.25227963525835867,-1.5803773111962325,0.0,0.317967332123412,0.85,24/24,74.98%,CLDN22;PIK3R1;PECAM1;CLDN2;CTNNA2;NCF2;RHOH;JAM3;MYL9;VCAM1;CLDN10;ITGAL;CTNNA3;JAM2;MYL10;CYBB;CLDN11;CXCL12;ITK;MYL2;PRKCB;THY1;MMP2;ITGA4
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.3824771154271744,1.579706565390709,0.04,1.0,1.0,14/17,48.64%,IGF1;SGCD;LAMA2;SGCG;CHODL;COL6A3;TCF21;EVC;ITGA11;BVES;TAGLN;FHL1;MRAS;MEF2C
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,-0.23023114355231145,-1.5731104106110607,0.07692307692307693,0.3189864581879101,0.86,26/26,77.19%,FOXO1;PIK3R1;COL4A1;COL4A5;EGR1;FN1;MAPK10;NFATC1;COL4A4;AKT3;TGFB2;VCAM1;BCL2;SERPINE1;CCL2;CYBB;IL6;COL4A6;COL1A1;COL1A2;SELE;PRKCB;AGTR1;TGFB3;MMP2;COL3A1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.3371636615097413,1.5677649290893396,0.047619047619047616,1.0,1.0,15/21,43.96%,PLN;SGCD;TRDN;SGCG;AGTR1;SGCZ;ELN;MYL2;CXCL12;OLR1;ACTC1;MEOX2;AVPR1A;GUCY1A1;HTR7
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.21672933501631197,-1.5608171509951776,0.09090909090909091,0.3287625193251328,0.88,15/25,30.18%,FGF8;SIK1;RUNX3;CSF2;FGFR1;NGF;NREP;PTHLH;MAFB;GDNF;NTF3;BMPR1B;IGF2;HOPX;PHLDB2
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.2626784087458245,-1.5578432775137243,0.0625,0.32175265750583354,0.88,21/21,73.93%,PIK3R1;PECAM1;CAV1;NCF2;DUSP1;MAPK10;SDC2;PLAT;BMPR1B;ITGB3;AKT3;VCAM1;BCL2;CCL2;MEF2C;IL1R1;GSTM5;SELE;IFNG;GSTT2;MMP2
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.23872050171068737,-1.553923973344787,0.125,0.3188810313536517,0.88,22/24,64.12%,IL2RB;LEF1;WASF1;LIN7A;FN1;BIN2;WAS;CAND2;RIMS1;WIPF1;P2RX7;MITF;MEFV;CD3E;NCKAP1L;FBXL7;LRRK2;SHANK1;PYGO1;FERMT2;CD3G;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.2457054286641213,-1.5476483294021117,0.0,0.32150030248033884,0.89,21/22,69.16%,LAPTM5;TNFAIP8L2;LILRB1;IFNL1;FOXP3;SPN;CD80;LILRB4;LILRB2;HAVCR2;CD86;PLA2G2D;NCKAP1L;VSIG4;PDCD1LG2;FCGR2B;RIPOR2;LAX1;IL10;GPNMB;TIGIT
prerank,KEGG_2021_Human__Inflammatory bowel disease,-0.2779615431324951,-1.5358719967446255,0.15,0.3265148410514607,0.89,15/20,40.46%,IL21;HLA-DPB1;TLR4;FOXP3;TBX21;HLA-DRA;HLA-DPA1;HLA-DQA2;NFATC1;TGFB2;HLA-DOA;HLA-DQA1;IL21R;IL12B;IL13
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.21575380701347696,-1.532655498168561,0.05555555555555555,0.3221075317604356,0.9,31/32,74.35%,TSLP;TREM2;NLRP12;AIF1;TLR4;LBP;CD200;LILRA5;WNT5A;LILRB4;LILRB2;LILRA2;TNFSF4;F2R;BPI;IL16;SYT11;NCKAP1L;IL33;CLEC7A;SCIMP;SLAMF1;GHRL;IL6;CD200R1;C1QTNF3;IL10;IFNG;TLR8;GHSR;TLR7
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.23030118649224215,-1.5233364836922518,0.0,0.33482923609965354,0.93,27/27,77.19%,OTOA;ITGA1;NID2;FN1;PARVG;TNN;ITGB3;ITGA8;VCAM1;DLC1;SIGLEC1;CD96;SORBS1;ITGAL;ADAMTS12;FERMT2;ITGA11;PPFIA2;ECM2;FBLN5;ITGBL1;ACTN3;THY1;LYVE1;CCL21;ITGA4;COL3A1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.3203891291301124,1.5168225313184087,0.0625,1.0,1.0,19/24,51.87%,CCL19;SFRP1;CCL14;PTGIS;CCL17;CCL21;CCL13;CCL7;SELE;CCL11;CCL16;ANKRD1;IL1R1;CCL25;HAS2;CCL22;CCL2;ADAMTS12;CCL8
prerank,KEGG_2021_Human__Oxytocin signaling pathway,-0.2326956412886304,-1.5056325996515316,0.06666666666666667,0.3452439414967439,0.94,23/24,71.15%,GUCY1B1;CAMK1D;KCNJ5;CAMK4;KCNJ12;NFATC1;CACNB4;CACNA2D3;MYL9;GUCY1A2;CD38;PIK3R5;MEF2C;CACNA2D1;CAMK2A;PIK3CG;GNAO1;ADCY5;GUCY1A1;ADCY2;CACNG5;RYR3;PRKCB
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",-0.2902638762511374,-1.496735230395489,0.15789473684210525,0.3482499351827845,0.95,17/17,71.15%,EGR1;FGFR1;SOST;PTHLH;MAFB;MMP17;MMP13;KL;PDE4B;BCL2;CASR;MEF2C;ADCY5;ADCY2;RXRG;MMP16;PRKCB
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.17720068733062597,-1.4964726950416567,0.058823529411764705,0.3400483968542045,0.95,28/35,55.31%,PEAK3;SIK1;MEX3B;RUNX3;FGFR1;FAM20A;ZAP70;CAMK4;NUAK1;MAPK10;CDK14;CERKL;BMPR1B;WNK3;NTRK1;AKT3;TGFB2;HTR2B;PRKD1;ERG;RET;PRKG1;LRRK2;BTK;CCL2;CAMK2A;PIK3CG;DGKB
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.30249517628029415,-1.4900104051813399,0.09090909090909091,0.340883896600775,0.95,16/17,62.43%,PIK3R1;LAMB4;FN1;PARVG;PKHD1;ITGB3;ATRNL1;NTNG1;ITGA8;TEK;MEF2C;TMEFF2;FERMT2;BVES;ANTXR1;RELN
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2597764307992392,1.4814478297531033,0.0967741935483871,1.0,1.0,28/49,39.68%,CHRM2;IAPP;MC4R;VIP;ADCYAP1;CRHR1;GPR119;GLP2R;ADRB3;GCG;ADGRE3;P2RY12;FPR2;ADCYAP1R1;PTGER3;ADGRD1;MC2R;CNR1;CALCR;ADGRB3;CNR2;UCN3;FPR1;CCR3;DRD5;PTGFR;ADCY2;AKAP12
prerank,KEGG_2021_Human__TGF-beta signaling pathway,0.33166087161319824,1.4807410854146286,0.047619047619047616,1.0,1.0,12/20,35.33%,GREM2;GREM1;GDF6;THBS1;LEFTY2;FBN1;DCN;TGFB3;IFNG;INHBA;BMP5;GDF5
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.19675151895338566,-1.479203644915497,0.125,0.34934568726716975,0.95,29/36,52.90%,MCF2;ARHGAP9;MAPT;TREM2;AKAP6;ARHGAP30;NLRP12;NTRK3;STARD8;RHOH;NUAK1;ARHGEF26;ARHGAP31;PKHD1;WNT5A;NTRK1;RHOJ;RASGRF2;PPP1R16B;DLC1;ARHGAP15;TEK;ARHGAP28;ARHGEF6;CLEC7A;LRRK2;CMKLR1;NLGN1;TAGAP
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.2129094904558538,1.4760700033318388,0.031578947368421054,1.0,1.0,64/83,60.74%,AGTR2;CCL19;CXCL13;CCL14;XCR1;THBS1;PTX3;IL2RA;HPR;TAC1;PROK2;FOLR2;CCL17;FPR2;CCL21;CCR5;CCL13;AGTR1;CCR7;CCL7;CCR2;IFNG;PTGER3;FPR3;PF4V1;SELE;ACKR1;CRHBP;CCL11;FPR1;OLR1;CCR3;PTGFR;ODAM;SCG2;CCL16;AOC3;TNFAIP6;FCGR2B;CCR1;IL6;CCL25;PIK3CG;CD40LG;GPR33;CCL22;CYBB;CCL2;CMKLR1;CXCR2;C3AR1;TLR10;CCL8;KIT;CSF1R;PLA2G2D;TACR1;ITGAL;NLRP3;MEFV;ADORA3;CD96;CXCL9;AZU1
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.22684654270550852,-1.4728248871660692,0.05555555555555555,0.34582344455302716,0.96,19/21,64.63%,LSP1;FCMR;NCF2;LBP;SPN;CX3CR1;CCR6;C5AR1;LILRB2;LY96;KLRG1;CLEC5A;CXCL9;CXCR2;MNDA;RAB23;CCR3;KLRC3;ITK
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.15223479545435226,-1.4712259366338618,0.09090909090909091,0.33982758620689657,0.96,46/51,71.54%,LAPTM5;LEF1;TREM2;LILRB1;NLRP12;IFNL1;TLR4;FN1;FOXP3;TBX21;HDAC9;CD200;LILRA5;CD33;LILRB4;AXL;NR1H4;HAVCR2;APOD;IL12B;TNFSF4;MEFV;BPI;CD84;SSC5D;SYT11;SRGN;NCKAP1L;VSIG4;CMKLR1;SLAMF1;PDCD1LG2;GHRL;IL6;FCGR2B;NAV3;CD200R1;C1QTNF3;IL10;INHBA;GPNMB;TIGIT;IFNG;TLR8;GHSR;CCR7
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.29685571894017126,1.4678145324398095,0.09523809523809523,1.0,1.0,19/25,51.87%,CCL19;SFRP1;CCL14;PTGIS;CCL17;CCL21;PSMA8;CCL13;CCL7;CCL11;CCL16;ANKRD1;IL1R1;CCL25;HAS2;CCL22;CCL2;ADAMTS12;CCL8
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.25068824713855464,-1.465129855849411,0.058823529411764705,0.3438183347350715,0.96,18/21,57.09%,AHSG;IL2RB;TREM2;SIRPB1;CD300LF;CAMK1D;FCER1G;SIRPG;PLA2G5;AZU1;DOCK2;TUB;NCKAP1L;CLEC7A;RAB31;CCL2;FCGR2B;STAP1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.20524145816800557,-1.4640659663142526,0.08333333333333333,0.33752484659925674,0.97,28/29,74.74%,ROBO2;NGF;CAMK1D;NTRK3;ROR1;PLXNC1;WNT5A;ZNF804A;MAP6;NTRK1;NDNF;PRKD1;RET;SLITRK1;ROR2;PTPRD;ROBO1;PTN;RELN;DPYSL3;TENM3;PLPPR5;PLXNA4;STMN2;CHODL;NGFR;EPHA3;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.2742645244181327,-1.4608415262345351,0.045454545454545456,0.3315240788418521,0.97,11/15,39.92%,AKAP6;CAV1;APLNR;CXCL10;TRPC1;P2RX7;CD19;F2R;CXCL9;P2RX5;TRPC3
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.0914778873059607,-1.4587991865028809,0.0,0.3270004949678271,0.97,94/102,79.39%,FOXH1;SOX11;FOXO1;PIK3R1;VENTX;LMX1A;EGR1;LEF1;LILRB1;GATA5;HEYL;TAL1;NR2F1;PID1;ASXL3;GDNF;LDB2;NPAS4;DAB2;TLR4;FOXP3;SMAD9;GLI2;WAS;BEX1;BMPR1B;WNT5A;HCLS1;NFATC1;SOX2;CXCL10;IGF2;GAL;NR1H4;TGFB2;LMO1;MITF;MLIP;ESR1;FGF2;HLF;PRKD1;CEBPE;ERG;TFEC;FOXF1;NLRP3;PKD2;GLI1;IL33;PRL;SERPINE1;MIXL1;ZEB2;CCN1;MEF2C;TCF4;OSM;FHL5;IL6;TNIP3;RORB;RGMA;MEOX2;EGR2;GLI3;RFX6;RXRG;WNT2;PEG3;BMP5;IRF4;IL10;INHBA;IL26;PGR;TCF21;HGF;AR;EOMES;ZFPM2;TGFB3;GATA1;NGFR;OSR1;HAND1;GALR1;MYOCD;HAND2;DCN;SFRP2;NKX6-3;NR4A3;NOS1
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,0.19755442938563353,1.4515858262659205,0.06060606060606061,1.0,1.0,68/121,45.20%,CHRM2;PENK;CTSG;IAPP;NPFFR2;MC4R;AGTR2;VIP;GRIA1;NPY;GABRG2;GLRA1;CHRNA6;CCKAR;ADCYAP1;CRHR1;HTR2A;GABRA1;GABRP;PPY;LEP;GLP2R;P2RY10;PRLHR;ADRB3;GCG;GABRA5;TAC1;P2RX2;P2RY14;FPR2;GALR1;HCRTR1;GLRA3;SST;HRH2;CHRNA1;AGTR1;GHSR;CHRNA3;ADCYAP1R1;PTGER3;FPR3;NTSR2;MC2R;CNR1;CALCR;CNR2;GIP;UCN3;FPR1;RXFP3;DRD5;PTGFR;GHR;PMCH;GRIA2;GABRQ;EDNRA;GABRG1;AVPR1A;F2RL2;HTR7;GHRL;GRIK3;LEPR;LPAR4;OPRM1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.2105964625600674,-1.4510385417474183,0.17647058823529413,0.33092155676547697,0.97,30/31,74.41%,NCS1;CRMP1;CTNNA2;CAMK1D;NTRK3;PTPRO;SEMA3A;ROR1;WNT5A;ZNF804A;NTRK1;LPAR1;NTNG1;NDNF;PRKD1;RET;ROR2;CDH2;LRRK2;ZDHHC15;PTN;PPFIA2;LRRC4C;RELN;DPYSL3;TENM3;PLPPR5;SPOCK1;STMN2;EPHA3
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.2613174323588393,-1.4504577419359295,0.07142857142857142,0.3243036376548568,0.97,16/20,47.80%,AHSG;IL2RB;TREM2;SIRPB1;CAMK1D;CLIP3;FCER1G;DAB2;SIRPG;CALY;PLA2G5;AZU1;GPC3;DOCK2;TUB;CLEC7A
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.225437337302599,1.444228457452101,0.10989010989010989,1.0,1.0,35/63,41.37%,IAPP;DES;GREM1;COL8A1;COL10A1;COL19A1;DPT;COL14A1;STMN4;MFAP4;COL24A1;CYP1B1;ADAMTS3;TRDN;MYH11;COL11A1;COL3A1;DDR2;SPTA1;COL6A3;STMN2;LOX;LUM;COL5A2;PGM5;TLL1;FBLN5;XIRP1;COL21A1;LMOD1;ACTC1;COL1A2;ODAM;COL1A1;COL4A6
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,-0.3151605536603277,-1.4321804555546043,0.043478260869565216,0.3563038189751709,0.98,10/15,28.30%,PIK3R1;ZAP70;PRKCQ;TLR4;CD4;PDCD1;NFATC1;CD3D;RASGRP1;AKT3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.34840667678300474,1.4320302470903712,0.14285714285714285,1.0,1.0,19/19,65.36%,GRIA1;GSG1L;CRHBP;CACNG5;RELN;GRIA2;OPRM1;SHANK1;CAMK2A;NLGN1;MEF2C;NEFL;NETO1;SHISA9;GRIA3;DLG2;NPTX1;SHISA6;GRIN2B
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.17060150459959894,-1.427833228971742,0.0,0.3560571687840291,0.98,35/40,66.45%,CLNK;FGFR1;NGF;ZAP70;NTRK3;RASGRP4;BLK;NTF3;CD4;ROR1;LCP2;NTRK1;AXL;PDGFRB;EFS;SHC4;RET;ROR2;TEK;CD8B;CSF1R;PTPRD;CD3E;PDGFRA;KIT;EPHA6;SLA;GFRA2;STAP1;CASS4;PTN;PTPRT;CD8A;ALK;FLT3
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.27113884373532543,1.4277427466136023,0.0898876404494382,1.0,1.0,25/37,48.01%,GPR15;IAPP;MC4R;VIP;ADCYAP1;CRHR1;GLP2R;ADRB3;GCG;HRH2;ADCYAP1R1;MC2R;CALCR;GIP;IL10;DRD5;ADCY2;CD3G;CD163;FCGR2B;HTR7;IL6;ADCY5;GLP1R;MC5R
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,-0.21799107795845624,-1.4249685391793419,0.05555555555555555,0.35473906440979297,0.98,22/25,63.07%,PIK3R1;GRM1;PLPP3;FCER1G;LPAR1;AKT3;PDGFRB;SHC4;F2R;PDGFC;PIK3R5;PDGFRA;KIT;CXCR2;MRAS;PIK3CG;LPAR4;ADCY5;DGKB;AVPR1A;ADCY2;PTGFR
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.2149162861491629,-1.42110428337364,0.16666666666666666,0.3545335753176044,0.98,29/29,78.73%,SLC8A3;TRPC6;CAV1;TRPC4;CACNA1I;CCL5;TRPC1;CHRNB2;P2RX7;NALCN;CALCRL;TRPC3;CACNA1G;PKD2;CASR;CACNA1B;SLC24A2;CCL8;SLC24A4;CACNA2D1;CAMK2A;TRPM3;CCR1;SLN;RYR3;CCR5;MS4A1;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.3453495748196708,1.4143554399064804,0.0945945945945946,1.0,1.0,8/15,27.76%,SCN2B;CASQ2;NOS1;MYL3;SLC8A1;ATP1A2;TNNT3;CHRNA1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.25643638260501744,-1.409441022457774,0.09090909090909091,0.36109035265648914,0.98,13/16,49.25%,FOXO1;ASB9;ASB11;CD80;WNT5A;RASGRP1;LILRA2;IL12B;NKD1;CD86;GPC3;HECW1;DACT1
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.35557432498453645,1.4065654042484614,0.09090909090909091,1.0,1.0,10/17,31.53%,ATP1A4;CASQ2;ABCC9;TRDN;NOS1;ANK2;SLC8A1;ATP1A2;RYR3;CASQ1
prerank,KEGG_2021_Human__Staphylococcus aureus infection,-0.1971764117963883,-1.4037527447957525,0.08695652173913043,0.3694331983805668,0.98,29/31,71.82%,HLA-DPB1;C1QB;HLA-DRA;HLA-DPA1;C1QC;HLA-DQA2;CFH;C5AR1;HLA-DOA;KRT40;KRT23;FCGR3A;HLA-DQA1;KRT39;FCGR2C;KRT27;KRT36;ITGAL;FCGR2A;SELP;C1R;C3AR1;FCGR2B;C1S;FCGR3B;FPR1;IL10;FPR3;MASP1
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.2640494365148185,1.4001001708615177,0.11494252873563218,1.0,1.0,17/33,35.70%,LGI1;PHOX2B;PLP1;MYOC;NPY;ADCYAP1;STMN4;ATCAY;SH3GL2;GPM6A;MYT1L;EPHA5;DCX;STMN2;TENM3;ALK;TENM2
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.26644437708396485,-1.3888527514135722,0.07407407407407407,0.3864602951751533,0.98,15/15,73.51%,SOX11;WNT16;CD200;KANK2;HTR2B;FGF2;PRKD1;CCN5;LRRK2;CCN1;FERMT2;CD200R1;CCN2;GPNMB;CCN4
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.2501122348146996,-1.3881025692205973,0.11764705882352941,0.3793036230422801,0.98,14/17,51.87%,H2BC3;ASB9;RNF144A;ASB11;SPSB1;KLHL13;SPSB4;PDZRN3;CAND2;MEFV;FBXL7;HECW1;ASB2;TRIM61
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3581056812433348,1.3865468280539819,0.14864864864864866,1.0,1.0,14/16,55.76%,FGF10;SFRP1;SFRP4;RSPO1;DKK2;SFRP2;PSMA8;DAAM2;COL1A1;ADGRA2;ZEB2;DACT1;LRRK2;GPC3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.21743706953219438,-1.3848538036024431,0.058823529411764705,0.37674311169773966,0.98,14/20,40.62%,APELA;FGFR1;SEMA5A;APLNR;VASH2;WNT5A;IGF2;ITGB3;AKT3;PPP1R16B;HTR2B;FGF2;PRKD1;TEK
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.28976294728718044,-1.37576691015778,0.1,0.3842105263157895,0.98,13/15,53.71%,FGFR1;TENM1;RASGRP1;PDGFRB;HTR2B;FGF2;PDGFC;PIK3R5;KIT;LRRK2;GH1;ROBO1;PIK3CG
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.3367478259979472,1.3750372755182882,0.1038961038961039,1.0,1.0,14/16,57.45%,MYOT;CADM3;HMCN1;NEXN;CNTN2;TENM3;PTPRT;ROBO1;PALLD;DSCAM;CNTN4;CDH2;CD84;CNTN6
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.15264941002334062,-1.3729402760202998,0.0,0.3835132295348171,0.98,57/67,65.18%,TREM2;LILRB1;PIANP;CD300LF;IFNL1;KLRK1;FOXP3;SAMHD1;HLA-DRA;SPN;RSAD2;PDCD1;CD200;SIGLEC9;TREML1;CD3D;SIGLEC7;CD33;SLAMF6;CD1D;CD300E;LILRB2;TGFB2;CD22;KIR2DL1;LAIR1;SELL;VCAM1;FCGR3A;CD19;FCGR2C;TNFSF4;KLRD1;CD96;TREML2;JAML;CD8B;ITGAL;LAIR2;FCGR2A;CD3E;KLRB1;TREML4;CD300LB;CD1A;CD40LG;LILRA1;FCGR2B;CRTAM;COL1A1;CD200R1;CD3G;COL1A2;CD226;FCGR3B;CD8A;IRF4
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.3474511000743408,1.3702232413129471,0.13924050632911392,1.0,1.0,7/15,24.05%,CHRDL1;MAB21L2;WT1;ABCB5;MAB21L1;FBN1;EFEMP1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.14885621462542867,-1.3700745390139932,0.06666666666666667,0.379642030164591,0.98,29/37,57.09%,PPBP;LILRB1;CXCL6;TLR4;LBP;CD80;CX3CR1;WNT5A;CXCL10;NUGGC;PDE4B;AXL;LILRB2;LY96;TNFSF4;F2R;CXCL9;NLRP3;CD86;SELP;SERPINE1;CCL2;CD180;MEF2C;PDCD1LG2;IL6;TNIP3;ANKRD1;STAP1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.16756436480339018,-1.3696049366101406,0.08333333333333333,0.3741056322864438,0.98,28/35,57.09%,PPBP;LILRB1;CXCL6;TLR4;LBP;CD80;CX3CR1;WNT5A;CXCL10;NUGGC;PDE4B;AXL;LILRB2;LY96;TNFSF4;CXCL9;NLRP3;CD86;SERPINE1;CCL2;CD180;MEF2C;PDCD1LG2;IL6;FCGR2B;TNIP3;ANKRD1;STAP1
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),0.2732279597387356,1.3673295213665158,0.12048192771084337,1.0,1.0,21/29,51.87%,TCL1A;ADIPOQ;CCL19;SFRP1;CCL14;CCL17;HMHB1;CCL21;CCL13;CCL7;SELE;CRHBP;CCL11;CCL16;ANKRD1;CCL25;HAS2;CCL22;CCL2;ADAMTS12;CCL8
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.26018660675226857,-1.359420776955176,0.09523809523809523,0.3815607985480944,0.99,11/15,36.69%,SOX11;SEMA3G;SEMA5A;SEMA3E;GDNF;KBTBD8;CYP26C1;SEMA3A;SEMA6D;SNAI2;HTR2B
prerank,KEGG_2021_Human__Tight junction,-0.23491494296679447,-1.3516538773628246,0.05555555555555555,0.3861652435214662,0.99,21/25,56.55%,CLDN22;CLDN2;RDX;AMOTL1;TUBA1A;MAPK10;WAS;HCLS1;JAM3;CD1D;PPP2R2B;MYL9;MYH10;CLDN10;DLG2;MPDZ;JAM2;CD1A;CD1E;CLDN11;BVES
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.3008072232822458,1.351648693390505,0.12048192771084337,1.0,1.0,18/23,52.53%,ADIPOQ;SFRP1;CYP1B1;SFRP2;SLIT2;NGFR;FBLN1;IGFBP5;THY1;PODN;DPYSL3;PTPRT;NAV3;TMEFF2;SULF1;ROBO1;RECK;SERPINE1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.2704664020766318,1.3512529763218304,0.1348314606741573,1.0,1.0,17/30,36.99%,CCR8;CCR4;XCR1;IRGM;P2RY12;PTPRC;ANK2;FPR2;SLC8A1;CCR5;AGTR1;CCR7;CCR2;SELE;CXCR6;CCR3;PTGFR
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.21718111205502405,-1.3434626034512747,0.05263157894736842,0.39104853345822843,0.99,8/19,12.98%,RAB41;LAPTM5;AKAP6;ARL11;CLIP3;SCG5;GPIHBP1;COPZ2
prerank,KEGG_2021_Human__Human papillomavirus infection,-0.14444811210123515,-1.3399339445004113,0.07142857142857142,0.3936738397718434,0.99,23/42,32.26%,FOXO1;FASLG;PIK3R1;COL4A1;ITGA5;COL4A5;ITGA1;FZD7;HEYL;COL6A2;LAMB4;FN1;WNT16;ITGA9;WNT5A;TNN;COL4A4;PPP2R2B;ITGB3;AKT3;CCNA1;PDGFRB;ITGA8
prerank,KEGG_2021_Human__Cell adhesion molecules,-0.13641663144703492,-1.3394551230325464,0.25,0.3891787658802178,0.99,58/59,84.13%,CLDN22;PECAM1;CLDN2;HLA-DPB1;HLA-DRA;SPN;HLA-DPA1;SDC2;CD80;ITGA9;CD4;NRXN2;NLGN3;PDCD1;HLA-DQA2;JAM3;NLGN4Y;CD22;NTNG1;SELL;HLA-DOA;ITGA8;VCAM1;HLA-DQA1;CLDN10;CNTNAP1;SIGLEC1;CD8B;ITGAL;CD86;JAM2;CDH2;SELP;CTLA4;NCAM1;CD2;NLGN1;CD40LG;CLDN11;PDCD1LG2;NRXN3;LRRC4C;CD226;NCAM2;CD8A;SELE;TIGIT;ICOS;CNTN1;CNTN2;NRXN1;ITGA4;PTPRC;VCAN;NEGR1;CD28;NLGN4X;CADM3
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.23366329219942175,1.3375496048425206,0.12359550561797752,1.0,1.0,29/46,48.01%,GPR15;IAPP;MC4R;VIP;ADCYAP1;CRHR1;CR1;GLP2R;ADRB3;GCG;COL3A1;HRH2;CCR2;ADCYAP1R1;MC2R;CALCR;GIP;IL10;DRD5;ADCY2;CD3G;SAMSN1;CD163;FCGR2B;HTR7;IL6;ADCY5;GLP1R;MC5R
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3355823965852331,1.3362261849785073,0.10588235294117647,1.0,1.0,10/15,40.31%,CCL19;P2RY12;GPM6A;CCL21;TGFB3;CCR7;PLPPR5;DPYSL3;TENM2;RIPOR2
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.32078438107671203,1.3315042500434093,0.20253164556962025,1.0,1.0,9/18,28.58%,ADIPOQ;GREM1;SFRP1;SH3GL2;PTPRC;SFRP2;SLIT2;FBLN1;THY1
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.2768358273630813,1.3223137957928497,0.14606741573033707,1.0,1.0,28/29,69.89%,ADIPOQ;SFRP1;HAS1;CYP1B1;SFRP2;COL3A1;SLIT2;NGFR;IGFBP5;THY1;PODN;NEXMIF;DPYSL3;PTPRT;NAV3;TMEFF2;SULF1;ROBO1;RECK;SERPINE1;ADORA3;CLIC4;FGF2;DLC1;MITF;GJA1;NODAL;PHLDB2
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.20762541329020534,-1.321450770636447,0.15,0.4137651821862348,0.99,22/23,73.69%,LAPTM5;TNFAIP8L2;SIRPB1;HLA-DPB1;PRKCQ;TBX21;HLA-DPA1;CD4;SIRPG;CCL5;SIT1;CCL2;CD2;CRTAM;LAX1;GPNMB;CD209;TIGIT;CCR2;TNFSF8;THY1;TNFSF18
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.34798423764777225,1.3191978011258885,0.136986301369863,1.0,1.0,15/15,65.36%,GRIA1;CCR2;IFNG;CRHBP;RELN;GRIA2;OPRM1;CAMK2A;NLGN1;MEF2C;NEFL;CCL2;GRIA3;DLG2;GRIN2B
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.1500126650033812,-1.3183671444122738,0.08333333333333333,0.4135181213221141,0.99,39/40,80.75%,KLK12;GZMA;AEBP1;TRABD2B;HTRA1;ECEL1;CPE;PCSK5;CPZ;VASH2;MMP17;PLAT;KLK4;PCSK1;TPSAB1;NAALAD2;TPSB2;ADAM19;RET;MMP7;AZU1;FAP;SRGN;ADAMTS12;HTRA4;MMP19;OLR1;MMP16;PAPPA2;HGF;CTSK;CPXM1;CPXM2;ADAM33;MMP2;CPA3;PCSK2;ADAMTS3;TPSD1
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.2540163685965444,-1.3182133018933393,0.125,0.4077416908199475,0.99,15/15,74.74%,MCF2;ROBO2;NGF;PLXNC1;MAP6;SLITRK1;CDH2;ROBO1;OMG;LRRC4C;PLXNA4;THY1;CHODL;NGFR;SLIT2
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.33092294652472554,1.3146362345855032,0.14102564102564102,1.0,1.0,11/16,44.69%,ADIPOQ;CARTPT;G6PC2;SLC30A8;NEUROD1;GCG;NGFR;KCNB1;RFX6;IL6;LEPR
prerank,KEGG_2021_Human__GABAergic synapse,0.28213645603524373,1.305006698458762,0.15853658536585366,1.0,1.0,17/21,57.54%,GNG8;GABRG2;GABRA1;GABRP;GABRA5;PRKCB;ADCY2;GABRQ;GABRG1;ADCY5;GNAO1;GNG3;PLCL1;GNB4;CACNA1B;GAD2;GNG2
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.27976744566186124,1.3046682303107093,0.15476190476190477,1.0,1.0,13/26,31.53%,DES;ATP1A4;CASQ2;PLN;ABCC9;TRDN;NOS1;ANK2;SLC8A1;ATP1A2;HSPB7;RYR3;CASQ1
prerank,KEGG_2021_Human__Estrogen signaling pathway,-0.2624393203883495,-1.3017720739806862,0.21739130434782608,0.43759474751788197,1.0,18/18,73.93%,PIK3R1;GRM1;KCNJ5;AKT3;KRT40;KRT23;SHC4;KRT39;ESR1;KRT27;BCL2;KRT36;GNAO1;OPRM1;ADCY5;ADCY2;PGR;MMP2
prerank,KEGG_2021_Human__Th17 cell differentiation,-0.23032696085417093,-1.2988690013302735,0.13636363636363635,0.4370130724111629,1.0,17/26,35.09%,IL2RB;IL21;HLA-DPB1;ZAP70;PRKCQ;FOXP3;TBX21;HLA-DRA;MAPK10;HLA-DPA1;CD4;HLA-DQA2;NFATC1;CD3D;HLA-DOA;HLA-DQA1;IL21R
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.33118237646017923,1.2927932631091499,0.15294117647058825,1.0,1.0,12/16,48.76%,ADIPOQ;GREM1;SFRP4;THBS1;SLCO1C1;AGTR1;IFNG;SELE;INHBA;ANGPT1;BVES;GH1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.31654455438302287,1.2915481743196162,0.19318181818181818,1.0,1.0,13/18,48.64%,WT1;SFRP1;LEP;SLIT3;NR4A3;SLIT2;ATP1A2;GATA1;AR;CRHBP;GHR;UCP1;MEF2C
prerank,KEGG_2021_Human__Chagas disease,-0.2038498359500118,-1.2911273137985253,0.1875,0.4451542649727768,1.0,21/22,72.60%,FASLG;PIK3R1;TLR4;C1QB;MAPK10;C1QC;CD3D;CCL5;PPP2R2B;AKT3;TGFB2;IL12B;CD3E;SERPINE1;CCL2;GNAO1;IL6;CD3G;IL10;IFNG;TGFB3
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.2470337639082887,1.2874820437148027,0.18681318681318682,1.0,1.0,24/37,48.01%,GPR15;IAPP;MC4R;VIP;ADCYAP1;CRHR1;GLP2R;ADRB3;GCG;HRH2;ADCYAP1R1;MC2R;CALCR;GIP;IL10;DRD5;ADCY2;CD3G;CD163;HTR7;IL6;ADCY5;GLP1R;MC5R
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.26128828558475664,1.2851439690791688,0.2261904761904762,1.0,1.0,13/26,34.76%,LGI1;WT1;AGTR2;IL2;SFRP1;SLIT3;SFRP2;SLIT2;AGTR1;SPOCK1;PAPPA2;INHBA;MYL2
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.22960266909311497,-1.2839621185014747,0.09523809523809523,0.45567853582474893,1.0,17/17,77.19%,ITGA5;PLPP3;DAB2;FN1;ITGB3;PRKD1;FYB1;PLEK;ADAMTS1;CD40LG;FERMT2;ITGA11;PTN;ITGBL1;THY1;FBLN1;COL3A1
prerank,KEGG_2021_Human__Human cytomegalovirus infection,-0.1966514400739369,-1.271444465322562,0.07692307692307693,0.4729028029844727,1.0,26/27,74.80%,FASLG;PIK3R1;GNGT2;IL10RA;NFATC1;CCL5;ITGB3;AKT3;CCL4;GNG2;PDGFRA;GNB4;CXCR2;CCL2;GNG3;GNAO1;ADCY5;IL6;CCR1;IL1R1;ADCY2;CCR3;CXCL12;PTGER3;PRKCB;CCR5
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.2898753010845026,1.2692727354501039,0.19540229885057472,1.0,1.0,12/22,35.33%,IGF1;FGF10;SFRP1;FGF7;FGF16;LEP;NR4A3;SFRP2;OSR1;IL26;BMP5;GDF5
prerank,KEGG_2021_Human__Systemic lupus erythematosus,-0.1934557095513985,-1.2691240422163323,0.11764705882352941,0.47078039927404725,1.0,17/28,34.70%,H3C13;H3C7;H4C12;H2BC3;C6;HLA-DPB1;H3-5;C1QB;HLA-DRA;HLA-DPA1;C1QC;CD80;HLA-DQA2;HLA-DOA;FCGR3A;HLA-DQA1;GRIN2B
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.3234684750023605,1.2660508836790152,0.21333333333333335,1.0,1.0,9/16,34.28%,OGN;IGF1;VIP;THBS1;NR4A3;CCN4;IGFBP5;IFNG;ELN
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.25795695665353136,-1.2566681353398377,0.18181818181818182,0.4916319223034287,1.0,15/15,74.35%,TSLP;EGR1;TREM2;AIF1;TLR4;WNT5A;LILRB4;TNFSF4;SNAI2;CSF1R;IL33;IL6;ACKR1;IFNG;TLR7
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.2310504897428563,-1.254744225259879,0.12,0.48860980036297647,1.0,16/17,69.16%,TSLP;LILRB1;TLR4;FOXP3;LILRA5;LILRB4;IL12B;TNFSF4;IL13;CLEC7A;CD40LG;PDCD1LG2;IL6;FCGR2B;IRF4;TIGIT
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.21046429460805532,-1.2532919834589167,0.3,0.4853185595567867,1.0,26/32,53.71%,PIK3R1;TREM2;FGFR1;NTRK3;FN1;WNT16;NTF3;ROR1;HCLS1;NTRK1;CCL5;TGFB2;PDGFRB;PPP1R16B;F2R;FGF2;PDGFC;ROR2;TEK;PIK3R5;SELP;PDGFRA;KIT;GH1;OSM;PIK3CG
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.25190527658859496,1.2507287505971627,0.24096385542168675,1.0,1.0,12/26,31.17%,PENK;NPY;GLRA1;SORCS3;ADCYAP1;PPY;SORCS2;GALR1;HCRTR1;GLRA3;NXPH2;AGRP
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.3159679386473234,1.2503549511040835,0.2236842105263158,1.0,1.0,11/15,47.34%,G6PC2;NEUROD1;GCG;FFAR1;IFNG;KCNB1;CRHBP;GIP;RFX6;IL6;GLP1R
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.15294268426009794,-1.2497883030869796,0.16666666666666666,0.4858981309072053,1.0,37/39,77.40%,FGF8;APELA;GATA5;LDB3;NTRK3;PCSK5;FN1;APLNR;HDAC9;GLI2;TGFBR3;TGFB2;DLC1;HTR2B;FOXF1;TEK;PKD2;GPC3;FLRT2;MMP21;HEG1;MIXL1;MEF2C;BVES;PDLIM3;BMP5;MYL2;ALPK2;SGCZ;ZFPM2;OSR1;HAND1;MYOCD;HAND2;SGCG;COL3A1;FBN1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.21062215477996965,-1.2433690573695724,0.2777777777777778,0.4908790543999256,1.0,19/19,79.09%,DUSP26;SIRPG;CCL5;TGFB2;NODAL;NDNF;IL12B;RET;AZU1;NCKAP1L;VIT;ECM2;CXCL12;FBLN2;CCR7;TNFSF18;CCL21;SFRP2;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.10042549933650215,-1.2424688637062862,0.0,0.4870132555307956,1.0,75/79,82.41%,LAPTM5;IL21;TSLP;EGR1;LILRB1;CSF2;HLA-DPB1;IFNL1;AIF1;RFTN1;FCER1G;HHLA2;PRKCQ;TLR4;LBP;HLA-DPA1;CD80;CD4;CD200;LILRA5;WNT5A;SLAMF6;RASGRP1;PDE4B;LILRB2;NR1H4;LILRA2;HAVCR2;NODAL;GBP5;IL12B;TNFSF4;F2R;HTR2B;IL13;NLRP3;LURAP1;CCBE1;IL16;CD86;CSF1R;IL33;SERPINE1;CLEC7A;CD2;SCIMP;LY9;OSM;CD40LG;CRLF2;PIK3CG;SULF1;IL6;IL1R1;CRTAM;CD226;C1QTNF3;ITK;IRF4;IL10;IL26;TIGIT;IFNG;TLR8;CCR2;CCR7;CLEC9A;FCN1;TLR7;CLEC6A;HMHB1;PTPRC;CYP1B1;CD28;IL27
prerank,KEGG_2021_Human__Hepatocellular carcinoma,-0.23415225962996664,-1.241174747552526,0.10714285714285714,0.48225045372050823,1.0,17/17,76.74%,PIK3R1;LEF1;FZD7;WNT16;WNT5A;IGF2;AKT3;TGFB2;SHC4;ACTL6B;GSTM5;WNT2;HGF;PRKCB;TGFB3;GSTT2;WNT9B
prerank,KEGG_2021_Human__Melanoma,0.3172154605431559,1.2375510992643706,0.24358974358974358,1.0,1.0,6/16,17.26%,IGF1;FGF10;FGF7;FGF19;FGF16;FGF5
prerank,KEGG_2021_Human__Leishmaniasis,-0.18519818479269828,-1.2352554929025994,0.23809523809523808,0.4874190585019382,1.0,20/21,74.98%,HLA-DPB1;NCF2;TLR4;HLA-DRA;HLA-DPA1;HLA-DQA2;TGFB2;HLA-DOA;FCGR3A;HLA-DQA1;FCGR2C;IL12B;FCGR2A;CYBB;FCGR3B;IL10;IFNG;PRKCB;TGFB3;ITGA4
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.27931367691197656,1.230739021973333,0.19753086419753085,1.0,1.0,10/21,30.05%,CHRM2;CR1;SLC18A3;IL7R;SH3GL2;TRDN;ANK2;CNTN2;RTP5;SGCZ
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.21222254425678727,-1.2295946382012024,0.3125,0.49278473728475947,1.0,18/19,70.43%,EGR1;NLRP12;TLR4;LILRA5;WNT5A;P2RX7;LILRA2;GBP5;AZU1;NLRP3;CD36;IL16;CLEC7A;MNDA;IL6;PYHIN1;IFNG;TLR8
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.25796508402971996,-1.2271963409062583,0.14285714285714285,0.4922747250344391,1.0,13/15,55.61%,IL21;RFTN1;PRKCQ;TLR4;FOXP3;SLAMF6;NR1H4;IL12B;TNFSF4;NCKAP1L;LY9;OSM;IL6
prerank,KEGG_2021_Human__Yersinia infection,-0.20346586027339447,-1.2242739618459002,0.17647058823529413,0.4933540748422781,1.0,17/24,43.27%,PIK3R1;ITGA5;ZAP70;TLR4;FN1;MAPK10;CD4;WAS;NFATC1;LCP2;AKT3;WIPF1;MEFV;NLRP3;FYB1;CD8B;FCGR2A
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),0.21073286301526142,1.2234649396544466,0.2289156626506024,1.0,1.0,25/38,51.87%,TCL1A;CCL19;SFRP1;CCL14;CCL17;HMHB1;TNFRSF13B;CCL21;TNFRSF17;PSMA8;CCL13;TNFSF18;TNFSF8;CCL7;CRHBP;CCL11;CCL16;ANKRD1;CCL25;HAS2;CD40LG;CCL22;CCL2;ADAMTS12;CCL8
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.18448898965658342,-1.2233747764457918,0.10526315789473684,0.4897320380057649,1.0,18/24,49.91%,SLAMF8;MAPT;TREM2;FGFR1;NTRK3;LDB2;CD4;ROR1;NTRK1;AXL;PDGFRB;RET;ROR2;TEK;CSF1R;PDGFRA;KIT;EPHA6
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.25278731797405507,1.2226922299289276,0.23529411764705882,1.0,1.0,21/30,51.24%,AGTR2;CCR8;CCR4;XCR1;NEUROD1;NOS1;P2RY12;FPR2;CCR5;AGTR1;CCR7;CCR2;SELE;CXCR6;FPR1;CCR3;GUCY1A1;CCR1;BTK;CXCR2;LRRK2
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.14768207026840657,-1.2204551195939901,0.3076923076923077,0.4908158527835226,1.0,24/32,53.92%,ATL1;CTNNA2;NGF;NYAP2;SDC2;NTF3;EPB41L3;TNN;MAP6;NTNG1;DOCK10;CNTNAP1;S100B;SLITRK1;SLITRK5;MAP1B;SLITRK2;NCKAP1L;CNTN4;SLITRK4;LRRK2;NLGN1;MAP1A;SHANK1
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,-0.22110070809778934,-1.2127821495416042,0.13333333333333333,0.5028391430419092,1.0,19/23,54.80%,CFL2;FASLG;PIK3R1;GNGT2;APOBEC3H;AP1S2;TLR4;SAMHD1;MAPK10;CD4;NFATC1;CD3D;AKT3;BCL2;GNG2;CD3E;GNB4;GNG3;GNAO1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.23154839350889705,1.2121818685230792,0.24175824175824176,1.0,1.0,30/36,64.33%,CIDEA;LEP;CD28;PTPRC;CLEC6A;CCN4;CLEC9A;CCR7;CCR2;IFNG;IL26;GPNMB;ACKR1;IL10;ITK;C1QTNF3;CRTAM;FCGR2B;IL6;PIK3CG;MOG;IL33;SRGN;SYT11;LURAP1;HTR2B;SNAI2;TNFSF4;IL12B;TRIL
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.3061097237948123,1.2098736132935743,0.2727272727272727,1.0,1.0,5/16,13.67%,LGI1;IGF1;IL2;SFRP1;SYT4
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.18311054673687546,1.208597044758832,0.25,1.0,1.0,39/82,39.05%,TCL1A;ADIPOQ;IGF1;CCL19;FGF10;FGF7;MUSK;ADCYAP1;FGF19;GDF6;LEFTY2;RSPO1;FGF16;LEP;IRGM;FGF5;NOS1;PTPRC;SFRP2;FPR2;DDR2;CLEC6A;CCL21;GATA1;TGFB3;CCR7;THBS4;IFNG;HGF;TMEM119;CALCR;GPNMB;INHBA;BMP5;GDF5;RASSF2;RELN;ODAM;GHR
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),-0.23643528341921793,-1.2057481785108304,0.19230769230769232,0.5136858604190728,1.0,15/15,76.49%,FGFR1;ZAP70;BLK;NTRK1;PDGFRB;TEK;CSF1R;PDGFRA;KIT;BTK;RELN;FLT3;EPHA3;EFEMP1;DDR2
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.2701744651305029,1.1972141046867724,0.24390243902439024,1.0,1.0,17/23,53.29%,CHRM2;AGTR2;NPY;XCR1;HTR2A;ADRB3;HRH2;MC2R;CNR1;CNR2;CCR1;HTR7;OPRM1;MC5R;CCL2;SSTR4;MTNR1B
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.20279850109824268,-1.1937358202264396,0.36363636363636365,0.536197720181896,1.0,25/31,53.71%,PIK3R1;TREM2;FGFR1;NTRK3;FN1;WNT16;NTF3;ROR1;HCLS1;NTRK1;CCL5;TGFB2;PDGFRB;F2R;FGF2;PDGFC;ROR2;TEK;PIK3R5;SELP;PDGFRA;KIT;GH1;OSM;PIK3CG
prerank,KEGG_2021_Human__Nicotine addiction,0.3017232870592561,1.1916278046869497,0.24390243902439024,1.0,1.0,7/18,18.83%,GRIA1;GABRG2;CHRNA6;SLC17A6;GABRA1;GABRP;GABRA5
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.29970073064742986,1.1911294891591382,0.3026315789473684,1.0,1.0,14/15,65.36%,CCL19;HTR2A;PTPRC;SLC8A1;CCL21;CCR7;RYR3;CACNA2D1;SLC24A2;PKD2;FGF2;HTR2B;F2R;GRIN2B
prerank,KEGG_2021_Human__Hippo signaling pathway,-0.18344981991857934,-1.1889885877096484,0.1875,0.5396612220205688,1.0,27/28,76.74%,CTNNA2;LEF1;FZD7;BMP8A;WNT16;GLI2;BMPR1B;WNT5A;SOX2;PPP2R2B;TGFB2;SNAI2;NKD1;DLG2;CTNNA3;FRMD6;DCHS1;SERPINE1;WNT2;CCN2;RASSF2;GDF5;BMP5;TGFB3;CRB1;FAT4;WNT9B
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.1943164705751955,1.1880560303664547,0.26881720430107525,1.0,1.0,34/58,48.01%,GPR15;ADIPOQ;IAPP;IGF1;MC4R;VIP;ADCYAP1;CRHR1;GLP2R;ADRB3;GCG;PTGIS;FPR2;HRH2;GHSR;ADCYAP1R1;LRFN5;MC2R;CALCR;GIP;IL10;DRD5;C1QTNF3;ADCY2;CD3G;CD200R1;CD163;TNFAIP6;HTR7;IL6;GHRL;ADCY5;GLP1R;MC5R
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.24837871285283766,1.1864803618089124,0.26506024096385544,1.0,1.0,22/28,58.51%,CCL19;IL2;LEP;CD28;PTPRC;CCL21;CCR7;CD1C;IRF4;CD8A;ITK;CD3G;CRTAM;LEPR;PIK3CG;CD2;CLEC7A;KIT;CD3E;CD8B;JAML;TREML2
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.2639289342280021,1.1857093724290666,0.25925925925925924,1.0,1.0,14/21,47.98%,OGN;OMD;KERA;HAS1;VCAN;DCN;LUM;CHSY3;PRELP;ANGPT1;DSEL;CHST9;HAS2;HS3ST2
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.1544023734514102,-1.1855873964019112,0.2857142857142857,0.5392632775572884,1.0,36/38,77.49%,ZIC2;CAMK1D;CAV1;PLPP3;PRKCQ;TLR4;ARID5B;SMO;ROR1;BEX1;CD200;CX3CR1;WNT5A;HCLS1;NTRK1;NODAL;ESR1;PRKD1;NLRP3;CD36;KIT;CLEC7A;BTK;CAMK2A;CD40LG;IL6;WNT2;RELN;IL10;ALK;AR;PRKCB;TNFSF18;MYOCD;DDR2;EPHA5
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,-0.15809917921508887,-1.1848955365136935,0.2,0.535129803519293,1.0,27/32,62.82%,H3C13;H3C7;FOXO1;TSPAN7;IL2RB;CSF2;H3-5;FEV;WNT16;PLAT;CDK14;NTRK1;CCNA1;MITF;FLI1;CEBPE;ERG;GRIA3;PTCRA;CD86;CSF1R;RUNX1T1;MEF2C;IL6;ZEB1;RXRG;MPO
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,0.23255989450024184,1.1839642237646133,0.24719101123595505,1.0,1.0,26/28,71.30%,MYLK;MYH11;AGTR1;PRKCB;KCNMB2;ACTG2;CALD1;ADCY2;IRAG1;PLA2G2A;EDNRA;AVPR1A;GUCY1A1;ADCY5;ACTA2;PLA2G2D;KCNMB1;PRKG1;PLA2G2C;CALCRL;ADRA1D;ADRA1A;MYH10;PLA2G5;GUCY1A2;MYL9
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.2602236349687384,-1.1822429251100708,0.2,0.5350740588958491,1.0,8/15,18.53%,ATL1;ALOX5AP;AQP4;EHD3;SAMHD1;KCNJ12;RNF112;STEAP4
prerank,KEGG_2021_Human__Dopaminergic synapse,-0.18626376919190818,-1.179879690903422,0.21052631578947367,0.5344557284627564,1.0,20/23,63.25%,GNGT2;KCNJ5;KIF5C;MAPK10;CALY;PPP2R2B;AKT3;GRIN2B;GRIA3;GNG2;CACNA1B;GNB4;KIF5A;CAMK2A;GNG3;GNAO1;ADCY5;SLC18A2;GRIA2;DRD5
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.21476182977072217,1.1634140183076138,0.25287356321839083,1.0,1.0,13/33,28.79%,LGI1;PLP1;NRK;MYOC;NPY;ADCYAP1;STMN4;ATCAY;SH3GL2;GPM6A;DCLK1;STMN2;NEFH
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.2524913883387205,1.1620674199478886,0.3048780487804878,1.0,1.0,15/23,47.34%,SFRP1;G6PC2;SLC30A8;NEUROD1;GCG;FFAR1;EPHA5;IFNG;KCNB1;GIP;RFX6;IL6;GHRL;ADCY5;GLP1R
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.28423699827925913,1.1603928884834531,0.323943661971831,1.0,1.0,9/17,34.76%,WT1;OSTN;AGTR2;SFRP1;SLIT3;SFRP2;SLIT2;INHBA;MYL2
prerank,KEGG_2021_Human__Alcoholism,-0.2182076030250817,-1.1591118013311974,0.25,0.5692730919858631,1.0,6/20,6.34%,H3C13;H3C7;H4C12;H2BC3;GNGT2;PKIA
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.21836172482044433,-1.1589060582599162,0.2857142857142857,0.5641712038717484,1.0,15/18,56.16%,TRPC6;GDNF;LILRA5;SCN3B;WNK3;CCL5;CHRNB2;P2RX7;CCL4;LILRA2;F2R;CAMK2A;SCN4B;FHL1;CCR1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.11677863650972267,-1.158370903190986,0.1,0.5589013415158943,1.0,47/51,76.74%,PPBP;LILRB1;FZD7;PID1;CXCL6;TLR4;LBP;CD80;MGARP;CX3CR1;WNT5A;CXCL10;NUGGC;PDE4B;AXL;LILRB2;NR1H4;LY96;TNFSF4;ESR1;RET;CXCL9;NLRP3;CD86;SERPINE1;CCL2;CD180;MEF2C;PDCD1LG2;ADCY5;IL6;UCP1;TNIP3;ANKRD1;STAP1;RORB;ADCY2;WNT2;IL10;CRHBP;PF4V1;AR;EPHA3;ATP1A2;CCR5;BRINP3;WNT9B
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.2410561961307259,1.1559142137996523,0.3176470588235294,1.0,1.0,25/29,65.36%,PIRT;GRIA1;GSG1L;NOS1;ANK2;KCNS2;JPH4;CRHBP;CACNG5;RELN;GRIA2;OPRM1;SHANK1;CAMK2A;NLGN1;MEF2C;NEFL;NETO1;SHISA9;GRIA3;KCNS1;DLG2;KCNE1;SHISA6;GRIN2B
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.06786439526341478,-1.1557751787257446,0.0,0.5599577762139338,1.0,118/130,79.39%,ZIC2;FOXH1;SOX11;FOXO1;PIK3R1;VENTX;MDFIC;RUNX3;LMX1A;EGR1;LEF1;LILRB1;GATA5;FZD7;SOST;HEYL;TAL1;NR2F1;IFNL1;POU3F1;MLLT11;PID1;ASXL3;MAFB;GDNF;LDB2;NPAS4;DAB2;SNAI1;TLR4;CAMK4;FOXP3;TBX21;CD80;CD4;GLI2;WAS;BEX1;BMPR1B;WNT5A;HCLS1;NFATC1;SOX2;CXCL10;IGF2;GAL;NR1H4;CAND2;LMO1;MITF;MLIP;F2R;ESR1;FGF2;HLF;IRX6;FLI1;PRKD1;CEBPE;ERG;RET;CD38;TFEC;FOXF1;NLRP3;PKD2;ZNF423;GLI1;CD86;ACTA2;IL33;SERPINE1;RFPL4A;MIXL1;EBF3;ZEB2;CCN1;MEF2C;TCF4;OSM;FHL5;IL6;TNIP3;RORB;RGMA;MEOX2;EGR2;GLI3;COL1A1;RFPL4AL1;RFX6;RXRG;WNT2;PEG3;BMP5;IRF4;IL10;INHBA;IL26;PGR;TCF21;HGF;PYHIN1;AR;EOMES;ZFPM2;TGFB3;GATA1;OSR1;HAND1;GALR1;MYOCD;HAND2;DCN;SFRP2;NKX6-3;NR4A3;NOS1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.2798344746967888,1.1553987163480317,0.3333333333333333,1.0,1.0,17/20,60.11%,IL1RAPL1;CADM3;HMCN1;FAT4;CRB1;TENM3;SELE;CD209;TENM2;CRTAM;NLGN1;SELP;PTPRD;DCHS1;ITGAL;JAML;CBLN1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.20189756471845358,1.1520966030234654,0.29473684210526313,1.0,1.0,24/48,37.81%,SFRP1;CXCL13;ADAM12;THBS1;FGF16;LEP;KRT1;CYP1B1;PTGIS;PROK2;SFRP2;DCN;PROK1;SMOC2;PRKCB;THBS4;CCR2;HSPB6;ISM1;SPARC;GPNMB;CCR3;THBS2;CNMD
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.07655420753392836,-1.1474703332841434,0.0,0.572234138114356,1.0,85/92,80.93%,SOX11;TDRD9;RUNX3;ITGA1;TREM2;LILRB1;APOBEC3H;NGF;SEMA5A;PTHLH;IFNL1;TENM1;SSTR3;IGFBP7;FOXP3;TNFRSF8;DUSP1;PKHD1;SPN;CRYAB;WNT16;DCSTAMP;SIRPG;PLXNC1;CD200;KANK2;CD33;NTRK1;AICDA;TGFBR3;HOPX;TGFB2;CCL23;GJA1;ATP8A2;ADRA1A;F2R;DLC1;FRZB;HTR2B;FGF2;PRKD1;BCL2;ROR2;ADORA3;ADAM22;PKD2;JAM2;SYT11;DACT3;DSCAM;RERG;SSTR4;CCN5;CCN1;ADAMTS1;OSM;PDPN;OPRM1;FHL1;IL6;FERMT2;FCGR2B;ANGPT1;RIPOR2;CCN2;BMP5;IL10;MYL2;INHBA;GPNMB;ASTL;AR;PODN;PLXNA4;FBLN1;TGFB3;SST;CCN4;SLIT2;MYOCD;SFRP2;NOS1;SLIT3;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.2075157914506428,-1.1313639742162844,0.36363636363636365,0.6067876588021779,1.0,17/18,70.43%,EGR1;NLRP12;TLR4;LILRA5;WNT5A;P2RX7;LILRA2;GBP5;AZU1;NLRP3;CD36;CLEC7A;MNDA;IL6;PYHIN1;IFNG;TLR8
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.14838470825477573,-1.1288302178421459,0.3,0.6078632908662918,1.0,40/41,81.93%,PIK3R1;HLA-DPB1;ZAP70;RFTN1;HHLA2;PRKCQ;BLK;HLA-DRA;HLA-DPA1;CD4;WAS;HLA-DQA2;CD3D;LCP2;PDE4B;CD79B;CD19;HLA-DQA1;BCL2;CD38;FYB1;CD79A;CD3E;NCKAP1L;CTLA4;BTK;MEF2C;MNDA;MOG;IGLL5;CD3G;LAX1;ITK;PRKCB;THY1;PSMA8;MS4A1;PTPRC;THEMIS;CD28
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.24440670773384116,1.1284365088314943,0.32142857142857145,1.0,1.0,18/27,50.12%,IGF1;FGF10;SFRP1;FGF7;PTPRC;SFRP2;CLEC6A;GATA1;THBS4;HGF;RELN;GHR;ANGPT1;SAMSN1;IL6;OSM;GH1;IL22RA2
prerank,KEGG_2021_Human__Dilated cardiomyopathy,0.23397626778485223,1.123841176754303,0.30952380952380953,1.0,1.0,17/27,48.04%,DES;IGF1;PLN;SGCD;LAMA2;MYL3;SGCG;SLC8A1;ITGA4;TGFB3;MYL2;CACNG5;ACTC1;ADCY2;ITGA11;ADCY5;CACNA2D1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.2596752116282305,1.1213140259910188,0.35135135135135137,1.0,1.0,15/21,51.87%,CCL19;CCL14;S100A12;FOLR2;CCL17;CCL21;CCL13;CCL7;CCL11;CCL16;IL6;CCL25;CCL22;CCL2;CCL8
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.20600280621347428,-1.1154035162772291,0.2857142857142857,0.6398313227287286,1.0,17/18,71.27%,ATL1;CTNNA2;SDC2;MAP6;NTNG1;S100B;SLITRK1;SLITRK5;MAP1B;SLITRK2;CNTN4;SLITRK4;MEF2C;MAP1A;PLPPR4;ACTBL2;NEFH
prerank,KEGG_2021_Human__Melanogenesis,-0.2340103061533798,-1.109382193664391,0.36,0.649054675523761,1.0,15/15,76.74%,LEF1;FZD7;WNT16;WNT5A;EDNRB;MITF;KIT;TYRP1;CAMK2A;GNAO1;ADCY5;ADCY2;WNT2;PRKCB;WNT9B
prerank,KEGG_2021_Human__Graft-versus-host disease,-0.22074132993148077,-1.10534257926031,0.35,0.6522406812787939,1.0,11/15,43.42%,FASLG;HLA-DPB1;HLA-DRA;HLA-DPA1;CD80;HLA-DQA2;KIR2DL1;HLA-DOA;HLA-DQA1;KLRD1;CD86
prerank,KEGG_2021_Human__Purine metabolism,-0.2195666248228085,-1.1042153480010928,0.3157894736842105,0.648047705470573,1.0,14/16,61.92%,PDE6B;GUCY1B1;PDE7B;PDE4B;PDE6G;GUCY1A2;ENTPD1;ADA2;ALLC;PDE3A;ADCY5;GUCY1A1;ADCY2;PDE1A
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,0.18536286499453153,1.1041401632375034,0.35555555555555557,1.0,1.0,28/45,51.87%,CCR8;CCR4;CCL19;IL2;CXCL13;CCL14;XCR1;IL2RA;CCL17;CCL21;CCR5;CCL13;CCR7;CCL7;CCR2;PF4V1;CCL11;IL10;CXCL12;CCR3;CCL16;CCR1;IL6;CCL25;CCL22;CCL2;CXCR2;CCL8
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,-0.1643692607686246,-1.1032857916159426,0.5,0.6439338424134506,1.0,28/36,55.61%,PIK3R1;IL2RB;IL21;TSLP;CSF2;IFNL1;IL24;THPO;IL10RA;AKT3;PDGFRB;CSF2RA;IL21R;IL12B;BCL2;IL13;GFAP;CSF2RB;PDGFRA;PRL;IL22RA2;GH1;OSM;IL5RA;CRLF2;FHL1;LEPR;IL6
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.17148886687952014,-1.1012648357062242,0.3125,0.6426208931933443,1.0,14/27,27.22%,PIK3R1;HLA-DPB1;ZAP70;RFTN1;HHLA2;PRKCQ;HLA-DRA;HLA-DPA1;CD4;WAS;HLA-DQA2;CD3D;LCP2;PDE4B
prerank,KEGG_2021_Human__Circadian entrainment,0.22490014111348594,1.1009218832912349,0.3448275862068966,1.0,1.0,20/26,59.35%,GNG8;GRIA1;ADCYAP1;NOS1;PRKCB;RYR3;ADCYAP1R1;ADCY2;GRIA2;GUCY1A1;ADCY5;GNAO1;GNG3;CAMK2A;GNB4;MTNR1B;PRKG1;GNG2;GRIA3;CACNA1G
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.16243686120855844,1.1008339346213774,0.32989690721649484,1.0,1.0,25/71,28.73%,CHRM2;PENK;PLP1;SCN2B;GRIA1;NPY;KCNA1;GABRG2;GLRA1;CHRNA6;HTR2A;GABRA1;GABRP;SLC18A3;NLGN4X;GABRA5;SYT10;HCRTR1;GLRA3;NRXN1;SST;HRH2;CHRNA1;KCND2;CHRNA3
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.2765058433127018,1.0990322301468232,0.3611111111111111,1.0,1.0,8/15,34.76%,WT1;AGTR2;SFRP1;SLIT3;SFRP2;SLIT2;INHBA;MYL2
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.23639169304276655,1.0925879924464932,0.35526315789473684,1.0,1.0,14/27,36.81%,CCL19;CCL14;ATP1A4;HTR2A;TRDN;ANK2;SLC8A1;ATP1A2;CCL13;CCL7;CCR2;CCL11;CXCL12;DRD5
prerank,KEGG_2021_Human__Apelin signaling pathway,0.22951728207183608,1.091970546869827,0.4090909090909091,1.0,1.0,21/28,57.54%,GNG8;MYLK;NOS1;MYL3;SLC8A1;AGTR1;RYR3;MYL2;CCN2;ADCY2;UCP1;ADCY5;GNG3;PIK3CG;MRAS;MEF2C;GNB4;SERPINE1;ACTA2;PIK3R5;GNG2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.196485307286318,-1.0904860623455126,0.22727272727272727,0.6629226322511259,1.0,19/21,67.59%,FGFR1;NTRK3;RASGRP4;NTF3;C5AR1;LPAR1;GPR55;PDGFRB;ADRA1A;HTR2B;ESR1;FGF2;CD86;PDGFRA;KIT;AVPR1A;EDNRA;ITK;SELE
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.1388812933023547,-1.0851034321536612,0.4,0.6687523934797449,1.0,26/31,63.04%,HCRT;SLC8A3;NGF;GRM1;NPAS4;NTF3;NLGN3;CX3CR1;CHRNB2;NLGN4Y;RIMS1;NPTX1;CLSTN2;CACNA1B;CDH2;SYT1;LRRK2;MEF2C;NLGN1;CAMK2A;RIMS2;GRIK3;CPLX2;LRRC4C;RELN;CACNG5
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,-0.1983430840881707,-1.0831088816169667,0.3103448275862069,0.6682131661442007,1.0,12/18,37.15%,PIK3R1;FZD7;FGFR1;SMAD9;WNT16;ID4;BMPR1B;WNT5A;SOX2;AKT3;NODAL;FGF2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.20183715747761133,1.0827901078006472,0.3793103448275862,1.0,1.0,19/38,38.62%,IAPP;MC4R;VIP;ADCYAP1;CRHR1;GPR119;ADRB3;ADGRE3;PTGER3;ADGRD1;MC2R;CNR1;CALCR;ADGRB3;CNR2;UCN3;DRD5;PTGFR;ADCY2
prerank,KEGG_2021_Human__Alzheimer disease,-0.19692712752743477,-1.080221126100895,0.36363636363636365,0.6698320825362567,1.0,11/22,23.08%,PIK3R1;MAPT;CHRM5;FZD7;CASP12;TUBA1A;KIF5C;MAPK10;WNT16;TUBB4A;WNT5A
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.1555789912726017,1.0771359073318363,0.3838383838383838,1.0,1.0,29/84,28.73%,CHRM2;SLC5A7;PENK;PLP1;SCN2B;GRIA1;NPY;KCNA1;GABRG2;GLRA1;CHRNA6;SLC17A6;HTR2A;GABRA1;GABRP;SLC18A3;CHAT;NLGN4X;GABRA5;SYT10;CDH8;HCRTR1;GLRA3;NRXN1;SST;HRH2;CHRNA1;KCND2;CHRNA3
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.17734588521105377,-1.0767644635827458,0.4,0.6723684210526316,1.0,21/21,82.41%,IL21;LILRB1;HLA-DPB1;IFNL1;TLR4;HLA-DPA1;SLAMF6;RASGRP1;PDE4B;IL12B;TNFSF4;CLEC7A;CD2;IL1R1;CRTAM;CD226;TLR8;CCR2;TLR7;HMHB1;IL27
prerank,KEGG_2021_Human__Malaria,0.23158109646287423,1.0672415561409472,0.3855421686746988,1.0,1.0,19/25,57.82%,THBS1;CR1;KLRC4-KLRK1;TGFB3;THBS4;IFNG;HGF;SELE;ACKR1;IL10;THBS2;IL6;CD40LG;CCL2;SELP;KLRB1;COMP;CD36;ITGAL
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.20354706925969535,-1.0668024082471987,0.2727272727272727,0.6901016655156352,1.0,13/19,41.28%,IL21;LILRB1;APOBEC3H;IFNL1;SAMHD1;SLFN11;RSAD2;CXCL10;AICDA;IFI44L;BCL2;AZU1;RNASE6
prerank,KEGG_2021_Human__Autoimmune thyroid disease,-0.20199664167173575,-1.0665660996276227,0.42857142857142855,0.6847454389148917,1.0,12/15,52.69%,FASLG;HLA-DPB1;HLA-DRA;HLA-DPA1;CD80;HLA-DQA2;TSHR;HLA-DOA;HLA-DQA1;CD86;CTLA4;CD40LG
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.16555240691715048,-1.0640412391340266,0.375,0.6854730529472105,1.0,13/18,47.80%,AHSG;IL2RB;TREM2;SIRPB1;CAMK1D;FCER1G;SIRPG;PLA2G5;AZU1;DOCK2;SYT11;TUB;CLEC7A
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,-0.138978089494121,-1.062390759239771,0.5,0.6848175730646474,1.0,30/32,76.58%,H3C13;H3C7;H4C12;H2BC3;PIK3R1;AQP9;NCF2;H3-5;TLR4;HDAC9;SIGLEC9;C5AR1;ITGB3;AKT3;FCGR3A;AZU1;ITGAL;FCGR2A;SELP;CLEC7A;CYBB;MPO;FCGR3B;FPR1;FPR3;TLR8;PRKCB;TLR7;PADI4;FPR2
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.19327916317751886,-1.0558817000971346,0.3,0.6943645586113825,1.0,17/19,66.45%,SIK1;MEX3B;FGFR1;CAMK4;WNK3;NTRK1;PDGFRB;PRKD1;TEK;CSF1R;PDGFRA;KIT;LRRK2;CAMK2A;ITK;ALK;FLT3
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.19223224829704044,-1.054781105042499,0.3,0.6893783260020303,1.0,19/20,73.69%,CAV1;PRKCQ;TLR4;ROR1;CX3CR1;WNT5A;NTRK1;PRKD1;NLRP3;CD36;CLEC7A;BTK;CAMK2A;CD40LG;IL6;ALK;AR;PRKCB;TNFSF18
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.13715330691862238,-1.0529068843435259,0.2857142857142857,0.6860345590141682,1.0,33/33,86.45%,FAM107A;IL2RB;WASF1;AIF1;RHOH;LIN7A;PARVG;WAS;NLGN3;WNT5A;NLGN4Y;RHOJ;RIMS1;WIPF1;MITF;GPM6B;FLNC;CD3E;NCKAP1L;CFAP206;NLGN1;HAS2;SHANK1;FERMT2;CD3G;CALD1;DPYSL3;NEFH;DCX;JCHAIN;NLGN4X;HAS1;LRRTM3
prerank,KEGG_2021_Human__Chemokine signaling pathway,0.16786477352101847,1.051726139420107,0.45652173913043476,1.0,1.0,33/54,51.87%,CCR8;CCR4;CCL19;GNG8;CXCL13;CCL14;XCR1;CCL17;CCL21;CCR5;CCL13;CCR7;PRKCB;CCL7;CCR2;PF4V1;CXCR6;CCL11;ITK;CXCL12;CCR3;ADCY2;CCL16;CCR1;ADCY5;CCL25;GNG3;PIK3CG;CCL22;CCL2;CXCR2;GNB4;CCL8
prerank,KEGG_2021_Human__MAPK signaling pathway,-0.11301401369848292,-1.0468358850124635,0.2857142857142857,0.6957743496672717,1.0,34/48,52.02%,FGF8;FASLG;MAPT;FGFR1;NGF;RASGRP4;DUSP1;CACNA1I;RASGRP2;MAPK10;NTF3;NFATC1;IGF2;RASGRP1;CACNB4;NTRK1;CACNA2D3;AKT3;TGFB2;PDGFRB;RASGRF2;FGF2;PDGFC;TEK;CACNA1G;CACNA1B;PTPN5;CSF1R;FLNC;PDGFRA;KIT;MEF2C;MRAS;CACNA2D1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.1816583959948586,-1.045931247379895,0.42857142857142855,0.6922140060896042,1.0,12/21,30.08%,PDZK1;EFR3B;CAV1;RDX;EHD3;LIN7A;P2RY1;EPB41L3;MYO5A;SCN3B;WNK3;RAB3C
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.2520515043143655,1.0456751189394367,0.4177215189873418,1.0,1.0,11/16,50.00%,CRYGD;EYA4;RD3;COL11A1;EFEMP1;TULP2;COL1A1;PRPH2;RPE65;CNGB1;CRYBB1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.2520515043143655,1.0456751189394367,0.4177215189873418,1.0,1.0,11/16,50.00%,CRYGD;EYA4;RD3;COL11A1;EFEMP1;TULP2;COL1A1;PRPH2;RPE65;CNGB1;CRYBB1
prerank,KEGG_2021_Human__Axon guidance,-0.13889687577318596,-1.0429188980479969,0.6666666666666666,0.6960965160215405,1.0,19/36,30.36%,SEMA3G;CFL2;PIK3R1;ROBO2;TRPC6;SEMA5A;TRPC4;SEMA3E;UNC5C;SMO;SEMA3A;PLXNC1;BMPR1B;WNT5A;SEMA6D;TRPC1;NTN3;MYL9;NTNG1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.23393520609069668,1.042559892702008,0.45454545454545453,1.0,1.0,13/20,49.16%,CCL19;FGF19;GDF6;LEP;HAND2;CCL21;CCR7;IL26;RASSF2;CCN2;FCGR2B;SLAMF1;SCIMP
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.11092530690208952,-1.0424015876146608,0.375,0.6919451699054195,1.0,46/50,76.49%,PEAK3;SIK1;MEX3B;RUNX3;FGFR1;CAMK1D;FAM20A;ZAP70;PCK1;PRKCQ;BLK;TLR4;CAMK4;NUAK1;MAPK10;CDK14;BMPR1B;WNK3;NTRK1;AKT3;TGFBR3;TGFB2;PDGFRB;PRKD1;ERG;RET;TEK;PRKG1;CSF1R;PDGFRA;KIT;LRRK2;BTK;CCL2;CAMK2A;RELN;ALK;CCL11;FLT3;PRKCB;DCLK1;CDK15;TLR7;EPHA3;EFEMP1;DDR2
prerank,KEGG_2021_Human__Phagosome,-0.12867855116565674,-1.0423355803974574,0.38461538461538464,0.6863649669223113,1.0,30/34,70.97%,ITGA5;HLA-DPB1;NCF2;TLR4;MRC2;HLA-DRA;TUBA1A;HLA-DPA1;TUBB4A;HLA-DQA2;ITGB3;HLA-DOA;FCGR3A;HLA-DQA1;FCGR2C;CD36;FCGR2A;COMP;CLEC7A;C1R;CYBB;MSR1;FCGR2B;MPO;THBS2;OLR1;FCGR3B;MRC1;CD209;THBS4
prerank,KEGG_2021_Human__Proteoglycans in cancer,-0.13541392962275495,-1.040106205358205,0.38461538461538464,0.6859615245009074,1.0,37/39,78.73%,FASLG;PIK3R1;ITGA5;FZD7;FGFR1;CAV1;RDX;TLR4;FN1;SDC2;WNT16;SMO;WNT5A;HCLS1;IGF2;ITGB3;AKT3;TGFB2;IL12B;ESR1;FGF2;TWIST2;GPC3;FLNC;MRAS;CAMK2A;TIMP3;COL1A1;COL1A2;WNT2;LUM;HGF;PRKCB;MMP2;DCN;WNT9B;ANK2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.19216757741347906,-1.038794596382756,0.4,0.6824100481087777,1.0,20/20,80.93%,FZD7;SEMA5A;PTPRO;DUSP1;SPN;PLXNC1;JAM3;SNAI2;CORO2B;ADAM22;DSCAM;SERPINE1;ANGPT1;RIPOR2;NEXMIF;SPOCK1;PLXNA4;FBLN1;PTPRC;CYP1B1
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.18920557913887204,-1.038465842086212,0.391304347826087,0.6778713005701873,1.0,16/16,81.20%,FOXO1;PCK1;TLR4;LBP;LY96;F2R;ESR1;CD36;SELP;GH1;RXRG;CSN1S1;SELE;WNT9B;NOS1;FFAR1
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,0.20878819013811103,1.036526423641621,0.42045454545454547,1.0,1.0,27/29,74.17%,SCN7A;AGTR2;ATP1A4;PLN;MYL3;SLC8A1;ATP1A2;AGTR1;MYL2;CACNG5;ACTC1;ADCY2;ADCY5;SCN4B;PIK3CG;CAMK2A;CACNA2D1;PIK3R5;BCL2;ADRA1D;KCNE1;ADRA1A;ADRB2;AKT3;CACNA2D3;PPP2R2B;CACNB4
prerank,KEGG_2021_Human__Relaxin signaling pathway,-0.15885809311731292,-1.0347402223495918,0.4666666666666667,0.6825119101633395,1.0,22/26,63.94%,RXFP4;PIK3R1;COL4A1;COL4A5;GNGT2;MAPK10;MMP13;COL4A4;EDNRB;AKT3;SHC4;GNG2;ACTA2;GNB4;GNG3;GNAO1;ADCY5;COL4A6;COL1A1;ADCY2;COL1A2;RXFP3
prerank,KEGG_2021_Human__Platelet activation,-0.18429658343573863,-1.0332798730974244,0.4166666666666667,0.6811238199749574,1.0,23/27,61.95%,APBB1IP;PIK3R1;GUCY1B1;FCER1G;PTGS1;RASGRP2;P2RY1;LCP2;RASGRP1;ITGB3;AKT3;GUCY1A2;F2R;PRKG1;FCGR2A;PIK3R5;BTK;PIK3CG;ADCY5;GUCY1A1;COL1A1;ADCY2;COL1A2
prerank,KEGG_2021_Human__FoxO signaling pathway,-0.19324903010599456,-1.0325939425042023,0.32,0.6781264833170461,1.0,10/16,32.11%,FOXO1;FASLG;PIK3R1;GRM1;PCK1;MAPK10;SLC2A4;AKT3;TGFB2;S1PR1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.2591978040627865,1.0324672491218223,0.4342105263157895,1.0,1.0,14/16,64.21%,IL2;PTPRC;GPR183;FCRL3;IGLL5;IL6;MEF2C;BTK;NCKAP1L;SASH3;CD27;CD38;BCL2;TNFSF4
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,0.210675142180326,1.0313134239099828,0.36363636363636365,1.0,1.0,21/29,57.91%,GNG8;GRIA1;GABRG2;SLC17A6;GABRA1;GABRP;GABRA5;PRKCB;CNR1;ADCY2;GRIA2;GABRQ;GABRG1;ADCY5;GNAO1;GNG3;SLC17A7;GNB4;CACNA1B;GNG2;GRIA3
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.19452173026004543,-1.0307009814782313,0.45454545454545453,0.6763885232956041,1.0,17/19,66.63%,SOX11;LILRB1;BLK;FOXP3;SPN;CD80;LILRB4;LILRB2;CD86;PLA2G2D;CTLA4;VSIG4;MNDA;PDCD1LG2;FCGR2B;IL10;GPNMB
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.27547483998751493,1.02942035034581,0.4383561643835616,1.0,1.0,8/16,32.29%,SCN7A;KCNA1;KCNA2;CHRNA1;KCND2;KCNB1;KCNMB2;KCNE4
prerank,KEGG_2021_Human__Serotonergic synapse,-0.17154123790488487,-1.0288221159442295,0.47058823529411764,0.6752791068580543,1.0,17/21,58.18%,GNGT2;KCNJ5;PTGS1;DUSP1;TRPC1;HTR1F;HTR2B;SLC6A4;GNG2;CACNA1B;GNB4;TPH2;GNG3;GNAO1;ADCY5;HTR7;SLC18A2
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.2458320703243407,-1.0265224004809683,0.391304347826087,0.674983283981278,1.0,15/15,75.56%,SOX11;KL;BMPR1B;WNT5A;TGFB2;P2RX7;FBN2;GPM6B;CCN1;MEF2C;PTN;TMEM119;TGFB3;OSR1;SLC8A1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.2758530844252418,1.0263275605222395,0.4189189189189189,1.0,1.0,12/15,56.00%,ATP1A2;NRXN1;CCR2;CACNG5;RELN;GRIK3;NLGN1;MEF2C;CCL2;LRRK2;SYT1;CDH2
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.11114398179029597,-1.0250436588798975,0.6,0.6735054311022023,1.0,14/37,19.89%,AHSG;SERPINA10;ASB9;MXRA8;ENAM;ASB11;SPSB1;IGFBP7;KLHL13;FBXL22;KBTBD8;FN1;CHGB;SDC2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.21802881966633014,1.019810311000269,0.43037974683544306,1.0,1.0,13/26,36.81%,CCL19;CCL14;SLC30A8;HTR2A;TRDN;ANK2;SLC8A1;CCL13;CCL7;CCR2;CCL11;CXCL12;DRD5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.1848387099145788,-1.018095906868779,0.34782608695652173,0.6850036969819184,1.0,18/19,74.35%,TSLP;AIF1;TLR4;LBP;LILRA5;WNT5A;LILRB2;LILRA2;TNFSF4;F2R;IL16;IL33;CLEC7A;SCIMP;IL6;IFNG;TLR8;TLR7
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.1690675246183108,1.013723370612646,0.4948453608247423,1.0,1.0,48/57,70.70%,CDH19;MYOT;SLITRK3;IL1RAPL1;UNC5D;CADM3;HMCN1;NEXN;CDH8;FAT4;CRB1;CNTN2;CDH11;LRFN5;TENM3;SELE;CD209;TENM2;LRRC4C;PTPRT;CDH18;CRTAM;CDH10;CLDN11;ROBO1;NLGN1;PALLD;DSCAM;SELP;CNTN4;PTPRD;SLITRK2;DCHS1;CDH2;CD84;CNTN6;ITGAL;JAML;CBLN1;SLITRK1;PCDHB3;CLDN10;VCAM1;SELL;NTNG1;TGFB2;GPC6;TENM4
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.13996934835127706,1.0134897761563288,0.44329896907216493,1.0,1.0,67/107,56.28%,CTSG;CMA1;GREM1;KLK5;ADAMTS16;COL8A1;COL10A1;ADAMTS8;COL19A1;ADAM12;THBS1;DPT;COL14A1;MFAP5;HAS1;LAMA2;VCAN;COL24A1;CYP1B1;ADAMTS3;MATN3;FBN1;COL11A1;COL3A1;DCN;DDR2;ITGA4;SMOC2;MMP2;COL6A3;TNC;LOX;CTSK;SPARC;LUM;COL5A2;ELN;TLL1;MMP16;FBLN5;COL21A1;ECM2;ITGAD;COL1A2;TNR;COL1A1;ADAMTSL3;COL4A6;MMP19;ITGA11;ADAMTSL1;P4HA3;COL5A1;HAS2;ADAMTS1;COL8A2;COL12A1;ADAMTS18;VIT;ADAMTS12;RECK;SERPINE1;MMP21;COL15A1;FLRT2;COMP;JAM2
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.1735946192079532,-1.0084338073112882,0.5454545454545454,0.7008140279705348,1.0,13/18,46.05%,MCF2;ARHGAP9;ARHGAP30;STARD8;RHOH;ARHGEF26;ARHGAP31;RHOJ;RASGRF2;DLC1;ARHGAP15;ARHGAP28;ARHGEF6
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.23940858670252174,1.007962473713364,0.5,1.0,1.0,15/19,59.44%,THBS1;DCN;THBS4;CCR2;ISM1;SPARC;THBS2;CNMD;GHRL;SULF1;ADAMTS1;SERPINE1;PRL;SERPINF1;TEK
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.18548702645508164,1.0079301911888887,0.45161290322580644,1.0,1.0,18/38,37.78%,DES;MYOT;GLRA1;CASQ2;MYLK;MYH2;TRDN;NOS1;MYH11;MYL3;SLC8A1;TNNT3;ACTG2;ACTN3;CALD1;MYL2;LMOD1;ACTC1
prerank,KEGG_2021_Human__Toxoplasmosis,-0.15749467923380966,-1.0079072474816497,0.38095238095238093,0.6976327049690675,1.0,25/25,84.40%,HLA-DPB1;LAMB4;TLR4;HLA-DRA;MAPK10;HLA-DPA1;HLA-DQA2;IL10RA;AKT3;TGFB2;HLA-DOA;LY96;HLA-DQA1;IL12B;BCL2;PIK3R5;CD40LG;PIK3CG;GNAO1;IL10;IFNG;TGFB3;CCR5;LAMA2;IRGM
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.1953280580984984,1.0062454029500962,0.4777777777777778,1.0,1.0,16/33,38.05%,PHOX2B;IL1RAPL1;PHOX2A;NLGN4X;NEUROD1;MYT1L;EPHA5;WNT9B;HAND2;SPOCK1;BHLHE22;TENM3;INHBA;ALK;TENM2;WNT2
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.1632754449680403,-1.0044304458507793,0.45454545454545453,0.7014098214050869,1.0,25/26,77.40%,APELA;LDB3;NTRK3;PCSK5;FN1;APLNR;HDAC9;GLI2;TGFB2;FOXF1;TEK;PKD2;HEG1;MIXL1;MEF2C;BVES;PDLIM3;MYL2;TCF21;ZFPM2;OSR1;HAND1;HAND2;COL3A1;FBN1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.1527951088452329,1.0016878894417722,0.5108695652173914,1.0,1.0,49/66,64.63%,IAPP;CCR8;CCR4;GPR174;CXCL13;ADCYAP1;XCR1;P2RY10;FFAR1;TAC1;PROK2;P2RX2;FPR2;SLC8A1;CCR5;AGTR1;CCR7;CCR2;PTGER3;FPR3;JPH4;CALCR;CXCR6;FPR1;CCR3;PTGFR;EDNRA;F2RL2;CCR1;GHRL;ADCY5;LPAR4;GLP1R;CACNA2D1;GPR33;CMKLR1;CXCR2;C3AR1;PDGFRA;TACR1;CD36;CYSLTR1;TRPC3;P2RX5;ADRA1D;ESR1;F2R;ADRA1A;S1PR3
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.071762886179283,-1.0,1.0,0.7060857303268093,1.0,175/194,78.76%,FEZF1;NKX6-2;ZIC2;FOXH1;SOX11;FOXO1;FASLG;PIK3R1;VENTX;RUNX3;LMX1A;EGR1;LEF1;ZNF667;LILRB1;AEBP1;ZNF471;GATA5;SP140;BACH2;ZNF677;MKX;CAV1;HEYL;ZNF418;TAL1;IKZF3;NR2F1;POU3F1;ZNF660;ZIK1;PID1;ASXL3;MAFB;GDNF;LDB2;NPAS4;DAB2;SNAI1;DUSP26;TLR4;NKX3-2;KLF8;FOXP3;TBX21;ZFP92;ARID5B;FEV;SMAD9;ZFP82;ID4;HDAC9;GLI2;WAS;BEX1;KLF12;KANK2;BMPR1B;WNT5A;HCLS1;NFATC1;SOX2;CXCL10;IGF2;ZNF382;ISX;TSHZ2;GAL;EDNRB;NR1H4;HOPX;TSHZ3;LMO1;PARP15;FOXP2;PKNOX2;MITF;PRDM6;ZFP42;MAFA;MLIP;ZIM2;ZNF354C;SNAI2;HSF5;ZNF135;ESR1;FGF2;HLF;IRX6;FLI1;TWIST2;PRKD1;ZBED2;CEBPE;ERG;ZNF154;NKX2-3;TFEC;FOXF1;MEOX1;NLRP3;PURG;PKD2;DMRT3;GLI1;ZNF366;ACTL6B;CSF1R;KIT;ZNF835;IL33;ZNF454;ZNF518B;SERPINE1;MIXL1;DACT1;EBF3;ZEB2;CCN1;MEF2C;TCF4;OSM;FHL5;IL6;IKZF1;TNIP3;ANKRD1;RORB;RGMA;FOXI2;MEOX2;EGR2;GLI3;ZEB1;RFX6;RXRG;WNT2;PEG3;ZNF99;TENM2;BMP5;IRF4;INHBA;DBX2;IL26;PGR;PRRX1;TCF21;HGF;BHLHE22;AR;ZNF208;FOSB;EOMES;IFNG;PRKCB;ZNF521;ZFPM2;ZFHX4;TGFB3;GATA1;DACH2;OSR1;HAND1;GALR1;MYOCD;HAND2;DCN;SUPT20HL2;EBF2;SFRP2;MYT1L;NKX6-3;NR4A3
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.24448875820616908,0.9997111346851193,0.4177215189873418,1.0,1.0,9/18,35.33%,PHOX2B;SFRP1;GDF6;LEFTY2;VSTM2A;TMEM100;TGFB3;BMP5;GDF5
prerank,KEGG_2021_Human__Morphine addiction,0.20683794943702466,0.998564504200947,0.43023255813953487,1.0,1.0,18/25,57.54%,GNG8;GABRG2;GABRA1;GABRP;GABRA5;PRKCB;PDE1A;ADCY2;GABRQ;GABRG1;ADCY5;OPRM1;GNAO1;GNG3;PDE3A;GNB4;CACNA1B;GNG2
prerank,KEGG_2021_Human__MicroRNAs in cancer,-0.15519343209492975,-0.9969754035790704,0.4444444444444444,0.7099377754731657,1.0,20/22,72.39%,PIK3R1;ITGA5;ABCB1;RDX;TNN;ITGB3;TGFB2;PDGFRB;SHC4;BCL2;PDGFRA;RECK;ZEB2;TIMP3;ZEB1;TNR;MMP16;PRKCB;TNC;ZFPM2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.14563556959176424,-0.9964665894770459,0.5,0.7056544516095815,1.0,29/31,76.80%,LAPTM5;IL21;LILRB1;HLA-DPB1;IFNL1;TLR4;FOXP3;HLA-DPA1;SLAMF6;RASGRP1;PDE4B;LILRB4;AXL;NR1H4;HAVCR2;IL12B;TNFSF4;CLEC7A;CD2;PDCD1LG2;IL1R1;CRTAM;CD226;INHBA;TLR8;CCR2;CCR7;TLR7;HMHB1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.10117243184120996,-0.9959103483986169,0.5,0.70180465734516,1.0,106/119,74.95%,H3C13;FOXO1;FASLG;PIK3R1;IL2RB;IL21;TSLP;EGR1;PPBP;CSF2;HLA-DPB1;CD300LF;IFNL1;XCL2;IL24;FCER1G;CXCL6;FN1;TNFRSF8;SAMHD1;LBP;HLA-DRA;HLA-DPA1;CD80;CD4;RSAD2;HLA-DQA2;TNFRSF9;IL10RA;EDARADD;SOX2;CXCL10;CCL18;NDN;CCL5;LILRB4;LTA;LILRB2;CCL4;CCL23;S1PR1;VCAM1;CSF2RA;HLA-DQA1;IL21R;IL12B;TNFSF4;IL1RL1;FGF2;RHEX;BCL2;CXCL9;IL13;CD27;CD36;IL16;CD86;CSF2RB;CSF1R;KIT;IL33;CCL8;CXCR2;NCAM1;CCL2;IL22RA2;CCL22;CAMK2A;OSM;CD40LG;SLA;IL5RA;CRLF2;CCL25;OPRM1;LEPR;IL6;CCR1;IL1R1;ZEB1;CCL16;FCER2;GHR;COL1A2;CXCL12;FPR1;SERPINB2;IRF4;IL10;CCL11;FLT3;IL26;HGF;PF4V1;IFNG;CCR2;CCL7;TNFSF8;CNTFR;TNFSF18;MMP2;CCL13;PSMA8;TNFRSF17;CCR5;CCL21
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.17433734112966087,0.9957057099221428,0.43333333333333335,1.0,1.0,20/48,33.61%,IAPP;CCL19;FGF10;MYOC;FGF7;FGF19;THBS1;TRAT1;FGF16;LEP;FGF5;CD28;P2RY12;CCL21;CCR7;ICOS;HGF;CALCR;IL26;FLT3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.21938724816329436,-0.992341934084926,0.375,0.7035675757998807,1.0,14/15,69.13%,IL21;KLRK1;HLA-DRA;SLAMF6;CD1D;RASGRP1;IL12B;KLRD1;CD1A;CD1E;STAP1;CRTAM;CD226;CD1C
prerank,KEGG_2021_Human__ECM-receptor interaction,0.18094701756926468,0.9920363365592798,0.45555555555555555,1.0,1.0,18/34,43.09%,COL6A6;THBS1;GP5;LAMA2;COL6A5;ITGA4;FREM1;COL6A3;TNC;THBS4;SV2C;THBS2;RELN;COL1A2;TNR;COL1A1;COL4A6;ITGA11
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.13516080576193593,-0.987903301287167,0.5833333333333334,0.7117463198225449,1.0,19/32,37.05%,NKX6-2;SOX11;RUNX3;FZD7;MAFB;RHOH;PRKCQ;FOXP3;TBX21;ZNF626;ELAVL2;HCLS1;SOX2;IGF2;MITF;MAFA;ZIM2;SNAI2;ESR1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.16006758466404344,-0.987623421153444,0.4666666666666667,0.7079341635897114,1.0,17/27,38.02%,FASLG;TREM2;NLRP12;RHOH;CD4;ROR1;TNFRSF19;WNT5A;LPAR1;LILRB4;NR1H4;GJA1;F2R;HTR2B;ESR1;S100B;PRKD1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.19605022953659712,-0.9838571395109349,0.47058823529411764,0.7107078039927405,1.0,16/21,48.61%,TREM2;NLRP12;CAV1;RHOH;APLNR;DUSP1;PKHD1;LILRB4;NR1H4;CD22;P2RX7;ESR1;BCL2;NLRP3;PDE3A;PLEK
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,0.2072224805125712,0.9823530522825527,0.5189873417721519,1.0,1.0,15/25,48.04%,DES;IGF1;SGCD;LAMA2;MYL3;SGCG;SLC8A1;ITGA4;TGFB3;MYL2;CACNG5;ACTC1;ITGA11;IL6;CACNA2D1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.21914694856422492,0.9820359439798406,0.46987951807228917,1.0,1.0,7/22,21.06%,PHOX2B;FGF10;SFRP1;THBS1;LEP;SPATA22;PTPRC
prerank,KEGG_2021_Human__Pathways of neurodegeneration,-0.13564635492706958,-0.9815344988986828,0.42857142857142855,0.7111004111263379,1.0,37/38,82.53%,FASLG;MAPT;CHRM5;FZD7;GRM1;CASP12;TUBA1A;KIF5C;MAPK10;UCHL1;WNT16;RAB39B;TUBB4A;DNAH8;WNT5A;NEFM;GRIN2B;BCL2;TRPC3;GRIA3;CACNA1B;LRRK2;KIF5A;CYBB;NEFL;CAMK2A;IL6;GRIA2;WNT2;RYR3;PRKCB;NEFH;PSMA8;WNT9B;NOS1;PRPH;DKK2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.2508550836714514,0.9809904069841549,0.5063291139240507,1.0,1.0,4/15,14.09%,CILP;CIDEA;GREM1;ASPN
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.15295576576167758,0.980326598612544,0.4835164835164835,1.0,1.0,45/61,64.63%,IAPP;CCR8;CCR4;CXCL13;ADCYAP1;XCR1;PLN;FFAR1;TAC1;PROK2;FPR2;SLC8A1;HCRTR1;CCR5;ATP1A2;SCGN;AGTR1;CCR7;CCR2;PTGER3;FPR3;CALCR;CXCR6;FPR1;CCR3;PTGFR;EDNRA;CCR1;GHRL;ADCY5;GLP1R;GPR33;CMKLR1;CXCR2;C3AR1;PDGFRA;TACR1;CD36;CYSLTR1;TRPC3;ADRA1D;ESR1;F2R;ADRA1A;S1PR3
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.18369728013940256,0.9788085291833833,0.4588235294117647,1.0,1.0,22/34,53.86%,ADIPOQ;GREM1;SFRP1;TCF23;SFRP2;RANBP3L;EFEMP1;MYOCD;OSR1;ZFPM2;IFNG;COL5A2;BMP5;GDF5;RORB;FERMT2;IL6;COL5A1;MIXL1;ADAMTS12;RUNX1T1;CNTN4
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.2192216615740444,0.9780393527434388,0.4810126582278481,1.0,1.0,16/20,62.40%,KCNA1;GLRA1;SYT4;SYT10;RYR3;CRHBP;SYT6;ACER1;NLGN1;MEF2C;LRRK2;SYT1;SYT11;PKD2;CLIC4;DLG2
prerank,KEGG_2021_Human__Ras signaling pathway,-0.09572951531654338,-0.9769220071687107,0.5,0.7138151763378624,1.0,36/47,59.17%,FGF8;FASLG;PIK3R1;GNGT2;FGFR1;NGF;ZAP70;RASGRP4;RASGRP2;MAPK10;NTF3;RGL1;IGF2;RASGRP1;NTRK1;AKT3;PDGFRB;PLA2G5;RASGRF2;SHC4;GRIN2B;FGF2;PDGFC;PLA2G2C;TEK;GNG2;PLA2G2D;CSF1R;PDGFRA;KIT;GNB4;MRAS;GNG3;HTR7;PLA2G2A;ANGPT1
prerank,KEGG_2021_Human__cAMP signaling pathway,0.1758761601989449,0.9748553544734139,0.4842105263157895,1.0,1.0,27/46,49.31%,CHRM2;VIP;GRIA1;NPY;ATP1A4;ADCYAP1;PLN;GPR119;GCG;ATP1A2;SST;GHSR;CNGA3;ADCYAP1R1;PTGER3;MC2R;GIP;DRD5;ADCY2;GRIA2;GLI3;EDNRA;GHRL;ADCY5;GLP1R;CAMK2A;CNGB1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.18860955147910569,-0.9747977767480792,0.5,0.7129368201805137,1.0,16/17,73.51%,SOX11;CRYAB;WNT16;SLFN11;CCL5;HTR2B;FGF2;PRKD1;CD36;CCN5;LRRK2;CCN1;FERMT2;CCN2;CALCR;CCN4
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.13942434848062457,0.9727251481617707,0.4897959183673469,1.0,1.0,78/90,75.98%,IAPP;IGF1;CCL19;FGF10;CCL14;ADCYAP1;FGF19;S100A12;HTR2A;LEP;ADRB3;PTPRC;GPR183;CCL17;FPR2;HAND2;CCL21;CCL13;CCR7;CCL7;CALCR;IL26;GPNMB;FLT3;CCL11;CCN2;FCRL3;CCL16;ANGPT1;PLA2G2A;TNFAIP8L3;FERMT2;CCR1;IL6;OPRM1;CCL25;PIK3CG;OSM;ROBO1;SLAMF1;GH1;SCIMP;CCL22;CCL2;LRRK2;CCL8;KIT;PDGFRA;PIK3R5;CSF1R;CD36;TEK;ROR2;RET;PDGFC;ADRA1D;FGF2;HTR2B;F2R;ADRA1A;BMPER;GLIPR2;NODAL;CCL23;CCL4;PLA2G5;PDGFRB;ADRB2;TGFB2;GPR55;LPAR1;CCL5;NTRK1;RASGRP1;C5AR1;IGF2;CCL18;SOX2
prerank,KEGG_2021_Human__Salivary secretion,0.22086767061893198,0.9721797121466087,0.524390243902439,1.0,1.0,17/19,70.10%,ATP1A4;ADRB3;NOS1;CST5;ATP1A2;PRKCB;RYR3;CST2;ADCY2;GUCY1A1;ADCY5;PRKG1;CD38;ADRA1D;ADRA1A;GUCY1A2;ADRB2
prerank,KEGG_2021_Human__Glutamatergic synapse,0.2234496276037481,0.9688277049604721,0.4642857142857143,1.0,1.0,15/20,57.91%,GNG8;GRIA1;SLC17A6;PRKCB;ADCY2;GRIA2;GRIK3;ADCY5;GNAO1;GNG3;SHANK1;SLC17A7;GNB4;GNG2;GRIA3
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.2243790920117925,0.9683146236283473,0.5128205128205128,1.0,1.0,13/20,49.09%,IGF1;GREM1;RANBP3L;DDR2;CCN4;HGF;TMEM119;HEMGN;RORB;FERMT2;IL6;MEF2C;CCN1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.16648247532103705,-0.9681458072995839,0.47368421052631576,0.7207259528130672,1.0,18/19,76.49%,IL21;FGFR1;ZAP70;BLK;NTRK1;PDGFRB;TEK;CSF1R;PDGFRA;KIT;BTK;GHR;RELN;ITK;FLT3;EPHA3;EFEMP1;DDR2
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.1387753747829287,0.9651196878315169,0.53125,1.0,1.0,53/84,56.28%,ADAMTS16;COL8A1;COL10A1;ADAMTS8;COL19A1;ADAM12;THBS1;COL14A1;MFAP5;LAMA2;VCAN;COL24A1;ADAMTS3;MATN3;FBN1;COL11A1;COL3A1;DCN;DDR2;ITGA4;SMOC2;MMP2;COL6A3;TNC;LOX;SPARC;LUM;COL5A2;ELN;MMP16;FBLN5;ECM2;ITGAD;COL1A2;TNR;COL1A1;ADAMTSL3;COL4A6;MMP19;ITGA11;ADAMTSL1;COL5A1;ADAMTS1;COL8A2;ADAMTS18;VIT;ADAMTS12;RECK;SERPINE1;MMP21;COL15A1;COMP;JAM2
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.1387753747829287,0.9651196878315169,0.53125,1.0,1.0,53/84,56.28%,ADAMTS16;COL8A1;COL10A1;ADAMTS8;COL19A1;ADAM12;THBS1;COL14A1;MFAP5;LAMA2;VCAN;COL24A1;ADAMTS3;MATN3;FBN1;COL11A1;COL3A1;DCN;DDR2;ITGA4;SMOC2;MMP2;COL6A3;TNC;LOX;SPARC;LUM;COL5A2;ELN;MMP16;FBLN5;ECM2;ITGAD;COL1A2;TNR;COL1A1;ADAMTSL3;COL4A6;MMP19;ITGA11;ADAMTSL1;COL5A1;ADAMTS1;COL8A2;ADAMTS18;VIT;ADAMTS12;RECK;SERPINE1;MMP21;COL15A1;COMP;JAM2
prerank,KEGG_2021_Human__Insulin resistance,-0.18699807357531142,-0.9605674375344432,0.5333333333333333,0.7329743632889028,1.0,14/15,71.15%,FOXO1;PIK3R1;PCK1;PRKCQ;MAPK10;SLC2A4;PYGM;AKT3;SLC2A2;CD36;IL6;SLC27A6;GFPT2;PRKCB
prerank,KEGG_2021_Human__Wnt signaling pathway,0.1909599255048854,0.9584504066516382,0.5064935064935064,1.0,1.0,13/27,38.59%,RSPO3;SFRP1;SFRP4;RSPO1;RSPO2;DKK2;SFRP2;WNT9B;CCN4;PRKCB;DAAM2;WNT2;PRICKLE1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.1719700262893731,-0.956827565224115,0.4782608695652174,0.7358224281211196,1.0,18/19,75.56%,SLC8A3;CAV1;TRPC4;CCL5;TRPC1;CHRNB2;CALCRL;TRPC3;PKD2;CACNA1B;CCL8;CACNA2D1;CAMK2A;CCR1;SLN;RYR3;CCR5;SLC8A1
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.19096093130777486,0.9542639481690195,0.48863636363636365,1.0,1.0,17/26,53.53%,CCR8;CCR4;XCR1;CCL21;CCR5;AGTR1;CCR7;CCR2;HGF;CXCR6;CXCL12;CCR3;CCR1;CCL25;CXCR2;KIT;PDGFRA
prerank,KEGG_2021_Human__Chemical carcinogenesis,0.19564099096194348,0.9515949753654503,0.5057471264367817,1.0,1.0,16/28,44.87%,FGF10;FGF7;FGF16;FGF5;ADRB3;CYP1B1;GSTT2;CHRNA3;PRKCB;AR;PGR;RXRG;ADCY2;GSTM5;HPGDS;ADCY5
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.24215779307383295,0.9491892821371056,0.5512820512820513,1.0,1.0,10/16,46.20%,GREM1;SFRP1;SFRP2;EPHA3;TGFB3;BMP5;COL1A1;FERMT2;IL6;PDPN
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.17624794522203696,0.9491340446003925,0.5760869565217391,1.0,1.0,18/44,33.43%,ADIPOQ;FGF10;FGF7;MUSK;FGF19;RSPO1;FGF16;LEP;IRGM;FGF5;SH3GL2;FPR2;SLIT2;FBLN1;IFNG;HGF;TMEM119;GPNMB
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.23364068533602012,0.9477874778231371,0.5128205128205128,1.0,1.0,15/18,63.37%,G6PC2;PTPRC;NUDT10;PLPPR5;GFPT2;ALK;PLPPR4;PLA2G2A;TNFAIP8L3;PIK3CG;LRRK2;PTPRD;PLA2G2D;PLA2G2C;HTR2B
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.1468910803146068,-0.9469311349247272,0.5625,0.7531807883467966,1.0,13/22,35.67%,KCNA5;SIK1;PDZK1;NKAIN4;GDNF;KCNJ5;KCNJ12;NKAIN2;ITGB3;CHRNB2;P2RX7;CLDN10;KCNJ15
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.207235019365696,0.9463390784803704,0.5128205128205128,1.0,1.0,18/23,62.16%,CASQ2;THBS1;SYT4;SYT10;RYR3;KCNMB2;CRHBP;SYT6;ACER1;NLGN1;MEF2C;SYT1;SYT11;CASR;KCNMB1;PKD2;TRPC3;CLIC4
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.13430744840499198,0.9457982114784202,0.5306122448979592,1.0,1.0,64/91,63.40%,SOX10;CHRM2;LGI1;MAB21L2;PHOX2B;DPYSL5;SCRG1;FGF19;ECRG4;NRSN1;NEUROD1;FGF5;VCAN;IL1RAPL2;SH3GL2;SNTG2;GPM6A;MYT1L;GFRA1;DCX;NRXN1;DCLK1;FAT4;CNTFR;CHRNA3;SPOCK1;LSAMP;INHBA;RELN;WNT2;PTN;EGR2;NAV3;TAGLN3;ST8SIA2;GFRA2;RBFOX3;ADAM23;MOG;ROBO1;NLGN1;MEF2C;ADGRA2;ZEB2;DACT1;DSCAM;CNTN4;DCHS1;CDH2;ACTL6B;CNTN6;PKD2;PCDHA6;ADAM22;PMP22;CBLN1;ST8SIA4;P2RX5;SLITRK1;GPM6B;PDGFC;FGF2;S100B;NPTX1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.19769284799637288,0.9397885440771552,0.5581395348837209,1.0,1.0,23/25,74.20%,FCRL1;CR2;PTPRC;GPR183;MS4A1;ITGA4;PRKCB;FLT3;IL10;LAX1;CD40LG;MEF2C;BTK;KIT;CD79A;CD86;BCL2;VCAM1;CD79B;CD22;AICDA;CHRNB2;RASGRP1
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.19527283486469024,0.9391035660347724,0.5476190476190477,1.0,1.0,18/28,51.87%,CCL19;CXCL13;CCL14;CCL17;CCL21;CCL13;CCL7;CCR2;PF4V1;CCL11;CXCL12;CCL16;RIPOR2;CCR1;CCL25;CCL22;CCL2;CCL8
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.18421589150872097,-0.9362305574474618,0.6,0.7711740165460674,1.0,12/18,41.28%,IL21;LILRB1;APOBEC3H;IFNL1;SAMHD1;SLFN11;RSAD2;AICDA;IFI44L;BCL2;AZU1;RNASE6
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.20200398351394383,0.9356494034059609,0.56,1.0,1.0,15/23,51.87%,CCL19;CXCL13;CCL14;GPR183;CCL17;CCL21;CCL13;CCL7;CCL11;CCL16;CCL25;PIK3CG;CCL22;CCL2;CCL8
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.23051108816174543,0.9354165671427136,0.5714285714285714,1.0,1.0,14/18,59.44%,THBS1;DCN;THBS4;CCR2;ISM1;SPARC;THBS2;CNMD;GHRL;SULF1;ADAMTS1;PRL;SERPINF1;TEK
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.17298937784522003,-0.9351636285186437,0.6428571428571429,0.768250102453018,1.0,19/19,82.83%,SOX11;FGFR1;NGF;NREP;HEYL;NTF3;SOX2;PCP4;CNTN4;LRRK2;MEF2C;TCF4;NLGN1;ZEB1;ALK;VWC2;BEND6;BRINP3;NEUROD1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.1824863194711553,-0.9350521297847061,0.6296296296296297,0.7633254223090884,1.0,14/15,71.48%,SIRPB1;HLA-DPB1;PRKCQ;HLA-DPA1;SIRPG;IL12B;TNFSF4;NCKAP1L;CLEC7A;CCL2;IL6;IGLL5;CCR2;THY1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.2315918440163834,0.9348699881317093,0.5324675324675324,1.0,1.0,3/16,5.46%,ADIPOQ;CIDEA;IGF1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.2315918440163834,0.9348699881317093,0.5324675324675324,1.0,1.0,3/16,5.46%,ADIPOQ;CIDEA;IGF1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.08238048913315367,-0.9335115682756687,0.4,0.7611638364525415,1.0,33/60,38.05%,SOX11;FASLG;RUNX3;AEBP1;CAV1;NR2F1;LDB2;DAB2;SNAI1;DUSP26;KLF8;FOXP3;TBX21;ARID5B;ID4;HDAC9;GLI2;KLF12;KANK2;SOX2;IGF2;LILRB4;EDNRB;NR1H4;PARP15;FOXP2;MITF;PRDM6;MLIP;ZIM2;SNAI2;ESR1;ZBED2
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.12403762920066805,-0.9326436790962159,0.4166666666666667,0.7575202738404282,1.0,27/34,60.32%,PDZK1;EFR3B;SYNE3;CAV1;RDX;CPE;RFTN1;EHD3;LIN7A;P2RY1;NRXN2;EPB41L3;MYO5A;SCN3B;WNK3;RAB3C;DLG2;FYB1;ITGAL;ZDHHC22;KCNB2;NLGN1;FERMT2;ZDHHC15;DPP6;PTN;TRARG1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.1533090467516697,-0.9308628419639364,0.4444444444444444,0.7569222340170529,1.0,20/20,84.79%,FOXO1;MAPT;TREM2;DAPL1;UCHL1;RAB39B;IL10RA;HTR2B;PRKD1;BCL2;GFAP;MEFV;LRRK2;LEPR;IL10;HGF;IFNG;DCN;IRGM;LEP
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.14636407467319834,0.9278296663847306,0.5729166666666666,1.0,1.0,56/64,75.80%,CCL19;FGF10;CCL14;ADCYAP1;FGF19;HTR2A;PTPRC;GPR183;CCL17;FPR2;HAND2;CCL21;CCL13;CCR7;CCL7;CALCR;IL26;GPNMB;CCL11;CCN2;CCL16;ANGPT1;PLA2G2A;TNFAIP8L3;FERMT2;CCR1;OPRM1;CCL25;SLAMF1;SCIMP;CCL22;CCL2;CCL8;PDGFRA;CSF1R;CD36;TEK;ROR2;PDGFC;FGF2;HTR2B;F2R;ADRA1A;BMPER;GLIPR2;NODAL;CCL23;CCL4;PLA2G5;PDGFRB;GPR55;CCL5;NTRK1;RASGRP1;C5AR1;CCL18
prerank,KEGG_2021_Human__Breast cancer,0.20280911223470485,0.9272309587914118,0.5256410256410257,1.0,1.0,6/22,17.26%,IGF1;FGF10;FGF7;FGF19;FGF16;FGF5
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.15690965666538492,-0.9264349334597408,0.6666666666666666,0.7601406533575318,1.0,16/23,46.20%,ZIC2;COL4A1;CTNNA2;ROBO2;SHROOM4;EML1;AFF2;ADGRL2;CX3CR1;SLC6A17;APOD;GRIN2B;SLC6A4;MDGA1;CDH2;CNTN4
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.19153721984012997,0.9247830547388565,0.5647058823529412,1.0,1.0,17/27,51.72%,CILP;PHOX2B;SFRP1;GAS1;HAS1;NOS1;VSTM2A;TMEM100;STMN2;HGF;WNT2;ANKRD1;HAS2;MEF2C;CCL2;ADAMTS12;PDE3A
prerank,KEGG_2021_Human__Viral myocarditis,-0.17738023044269255,-0.9244231523585659,0.6190476190476191,0.7615087193245482,1.0,16/16,82.38%,HLA-DPB1;CAV1;HLA-DRA;HLA-DPA1;CD80;SGCA;HLA-DQA2;HLA-DOA;HLA-DQA1;ITGAL;CD86;CD40LG;SGCG;LAMA2;CD28;SGCD
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.18308578357077904,-0.9239367183327929,0.5454545454545454,0.7576258654298582,1.0,15/15,81.80%,AEBP1;ECEL1;CPE;PCSK5;CPZ;PCSK1;ADAM19;SRGN;C1R;MMP16;CPXM1;CPXM2;PCSK2;ADAMTS3;HPR
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.2032197555902323,0.9217362033981741,0.5487804878048781,1.0,1.0,16/20,64.30%,CCL19;THBS1;CCR7;TLR8;IFNG;TIGIT;IL10;CD40LG;SLAMF1;SCIMP;CMKLR1;CLEC7A;IL16;MEFV;TNFSF4;IL12B
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.162837899454866,-0.9208625486559121,0.6,0.7591551334439335,1.0,15/16,74.35%,SCARA3;RFTN1;TLR4;LBP;NR1H4;LY96;TRIL;CD36;TLR10;BTK;SCIMP;TNIP3;CTSK;TLR8;TLR7
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.231282206729312,0.9188956213424241,0.5333333333333333,1.0,1.0,15/15,76.98%,THBS1;DCN;SLIT2;SMOC2;SPARC;PTN;ANGPT1;PIK3CG;TEK;PRKD1;FGF2;BMPER;RHOJ;ITGB3;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.23128220672931188,0.9093824152577207,0.6233766233766234,1.0,1.0,15/15,76.98%,FGF10;FGF7;THBS1;SMOC2;IFNG;SPARC;ANGPT1;PIK3CG;TEK;PRKD1;FGF2;GLIPR2;TGFB2;ITGB3;WNT5A
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,-0.15606930695320778,-0.9084075305198314,0.6111111111111112,0.7769841972466912,1.0,12/20,36.99%,FASLG;PIK3R1;CSF2;ZAP70;FCER1G;KLRK1;NFATC1;LCP2;KIR2DL1;FCGR3A;SHC4;KLRD1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.17084652053779326,-0.9080756889774317,0.5789473684210527,0.7733993290436122,1.0,15/19,53.71%,FGFR1;TENM1;DUSP1;UCHL1;RASGRP1;PDGFRB;HTR2B;FGF2;PDGFC;PIK3R5;KIT;LRRK2;GH1;ROBO1;PIK3CG
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.19813658786970637,0.9077678097790272,0.5394736842105263,1.0,1.0,14/21,53.83%,GLRA1;ATP1A4;SLC17A6;SLC8A1;CHRNA3;CNGA3;SLC9A9;TRPM3;SLC17A7;CNGB1;SLC24A4;SLC12A1;PIEZO2;SLC24A2
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.13183816667644788,-0.9067657901557504,0.65,0.7704961406424246,1.0,26/28,76.58%,IL21;TSLP;NLRP12;TLR4;PLA2G7;LILRA5;WNT5A;CD1D;CCL5;GBP5;IL12B;TNFSF4;IL16;IL33;SERPINE1;MEF2C;OSM;PLA2G2A;TASL;IFNG;TLR8;CCR2;AGTR1;CCN4;TLR7;FPR2
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.08454719265004625,-0.9055883153565383,0.5,0.7695317169653433,1.0,52/87,43.03%,NKX6-2;ZIC2;SOX11;FOXO1;FASLG;MDFIC;RUNX3;LEF1;AEBP1;CSF2;CAV1;HEYL;NR2F1;IFNL1;LDB2;DAB2;SNAI1;DUSP26;KLF8;FOXP3;TBX21;ARID5B;CRYAB;ID4;HDAC9;GLI2;KLF12;KANK2;WNT5A;SOX2;IGF2;MAEL;EDNRB;BASP1;NR1H4;TSHZ3;PARP15;FOXP2;MITF;PRDM6;MLIP;ZIM2;TNFSF4;SNAI2;ESR1;TWIST2;ZBED2;CD38;TFEC;DKK3;ZNF423;ZNF366
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,0.1632386982496281,0.9018370397927636,0.6222222222222222,1.0,1.0,28/33,71.85%,ATP1A4;PLN;MYLK;ADRB3;SLC8A1;ATP1A2;AGTR1;KCNMB2;ADCY2;IRAG1;EDNRA;GUCY1A1;ADCY5;PIK3CG;MEF2C;CNGB1;PDE3A;PIK3R5;KCNMB1;PRKG1;ADORA3;ADRA1D;ADRA1A;GUCY1A2;ADRB2;MYL9;AKT3;EDNRB
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.22636716471298704,0.900780569124467,0.5679012345679012,1.0,1.0,6/15,27.67%,ADIPOQ;SFRP1;LEP;MEDAG;SFRP2;ZFPM2
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.22153229228579624,0.8975232053204735,0.6419753086419753,1.0,1.0,8/19,29.75%,SLC5A7;SLC6A15;SLC17A6;SLC18A3;CHAT;ATP1A2;NRXN1;SLC22A2
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.20639373119306742,0.8965676848352115,0.6144578313253012,1.0,1.0,7/19,26.10%,GABRG2;CBLN4;LRRTM3;GABRA1;NLGN4X;GPM6A;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.1140118767661563,-0.8963433979973532,0.6666666666666666,0.7810388039063176,1.0,20/29,49.25%,KREMEN2;TMEM170B;DRAXIN;CAV1;SOST;PTPRO;DAB2;WNT5A;TNN;SOX2;SHISA6;SNAI2;NKD1;FRZB;DKK3;GLI1;DACT3;BICC1;HECW1;DACT1
prerank,KEGG_2021_Human__Cushing syndrome,0.21017467479759575,0.8930763974501827,0.5694444444444444,1.0,1.0,11/18,47.95%,CRHR1;MRAP;KCNK2;WNT9B;AGTR1;MC2R;WNT2;ADCY2;ADCY5;STAR;CAMK2A
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.23297281904117895,0.8907983246905625,0.575,1.0,1.0,13/15,66.78%,SFRP1;MYOC;IL1RAPL1;NRXN1;THY1;FERMT2;GHRL;NLGN1;PTPRD;SLITRK2;TEK;CLSTN2;SRPX2
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.11215194789513325,-0.8889723251349475,0.7,0.7916257691770745,1.0,22/32,49.25%,KREMEN2;TMEM170B;SHISA2;TRABD2B;DRAXIN;CAV1;SOST;PTPRO;DAB2;WNT5A;NFATC1;SOX2;SHISA6;SNAI2;NKD1;FRZB;DKK3;GLI1;DACT3;BICC1;HECW1;DACT1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.1493624772313297,-0.886892141691426,0.5454545454545454,0.7916451371837302,1.0,20/20,85.18%,TRPC6;CAV1;LILRA5;WNK3;CCL5;P2RX7;PDGFRB;CCL4;LILRA2;F2R;P2RX5;TRPC3;CCL2;CAMK2A;CCR1;CXCL12;ANK2;P2RX2;FFAR1;MYLK
prerank,KEGG_2021_Human__Calcium signaling pathway,0.1467389211386682,0.885714329048562,0.6129032258064516,1.0,1.0,45/62,64.15%,CHRM2;FGF10;FGF7;CCKAR;FGF19;CASQ2;PLN;HTR2A;FGF16;MYLK;FGF5;ADRB3;TRDN;P2RX2;NOS1;SLC8A1;HRH2;AGTR1;PRKCB;RYR3;PTGER3;CASQ1;HGF;DRD5;PTGFR;PDE1A;ADCY2;EDNRA;AVPR1A;HTR7;CAMK2A;PDGFRA;CACNA1B;TACR1;CYSLTR1;CACNA1G;P2RX5;CD38;RET;PDGFC;ADRA1D;FGF2;HTR2B;F2R;ADRA1A
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.20155806536163173,0.8853704975569961,0.5925925925925926,1.0,1.0,10/23,33.65%,WT1;SFRP1;GABRG2;GLRA1;P2RY12;SLIT2;IGFBP5;RYR3;DEFB124;CRHBP
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.1699248521312668,-0.8848518004822388,0.6086956521739131,0.7913543689835598,1.0,16/17,74.74%,SOX11;ROBO2;NGF;PLXNC1;CX3CR1;MAP6;SLITRK1;PTPRD;SERPINF1;ROBO1;OPRM1;IFNG;PLXNA4;CHODL;NGFR;SLIT2
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.18430938365150015,0.8815750935560323,0.6707317073170732,1.0,1.0,17/27,51.87%,CCL19;CXCL13;CCL14;CCL17;CCL21;CCL13;CCL7;CCR2;PF4V1;CCL11;CXCL12;CCL16;CCR1;CCL25;CCL22;CCL2;CCL8
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,0.20844747539196185,0.8775949378930518,0.6410256410256411,1.0,1.0,12/19,50.03%,CMA1;PLN;COL3A1;MMP2;TGFB3;AGTR1;PRKCB;GFPT2;COL1A2;COL1A1;CAMK2A;CYBB
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.18547928302288488,0.8744487188836343,0.618421052631579,1.0,1.0,10/26,29.87%,TCL1A;NRK;CCL19;ADCYAP1;IRGM;PTPRC;DDR2;CCL21;CCR7;IFNG
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.14225803366160153,0.8712708091554476,0.6559139784946236,1.0,1.0,38/56,60.29%,ADIPOQ;RSPO3;IGF1;SFRP1;KLK5;RSPO1;IL7R;RSPO2;ADAMTS3;PTGIS;PTPRC;CLEC6A;SMOC2;NRXN1;PRKCB;CD226;RELN;EVC;IL6;GHRL;SULF1;SHANK1;CRLF2;RIMS2;ROBO1;NLGN1;GH1;SCIMP;LY86;CD180;DACT1;LRRK2;MN1;GLI1;CCBE1;PKD2;TEK;SORBS1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.15099449088230102,0.8697456783114222,0.6404494382022472,1.0,1.0,20/51,33.61%,IAPP;CCL19;FGF10;MYOC;FGF7;FGF19;THBS1;TRAT1;FGF16;LEP;FGF5;CD28;P2RY12;CCL21;CCR7;ICOS;HGF;CALCR;IL26;FLT3
prerank,KEGG_2021_Human__Cholinergic synapse,0.17949888825109744,0.8694017133006918,0.6547619047619048,1.0,1.0,19/28,57.54%,CHRM2;SLC5A7;GNG8;CHRNA6;SLC18A3;CHAT;CHRNA3;PRKCB;KCNQ5;ADCY2;ADCY5;GNAO1;GNG3;PIK3CG;CAMK2A;GNB4;PIK3R5;CACNA1B;GNG2
prerank,KEGG_2021_Human__B cell receptor signaling pathway,-0.1637587501784312,-0.8693066584756831,0.7,0.8194129067657114,1.0,16/20,56.94%,PIK3R1;LILRB1;LILRA5;NFATC1;LILRB4;AKT3;LILRB2;CD22;CD79B;LILRA2;CD19;LILRA6;CD79A;BTK;LILRA1;FCGR2B
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.17411715873101094,0.8680140056507346,0.627906976744186,1.0,1.0,24/31,64.82%,SFRP1;CXCL13;LEP;KRT1;PROK2;PROK1;CHRNA3;SPARC;ADGRB3;GPNMB;LRRC4C;PPFIA2;ZDHHC15;FERMT2;IL6;MEF2C;ADGRA2;LRRK2;HECW1;CDH2;LZTS1;FGF2;ZNF135;BMPER
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.21332987825267183,0.8650417301831829,0.5616438356164384,1.0,1.0,4/16,13.64%,CR2;CXCL13;C7;CR1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.14519677122197633,-0.8633412320396897,0.631578947368421,0.8263168385384431,1.0,20/22,72.06%,AHSG;PDE6B;TREM2;CAV1;CASP12;SAMHD1;WNT5A;PDE6G;TNFSF4;F2R;CD36;PDGFRA;ADAMTS12;ADGRA2;CNGB1;IL1R1;FCGR2B;SELE;CCR2;AGTR1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.14556551891098418,-0.8606125174539779,0.5789473684210527,0.8281160690072388,1.0,22/23,79.00%,LILRB1;IFNL1;PCK1;HLA-DRA;RSAD2;CD1D;CCL5;TGFB2;GBP5;IL12B;TNFSF4;SASH3;NLRP3;FCGR2B;TASL;CD226;IL10;IFNG;TLR8;CCR7;FPR2;PTPRC
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.18599251578145587,0.8581882520481531,0.56,1.0,1.0,4/21,9.38%,SCN7A;SCN2B;ATP1A4;SLC6A15
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.20792783424777916,0.8561823096984582,0.6385542168674698,1.0,1.0,8/19,29.93%,ADAM12;THBS1;CYP1B1;PTGIS;SFRP2;SMOC2;PRKCB;HSPB6
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.21018300464688572,0.8507996613264646,0.6794871794871795,1.0,1.0,15/17,69.82%,LGI1;NRXN1;CCR2;CACNG5;RELN;RIMS2;NLGN1;CCL2;SLC24A2;SYT1;CLSTN2;ADRA1A;GRIN2B;TSHZ3;RIMS1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.14927184466019416,-0.8504409590004366,0.6875,0.8415535390199637,1.0,18/18,85.18%,AIF1;SSTR3;EHD3;PTPRO;PKHD1;CYS1;EMP1;P2RX7;S1PR1;PMP22;ARHGEF6;KIT;CNGB1;RAB23;CCL21;NME8;P2RY12;MYLK
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.1905931173187791,0.8488306873729851,0.6987951807228916,1.0,1.0,14/24,47.34%,IGF1;G6PC2;NEUROD1;GCG;STXBP5L;FFAR1;TGFB3;IFNG;KCNB1;GIP;RFX6;ANKRD1;IL6;GLP1R
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.10603459207699012,-0.8474597777891063,0.5714285714285714,0.8433963042402245,1.0,40/43,77.91%,NKX6-2;ZIC2;FOXO1;MDFIC;LEF1;CSF2;HEYL;IFNL1;FOXP3;TBX21;ARID5B;CRYAB;ID4;HDAC9;SLFN11;WNT5A;MAEL;BASP1;TSHZ3;FOXP2;TNFSF4;TWIST2;CD38;DKK3;ZNF423;SAMD11;RUNX1T1;MAGEL2;IKZF1;ANKRD1;RORB;GLI3;ZEB1;PRICKLE1;TCEAL7;IFNG;IGFBP5;ZFPM2;HAND1;SFRP2
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.2163247527021041,0.8468978118117448,0.6704545454545454,1.0,1.0,7/17,30.69%,TCL1A;CCL19;FRMPD4;NRXN1;TGFB3;IFNG;AR
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.18807708027131304,0.8466647494100475,0.6301369863013698,1.0,1.0,4/21,9.38%,SCN7A;SCN2B;ATP1A4;SLC6A15
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.1926238353914016,0.8445335739086167,0.6447368421052632,1.0,1.0,9/18,37.63%,PIRT;LRRC55;TRDN;ANK2;CCR2;IFNG;CASQ1;LRRC38;RELN
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.21500365550163553,0.8423195466997098,0.6282051282051282,1.0,1.0,15/17,69.10%,PTPRC;MS4A1;PRKCB;ITK;IGLL5;MNDA;MEF2C;BTK;CTLA4;NCKAP1L;CD79A;CD38;BCL2;CD19;CD79B
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.16736936232852132,0.840138722410388,0.6341463414634146,1.0,1.0,19/31,51.87%,CCL19;SFRP1;CCL14;ADCYAP1;CCL17;CCL21;CCL13;THY1;CCL7;CCL11;RGS8;ODAM;CCL16;FERMT2;CCL25;CCL22;CCL2;RGS1;CCL8
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.19330481291033608,0.8385306314679674,0.6052631578947368,1.0,1.0,12/19,51.72%,CILP;SFRP1;LEFTY2;COL3A1;TGFB3;GDF5;WNT2;COL1A2;ANKRD1;FERMT2;MEF2C;PDE3A
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.13065288769025601,-0.8365436232973333,0.7272727272727273,0.8598890563638787,1.0,20/27,53.14%,AHSG;PECAM1;SERPING1;PPBP;ITIH3;BLK;FN1;PCDH7;IGF2;ITGB3;TGFB2;ISLR;CD36;SRGN;SELP;SERPINE1;PLEK;MMRN1;SCG3;TIMP3
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.09321847446530494,-0.8345803987963888,0.7777777777777778,0.8581843022900142,1.0,45/52,71.54%,SEMA3G;FAM107A;PECAM1;LEF1;CAVIN1;SEMA5A;CAV1;RDX;NTRK3;AIF1;SEMA3E;DAB2;SNAI1;LRRC15;SMO;NTF3;SEMA3A;SEMA6D;CCL5;PDGFRB;F2R;SNAI2;PDGFC;TWIST2;RET;MMP7;ROR2;CSF1R;PDGFRA;KIT;CLEC7A;CCN1;HAS2;PDPN;CCR1;FERMT2;CASS4;COL1A1;SEMA3C;CXCL12;CCL11;GPNMB;HGF;CCL7;CCR7
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.1647842655277523,-0.8335753338265495,0.6956521739130435,0.855166330389642,1.0,15/16,74.95%,CFL2;SEMA5A;NTRK3;TENM1;NTF3;HCLS1;P2RX7;TEK;NCKAP1L;PLEK;STAP1;LMOD1;CCL11;CCR7;CCL21
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.14082851288885198,0.8326161754547005,0.6804123711340206,1.0,1.0,23/59,34.37%,ADIPOQ;IGF1;FGF10;FGF7;MUSK;FGF19;THBS1;RSPO1;FGF16;LEP;IRGM;FGF5;EPHA5;FPR2;DDR2;EPHA3;IFNG;AR;HGF;TMEM119;GPNMB;FLT3;ALK
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.15379805999202545,0.8308744267847531,0.6989247311827957,1.0,1.0,10/42,17.26%,ADIPOQ;FGF10;FGF7;MUSK;FGF19;RSPO1;FGF16;LEP;IRGM;FGF5
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.21435235347947157,0.8285763162068506,0.6708860759493671,1.0,1.0,11/16,53.23%,IL7R;LEP;CYP1B1;IL26;IL10;GHR;IL6;CRLF2;GH1;PRL;KIT
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,0.11794580732519097,0.8278241203429609,0.7127659574468085,1.0,1.0,56/98,53.05%,CCR8;CCR4;CCL19;IL2;CXCL13;CCL14;XCR1;GDF6;IL7R;LEP;IL27;IL2RA;CCL17;TNFRSF13B;CCL21;CCR5;TNFRSF17;NGFR;CCL13;TNFSF18;TGFB3;CCR7;CNTFR;TNFSF8;CCL7;CCR2;IFNG;PF4V1;IL26;CXCR6;INHBA;CCL11;IL10;BMP5;GDF5;CXCL12;CCR3;GHR;CCL16;IL1R1;CCR1;IL6;LEPR;BMP3;CCL25;CRLF2;IL5RA;CD40LG;OSM;GH1;CCL22;CCL2;CXCR2;CCL8;PRL;IL33
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.18293343312530808,0.8276225000448527,0.625,1.0,1.0,9/19,38.68%,GOLGA8Q;MAP1LC3C;IRGM;NME8;GOLGA8O;PGM5;LMOD1;GOLGA8M;RAB23
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.20405514240275882,0.8243510323719424,0.7051282051282052,1.0,1.0,12/18,52.72%,SFRP1;THBS1;SFRP2;SPARC;IL26;GDF5;CNMD;SCG2;GHRL;SULF1;ROBO1;PRL
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.195854374241975,0.8228043596142363,0.6388888888888888,1.0,1.0,5/17,18.83%,GABRG2;GLRA1;GABRA1;GABRP;GABRA5
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,-0.1634601842322969,-0.8216460883974379,0.6521739130434783,0.8704355716878404,1.0,15/16,74.68%,CAMK1D;ATP2B3;KCNJ5;CAMK4;CACNA1I;PRKD1;CACNA1G;CAMK2A;STAR;ADCY5;ADCY2;MC2R;PRKCB;AGTR1;ATP1A2
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.2194515749672007,0.821353777375281,0.6911764705882353,1.0,1.0,12/15,62.16%,SYT4;SYT10;RYR3;CRHBP;SYT6;ACER1;NLGN1;MEF2C;SYT1;SYT11;PKD2;CLIC4
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.16505576159000568,0.8200630613459685,0.6785714285714286,1.0,1.0,21/28,62.64%,ADIPOQ;PHOX2B;ADCYAP1;LEP;ADRB3;JCHAIN;EBF2;CCR2;IFNG;FABP4;SLN;IRF4;UCP1;GHRL;LEPR;CMKLR1;CLEC7A;CD36;IL13;DIO2;PDGFC
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.13424534868356214,-0.8186467272460596,0.75,0.8695791679618172,1.0,31/33,77.37%,AQP4;HLA-DPB1;XCL2;AIF1;TLR4;GBP6;HLA-DRA;HLA-DPA1;HLA-DQA2;WNT5A;CCL18;CCL5;CCL4;CCL23;VCAM1;HLA-DQA1;GBP5;CCL8;NCAM1;CCL2;CCL22;CAMK2A;CCL25;CCL16;IRF4;CCL11;IFNG;CCL7;CCL13;CCL21;CCL17
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.16554434164496779,0.8183902486029525,0.7529411764705882,1.0,1.0,9/29,24.14%,CILP;IGF1;SFRP1;FGF19;TRAT1;CD28;SH3GL2;SFRP2;HAND2
prerank,KEGG_2021_Human__Gap junction,-0.16236479475716775,-0.8183116121419964,0.7222222222222222,0.8656747970722564,1.0,15/18,61.44%,GUCY1B1;GRM1;TUBA1A;TUBB4A;LPAR1;PDGFRB;GUCY1A2;GJA1;HTR2B;PDGFC;PRKG1;PDGFRA;ADCY5;GUCY1A1;ADCY2
prerank,KEGG_2021_Human__Antigen processing and presentation,-0.15441178134194375,-0.8180801675826063,0.8260869565217391,0.8613787153015382,1.0,10/15,42.21%,HLA-DPB1;HLA-DRA;HLA-DPA1;CD4;HLA-DQA2;KIR2DL1;HLA-DOA;HLA-DQA1;KLRD1;CD8B
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.12916997713215025,-0.8171445467860438,0.7222222222222222,0.858569399510771,1.0,16/22,50.51%,FOXO1;FASLG;SEPTIN4;GZMA;CASP12;TNFRSF19;GZMH;MAL;LTA;ADRA1A;DLC1;BCL2;NLRP3;FAP;ARHGEF6;CD2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.1323238173958443,0.8165136729179157,0.7157894736842105,1.0,1.0,9/67,7.97%,TCL1A;CTSG;WT1;CIDEA;IGF1;VIP;GREM1;IL2;SFRP1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.12619647193868527,0.8162600351831897,0.75,1.0,1.0,31/53,53.86%,LGI1;SEMA3D;UNC5D;LAMA2;SLIT3;TMEFF1;NEXN;EPHA5;GFRA1;SPTA1;GAP43;SLIT2;EPHA3;NRXN1;CNTN2;PLXNA4;DOK6;CXCL12;RELN;SEMA3C;TNR;DOK5;NRXN3;GFRA2;ROBO1;KIF5A;EPHA6;NCAM1;PALLD;DSCAM;CNTN4
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.14324417572243553,-0.8140724389252232,0.7142857142857143,0.8585117967332123,1.0,20/21,78.46%,CDH20;CDH22;CDH6;FN1;NRXN2;NLGN3;PCDHB3;SLITRK1;CDH2;DCHS1;FLNC;DSCAM;NLGN1;FERMT2;CDH10;CDH18;CDH11;NRXN1;CDH8;GPM6A
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,-0.1631548872655359,-0.8137548452737379,0.6842105263157895,0.8543235173584685,1.0,17/18,74.95%,ZAP70;PRKCQ;TLR4;LBP;EDARADD;LTA;CCL4;VCAM1;LY96;BCL2;BTK;CD40LG;IL1R1;CXCL12;PRKCB;CCL13;CCL21
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.1641747086908498,0.8124873122663859,0.6923076923076923,1.0,1.0,18/29,52.72%,WT1;LEP;NEUROD1;AMTN;DCN;NRXN1;AR;TMEM119;ALK;BMP5;RELN;CCN2;PTN;ZDHHC15;SHANK1;NLGN1;MIXL1;PRL
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.2096638760972261,0.8102399886264787,0.7466666666666667,1.0,1.0,7/16,31.53%,CASQ2;TRDN;NOS1;ANK2;THY1;JPH4;CASQ1
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.11769279329962824,-0.8094981808975021,0.7692307692307693,0.8571231693469336,1.0,9/29,12.98%,RAB41;SEPTIN4;LAPTM5;ARL11;SCG5;CPE;GPIHBP1;RIC3;COPZ2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.20492742298675087,0.8014284405214253,0.684931506849315,1.0,1.0,12/17,55.67%,THBS1;FPR2;CCR7;CCR2;DEFB124;CXCL12;PTN;CCR1;IL6;CMKLR1;SERPINE1;CSF1R
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.14380453042633778,0.7953060986517073,0.7325581395348837,1.0,1.0,6/42,8.06%,IAPP;NRK;IGF1;GREM1;FGF10;MYOC
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.15704600444437353,0.7941905090764944,0.6931818181818182,1.0,1.0,11/34,27.46%,ADIPOQ;IAPP;SFRP1;SFRP4;NEUROD1;CYP1B1;PTGIS;SFRP2;SLIT2;NGFR;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.18431148038281892,0.7925816111771906,0.7160493827160493,1.0,1.0,7/19,28.91%,ADIPOQ;CCL19;S100A12;CLEC6A;CCL21;CCR7;PRKCB
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.16265860602513338,0.7924413715684686,0.7078651685393258,1.0,1.0,19/26,62.91%,IGF1;AGTR2;CCL19;THBS1;CD28;CCL21;SMOC2;IFNG;HGF;IL6;STAR;ZEB2;TYRP1;CLEC7A;GLI1;CD36;PKD2;SORBS1;FGF2
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.18566119030521575,0.7880428319497874,0.6785714285714286,1.0,1.0,13/18,59.60%,ADIPOQ;PTGIS;FPR2;GHSR;LRFN5;IL10;C1QTNF3;TNFAIP6;GHRL;NLRP3;MEFV;TEK;IL13
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.1712315050454222,0.7872996062213193,0.7037037037037037,1.0,1.0,20/24,70.10%,TCL1A;ADIPOQ;S100A12;IRGM;IFNG;FLT3;FERMT2;PIK3CG;ROBO1;GH1;LRRK2;KIT;PIK3R5;CSF1R;PKD2;PDGFC;FGF2;HTR2B;PDGFRB;ADRB2
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.1632352286034652,0.7871226845093795,0.6790123456790124,1.0,1.0,12/27,36.81%,CCL19;CCL14;HTR2A;TRDN;ANK2;SLC8A1;CCL13;CCL7;CCR2;CCL11;CXCL12;DRD5
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),-0.15839304922406686,-0.7841043605426729,0.8235294117647058,0.894424064563463,1.0,8/17,22.87%,SOX11;VWC2L;SOST;RBPMS2;GDF3;SMAD9;ELAPOR2;BMPR1B
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.16042977227244226,0.7815635331576158,0.735632183908046,1.0,1.0,7/28,18.35%,CTSG;COLEC12;CXCL13;RNASE3;S100A12;IRGM;JCHAIN
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.12635554485811526,0.7791591815414232,0.7835051546391752,1.0,1.0,34/61,50.42%,IGF1;SFRP1;GDF6;MEDAG;NEUROD1;SFRP2;RANBP3L;BRINP3;DDR2;BEND6;BOC;TMEM100;CCN4;TGFB3;AGTR1;VWC2;AR;HGF;TMEM119;GDF5;CCN2;PTN;RIPOR2;COL1A1;ZEB1;PLA2G2A;FERMT2;IL6;PDPN;TCF4;MEF2C;CCN1;MSR1;CMKLR1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.20522515517175874,0.7766689301818159,0.7375,1.0,1.0,12/15,64.30%,CTSG;RNASE3;IRGM;MPEG1;IL6;RNASE2;SERPINE1;SELP;RNASE6;BPI;AZU1;IL12B
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.14429340877654367,0.7746470620875641,0.6951219512195121,1.0,1.0,21/36,51.87%,CCL19;SFRP1;CXCL13;CCL14;ADCYAP1;CCL17;CCL21;CCL13;CCR7;THY1;CCL7;CCL11;RGS8;ODAM;CCL16;FERMT2;CCL25;CCL22;CCL2;RGS1;CCL8
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.13679102214134062,-0.7731686911871107,0.8095238095238095,0.9072163166537033,1.0,17/17,86.42%,LAPTM5;FOXP3;TBX21;CD80;CD4;PDE4B;LILRB4;HAVCR2;CD86;VSIG4;CLEC7A;NAV3;IRF4;CCR2;PTPRC;CD28;CR1
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.16927158689599658,0.7730032326868874,0.717948717948718,1.0,1.0,3/20,7.51%,SOX10;WT1;FGF10
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.14029396214228132,0.7726539375012226,0.7058823529411765,1.0,1.0,24/41,51.87%,CCL19;SFRP1;CCL14;ADCYAP1;EPHA5;CCL17;CCL21;EPHA3;CCL13;THY1;PLXNA4;CCL7;CCL11;RGS8;ODAM;CCL16;BVES;FERMT2;CCL25;CCL22;CCL2;RGS1;LRRK2;CCL8
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.15282501270546814,0.7726233707112277,0.735632183908046,1.0,1.0,26/28,79.24%,PLN;MYLK;FFAR1;NOS1;ANK2;CASQ1;SLN;FCRL3;CCR1;CAMK2A;CACNA2D1;CASR;IL16;CD84;PKD2;BCL2;F2R;LILRA2;CCL4;LILRB2;CCL5;WNK3;CD33;LILRA5;PLPP4;CD4
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.1657354890980582,-0.7723726329390621,0.7,0.9032782500716401,1.0,12/15,53.71%,PIK3R1;FGFR1;NGF;NYAP2;NTRK1;PDGFRB;HTR2B;CSF1R;PIK3R5;PDGFRA;PLCL1;PIK3CG
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.13735395069049525,-0.7696910801448461,0.6785714285714286,0.9024334622438023,1.0,10/19,30.08%,PDZK1;EFR3B;RDX;EHD3;P2RY1;EPB41L3;MYO5A;SCN3B;WNK3;RAB3C
prerank,KEGG_2021_Human__Amoebiasis,0.15097557301496306,0.7691326754957649,0.7011494252873564,1.0,1.0,16/28,50.24%,CTSG;CD1B;LAMA2;COL3A1;TGFB3;PRKCB;IFNG;CD1C;IL10;COL1A2;COL1A1;COL4A6;IL1R1;IL6;CD1E;CD1A
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.16298432523788964,0.7683760450803249,0.7529411764705882,1.0,1.0,15/25,51.15%,COLEC12;ADRB3;HPR;JCHAIN;FPR2;CLEC9A;MASP1;SPARC;MRC1;SNAP91;CD163;FCGR2B;MSR1;RAB31;CXCR2
prerank,KEGG_2021_Human__Allograft rejection,-0.16166997567790842,-0.7669827699617219,0.75,0.9029775408348458,1.0,9/15,35.76%,FASLG;HLA-DPB1;HLA-DRA;HLA-DPA1;CD80;HLA-DQA2;HLA-DOA;HLA-DQA1;IL12B
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.1501177445696941,0.76671323071604,0.7241379310344828,1.0,1.0,7/31,17.11%,ADIPOQ;RSPO3;FRRS1L;ADCYAP1;GAS1;IGFBPL1;KCTD8
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.16988359416164203,0.7656386350124438,0.7380952380952381,1.0,1.0,11/21,43.60%,GDF6;LEFTY2;COL3A1;TMEM100;TGFB3;INHBA;BMP5;GDF5;COL1A2;RGMA;FERMT2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.1449093674697923,0.7653811136609325,0.7530864197530864,1.0,1.0,33/37,77.43%,CHRM2;VIP;GPR174;CCKAR;HTR2A;P2RY10;P2RY12;FPR2;AGTR1;PTGER3;FPR3;FPR1;DRD5;F2RL2;LPAR4;OPRM1;GPR33;CMKLR1;CXCR2;C3AR1;TACR1;ADRA1D;ESR1;HTR2B;F2R;ADRA1A;GPR65;GPR55;LPAR1;GPR18;C5AR1;P2RY8;CX3CR1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.20551938149294763,0.7641597105017868,0.7027027027027027,1.0,1.0,7/15,34.82%,IGF1;THBS1;NR4A3;MMP2;CCN4;IGFBP5;IL10
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.1454925853815702,-0.7640742393862962,0.7619047619047619,0.9040651476824991,1.0,13/20,42.40%,FOXH1;SIK1;NLRP12;HEYL;FOXP3;PKHD1;CD200;HAVCR2;TNFSF4;ESR1;ADORA3;NLRP3;PKD2
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.11320519817146762,-0.7623543713517793,0.8,0.9014537766385391,1.0,32/40,61.47%,NKX6-2;ZIC2;FOXO1;MDFIC;LEF1;CSF2;HEYL;IFNL1;FOXP3;TBX21;ARID5B;CRYAB;ID4;HDAC9;WNT5A;MAEL;BASP1;TSHZ3;FOXP2;TNFSF4;TWIST2;CD38;DKK3;ZNF423;SAMD11;RUNX1T1;MAGEL2;IKZF1;RORB;GLI3;ZEB1;PRICKLE1
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.14784456587735278,-0.7568369118978436,0.6428571428571429,0.9030815766205965,1.0,20/20,85.33%,RAB41;LAPTM5;ARL11;SCG5;GPIHBP1;COPZ2;IL10RA;LTBP2;RAB3C;SNX31;CALCRL;CD36;RAB31;SCG2;CD3G;RAB23;PRKCB;NGFR;RD3;PPY
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.1837904656277384,0.7544637611232237,0.8170731707317073,1.0,1.0,3/18,8.18%,CTSG;CMA1;KLK5
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.1837904656277384,0.7544637611232237,0.8170731707317073,1.0,1.0,3/18,8.18%,CTSG;CMA1;KLK5
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.16573390419334863,0.7541395814372798,0.7674418604651163,1.0,1.0,5/29,8.78%,IGF1;VIP;FGF10;SFRP1;FGF7
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.11415033065033661,0.7522970713040734,0.7755102040816326,1.0,1.0,27/90,27.67%,TCL1A;IGF1;VIP;GREM1;FGF10;IL2;SFRP1;FGF7;CCL14;FGF19;THBS1;CR1;FGF16;IL7R;GLP2R;FGF5;PROK2;FOLR2;PTPRC;NR4A3;SFRP2;DDR2;OSR1;PROK1;CCN4;TGFB3;ZFPM2
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),0.11579383224081605,0.750951851019564,0.7422680412371134,1.0,1.0,62/74,75.80%,ADIPOQ;CCL19;FGF10;CCL14;ADCYAP1;FGF19;HTR2A;PTPRC;GPR183;CCL17;FPR2;HAND2;CCL21;CCL13;FBLN1;CCR7;CCL7;CALCR;IL26;GPNMB;CCL11;CCN2;CCL16;ANGPT1;PLA2G2A;TNFAIP8L3;FERMT2;CCR1;OPRM1;CCL25;TIMP3;SLAMF1;CCN1;SCIMP;CCL22;CCL2;CCL8;PDGFRA;CSF1R;CD36;TEK;ROR2;PDGFC;FGF2;HTR2B;F2R;ADRA1A;LMO3;BMPER;GLIPR2;NODAL;CCL23;CCL4;PLA2G5;PDGFRB;TGFBR3;GPR55;CCL5;NTRK1;RASGRP1;C5AR1;CCL18
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.1466498378282873,0.7486053335277983,0.7325581395348837,1.0,1.0,28/32,75.92%,CCL19;CXCL13;CCL14;S100A12;CCL17;CCL21;CCL13;CCL7;PF4V1;CCL11;SCG2;CCL16;CCL25;PIK3CG;CCL22;CCL2;CXCR2;CCL8;NCKAP1L;JAML;CXCL9;CCL23;CCL4;TGFB2;PDE4B;CCL5;CCL18;CXCL10
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.14244514930586868,-0.7464238285448208,0.7058823529411765,0.911587466202452,1.0,16/17,76.58%,TREM2;TLR4;MMP13;NTRK1;ADRB2;VCAM1;GJA1;CD36;CACNA1B;CACNA2D1;FCGR2B;CALCR;MMP2;NGFR;ITGA4;FPR2
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.09784298839091586,-0.74473926638934,0.9166666666666666,0.9095156936626531,1.0,36/39,77.91%,KREMEN2;SLAMF8;NOVA1;CHSY1;NLRP12;ADAMTS5;SOST;PTPRO;TLR4;FOXP3;ELAPOR2;HDAC9;NR1H4;NODAL;GJA1;F2R;SLC6A4;IL13;ZNF423;SYT11;SRGN;PLCL1;MEF2C;ROBO1;FCGR2B;TIFAB;BMP5;IL10;ALPK2;CRHBP;GPNMB;ACTN3;IFNG;MYOCD;WNT9B;SFRP2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.1456505091501043,0.7443014115929917,0.8202247191011236,1.0,1.0,20/37,48.76%,IGF1;GREM1;FGF10;IL2;FGF7;PTPRC;CLEC6A;TNFSF18;GATA1;THBS4;IFNG;HGF;FLT3;RELN;GHR;ANGPT1;CASS4;IL6;OSM;GH1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.16494602774061448,0.7437039785188384,0.7435897435897436,1.0,1.0,13/24,44.69%,ADIPOQ;PHOX2B;ADCYAP1;LEP;ADRB3;EBF2;CCR2;FABP4;SLN;IRF4;UCP1;GHRL;LEPR
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.19508260181642137,0.7399594638495662,0.8072289156626506,1.0,1.0,10/15,53.23%,LEP;CYP1B1;PTPRC;IL26;IL10;GHR;IL6;GH1;PRL;KIT
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.12628685393864314,-0.7382923170852174,1.0,0.9160296247410585,1.0,9/20,23.51%,FOXO1;PIK3R1;CAV1;PCK1;SLC2A4;MGARP;HDAC9;MYO5A;TSHR
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.1363806869369308,0.7382132434918892,0.7865168539325843,1.0,1.0,34/35,84.40%,ADIPOQ;CIDEA;IGF1;CCL19;THBS1;LILRA4;PTPRC;GHSR;CCR2;IFNG;IL10;IL6;GHRL;SLAMF1;CD2;CLEC7A;IL33;SYT11;BPI;AZU1;IL12B;LY96;HAVCR2;LILRA2;NR1H4;RASGRP1;CD33;WNT5A;LILRA5;CX3CR1;SPN;LBP;TNFRSF8;TLR4
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.18898931101705368,0.7367494241176346,0.7701149425287356,1.0,1.0,13/18,58.84%,ADIPOQ;LEP;PTPRC;TLR7;FCN1;TLR8;IL10;IL6;CD2;CLEC7A;SERPINE1;SSC5D;BPI
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.11363287674608041,0.7355292284578986,0.7216494845360825,1.0,1.0,59/80,67.26%,ADIPOQ;PHOX2B;VIP;IL2;ADCYAP1;LEP;ADRB3;CD28;AMTN;EBF2;CLEC6A;TGFB3;CLEC9A;GHSR;CCR2;IFNG;FABP4;SLN;TMEM119;IL26;INHBA;IL10;IRF4;ITK;C1QTNF3;GHR;PTN;COL1A1;CRTAM;AVPR1A;FERMT2;UCP1;IL6;GHRL;LEPR;PDPN;PIK3CG;NLGN1;GH1;CMKLR1;SERPINE1;PRL;IL33;CD36;LURAP1;IL13;DIO2;ZBED2;PDGFC;ADRA1D;FGF2;HTR2B;F2R;ADRA1A;TNFSF4;IL12B;GLIPR2;GJA1;NODAL
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.12769836735822745,0.7345921983242697,0.8064516129032258,1.0,1.0,15/47,28.36%,CHRDL1;PENK;CTSG;IGF1;SFTPC;VCAN;AMTN;MATN3;FBN1;PADI4;MMP2;MSRB3;TNC;IGFBP5;LOX
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.1685295736055038,0.7223829790771259,0.7976190476190477,1.0,1.0,8/21,29.93%,ADAM12;THBS1;CYP1B1;PTGIS;SFRP2;SMOC2;PRKCB;HSPB6
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.14340677051783704,0.7207374052085153,0.7738095238095238,1.0,1.0,27/31,75.92%,CCL19;CXCL13;CCL14;S100A12;CCL17;CCL21;CCL13;CCL7;PF4V1;CCL11;CCL16;CCL25;PIK3CG;CCL22;CCL2;CXCR2;CCL8;NCKAP1L;JAML;CXCL9;CCL23;CCL4;TGFB2;PDE4B;CCL5;CCL18;CXCL10
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.10985843715416295,0.7205424977957845,0.7878787878787878,1.0,1.0,34/87,38.23%,TCL1A;IAPP;WT1;CIDEA;IGF1;VIP;GREM1;IL2;SFRP1;SFRP4;THBS1;GAS1;NEUROD1;GCG;CD28;CYP1B1;PROK2;SFRP2;FMN2;OSR1;SLIT2;NGFR;TNFSF18;GATA1;TGFB3;HGF;ACTN3;FLT3;ALK;ALPK2;IL10;RASSF2;MPO;FSTL1
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.11401769027484283,-0.7195116810374381,0.7692307692307693,0.935260695491979,1.0,23/31,55.61%,IL21;SIRPB1;HLA-DPB1;ZAP70;AIF1;RHOH;PRKCQ;HLA-DPA1;CD80;SIRPG;CD1D;CCL5;LILRB2;VCAM1;IL12B;TNFSF4;CD86;CD3E;NCKAP1L;CCL2;CD40LG;PDCD1LG2;IL6
prerank,KEGG_2021_Human__Endocytosis,0.17329082364577209,0.7183118465957351,0.7972972972972973,1.0,1.0,6/18,25.26%,IZUMO1R;FOLR3;IL2RA;SH3GL2;FOLR2;CCR5
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.06470833535730663,-0.7174935142336845,1.0,0.933366606170599,1.0,66/73,79.09%,FOXO1;EGR1;PPBP;MAPT;LILRB1;AKAP6;AQP9;FZD7;GUCY1B1;PID1;HCN4;CXCL6;TLR4;LBP;P2RY1;CD80;CX3CR1;WNT5A;TSHR;CXCL10;NUGGC;PDE4B;AXL;LILRB2;NR1H4;P2RX7;LY96;TNFSF4;KCNE1;ESR1;PRKD1;RET;CXCL9;NLRP3;PKD2;GNG2;CD86;PDGFRA;SERPINE1;PDE3A;CPEB1;CCL2;CD180;MEF2C;PDCD1LG2;IL6;UCP1;TNIP3;ANKRD1;STAP1;RORB;WNT2;DRD5;IL10;CRHBP;DEFB124;PF4V1;RYR3;IGFBP5;EPHA3;SLIT2;CCR5;BRINP3;WNT9B;NR4A3;P2RY12
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.1209745608675469,0.7159752785660844,0.7865168539325843,1.0,1.0,32/49,59.60%,ADIPOQ;CMA1;IL2;S100A12;PTGIS;FPR2;TLR7;CCN4;AGTR1;GHSR;CCR2;IFNG;LRFN5;SELE;IL10;C1QTNF3;CD200R1;PLA2G2A;TNFAIP6;IL1R1;IL6;GHRL;OSM;ADAMTS12;SERPINE1;DNASE1L3;IL33;IL16;NLRP3;MEFV;TEK;IL13
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.1305414590600341,-0.7136002277719012,0.8571428571428571,0.9341279085516158,1.0,21/23,74.35%,IL21;TSLP;NLRP12;TLR4;PLA2G7;LBP;LILRA5;WNT5A;IL12B;TNFSF4;IL16;IL33;SERPINE1;OSM;IL6;PLA2G2A;IFNG;CCR2;AGTR1;CCN4;TLR7
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.12670882366474528,0.7135809996161538,0.7777777777777778,1.0,1.0,37/51,65.54%,ADIPOQ;CILP;AGTR2;SFRP1;SFRP4;THBS1;DLK1;NLGN4X;PTPRC;SFRP2;DCN;BEND6;IGFBP5;PRKCB;CRHBP;IL10;BMP5;CNMD;PTPRT;GLI3;SULF1;SLAMF1;DACT1;LRRK2;PLEK;ADAMTS12;DACT3;GPC3;DKK3;CBLN1;BCL2;FGF2;FRZB;NKD1;SNAI2;IL12B;APOD
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.13722680676262583,0.7116991733003717,0.7380952380952381,1.0,1.0,15/36,36.81%,CCL19;CCL14;PLN;HTR2A;TRDN;ANK2;SLC8A1;HCRTR1;CCL13;SCGN;CCL7;CCR2;CCL11;CXCL12;DRD5
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.14934071491984693,-0.7087342518207168,0.8888888888888888,0.9363245943469121,1.0,14/15,74.23%,WASF1;AIF1;RHOH;RASGRP2;WAS;RASGRP1;FGF2;PRKD1;RERG;MRAS;PDPN;COL1A2;AGTR1;NGFR
prerank,KEGG_2021_Human__Hematopoietic cell lineage,0.11827398928566578,0.7087341631288827,0.7777777777777778,1.0,1.0,42/46,81.65%,CR2;CD8B2;GP5;CR1;IL7R;CD1B;IL2RA;MS4A1;ITGA4;CD1C;FLT3;CD8A;CD3G;FCER2;IL1R1;IL6;IL5RA;CD1E;CD2;CD1A;KIT;CD3E;CSF1R;CD36;CD8B;CD38;HLA-DQA1;CD19;CSF2RA;HLA-DOA;CD22;CD5;CD37;ITGB3;CD1D;CD33;CD3D;HLA-DQA2;CD4;HLA-DPA1;THPO;HLA-DRA
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.14314444464354703,-0.7040686573041876,1.0,0.9375859386873843,1.0,7/15,23.08%,LEF1;FZD7;PLPP3;CPE;DIXDC1;WNT16;WNT5A
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.14745724071025196,-0.7024548667972056,0.8636363636363636,0.9349382584249671,1.0,7/15,22.96%,ABCB1;SLC16A2;SLC16A12;SLCO2B1;SLC2A4;SLC1A3;SLC6A17
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.0659468237563974,-0.7016839096579645,1.0,0.9316701341242087,1.0,61/69,75.92%,ZIC2;FOXH1;SOX11;FOXO1;MDFIC;RUNX3;EGR1;LEF1;FZD7;SOST;TAL1;IFNL1;POU3F1;MLLT11;MAFB;SNAI1;CAMK4;FOXP3;TBX21;CD80;CD4;GLI2;WNT5A;NFATC1;SOX2;NR1H4;CAND2;MITF;F2R;ESR1;FGF2;IRX6;FLI1;RET;CD38;FOXF1;ZNF423;GLI1;CD86;ACTA2;RFPL4A;EBF3;MEF2C;TCF4;IL6;RORB;EGR2;GLI3;COL1A1;RFPL4AL1;RFX6;IRF4;IL10;INHBA;PYHIN1;AR;EOMES;TGFB3;GATA1;MYOCD;HAND2
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.10468075754157552,-0.7009885840760205,0.9,0.9276619738163622,1.0,21/34,42.49%,NKX6-2;SOX11;RUNX3;FZD7;MAFB;RHOH;PRKCQ;FOXP3;TBX21;ZNF626;ELAVL2;HCLS1;SOX2;IGF2;MITF;MAFA;ZIM2;SNAI2;ESR1;DDX25;ZNF423
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.12374641660688243,0.7009590279828736,0.8494623655913979,1.0,1.0,38/50,68.92%,NRK;IGF1;FGF10;IL2;FGF7;FGF19;FGF16;FGF5;IL2RA;GFRA1;SPTA1;CCR5;PSMA8;HGF;FLT3;SCG2;ANGPT1;GFRA2;IL5RA;CAMK2A;MRAS;MEF2C;NEFL;CCL2;NCAM1;LRRK2;KIT;PDGFRA;CSF2RB;TEK;RET;DLG2;FGF2;HTR2B;GRIN2B;CSF2RA;RASGRF2;PDGFRB
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.12934847534746519,-0.6985086692182895,0.88,0.9261246569697608,1.0,12/15,60.62%,CDH20;CDH22;CDH6;EPB41L3;JAM3;GJA1;CNTNAP1;CDH2;DCHS1;CLDN11;CDH10;CDH18
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.07842727846209924,-0.6980695485330239,0.7142857142857143,0.922563869886919,1.0,52/60,73.69%,SEMA3G;FAM107A;APELA;PECAM1;LEF1;SEMA5A;CAV1;RDX;NTRK3;AIF1;SEMA3E;DAB2;SNAI1;LRRC15;FN1;SMO;NTF3;SEMA3A;SEMA6D;CCL5;TGFB2;PDGFRB;GLIPR2;F2R;SNAI2;PDGFC;TWIST2;RET;MMP7;ROR2;CSF1R;NCKAP1L;PDGFRA;KIT;CLEC7A;CCN1;HAS2;PDPN;CCR1;FERMT2;CASS4;COL1A1;SEMA3C;CXCL12;CCL11;GPNMB;HGF;IFNG;CCR2;CCL7;CCN4;TNFSF18
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.15704738760631878,0.6932515124564753,0.9012345679012346,1.0,1.0,22/22,84.40%,CCL19;THBS1;PTPRC;CCR2;IFNG;IL6;CD2;CLEC7A;IL33;CD86;AZU1;IL12B;LY96;HAVCR2;LILRA2;RASGRP1;WNT5A;LILRA5;SPN;LBP;TNFRSF8;TLR4
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.1355326295527342,0.6922249305237149,0.8192771084337349,1.0,1.0,22/32,61.53%,CCL19;MUSK;ADCYAP1;PTPRC;EPHA5;DDR2;CCL21;EPHA3;CCR7;FLT3;ALK;RASSF2;RELN;CCN1;EPHA6;KIT;PDGFRA;CSF1R;TEK;ROR2;AZU1;RET
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.17106577195645445,0.6910066021188432,0.8701298701298701,1.0,1.0,14/19,61.65%,IL2;PTPRC;GPR183;TNFRSF13B;IL10;FCRL3;FCGR2B;MNDA;MEF2C;CTLA4;NCKAP1L;SASH3;CD38;BCL2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.17400354412922223,0.6905510347657658,0.8208955223880597,1.0,1.0,6/15,33.31%,TCL1A;IRGM;NOS1;SFRP2;IFNG;CALCR
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,0.09725092710133168,0.6841266625821036,0.8854166666666666,1.0,1.0,47/82,56.22%,CHRM2;TCL1A;IGF1;GNG8;FGF10;IL2;FGF7;G6PC2;FGF19;COL6A6;THBS1;FGF16;IL7R;FGF5;IL2RA;LAMA2;EIF4E1B;COL6A5;ITGA4;NGFR;COL6A3;TNC;THBS4;HGF;FLT3;THBS2;RELN;COL1A2;GHR;TNR;COL1A1;ANGPT1;COL4A6;ITGA11;IL6;LPAR4;GNG3;PIK3CG;OSM;GH1;GNB4;PRL;KIT;PDGFRA;PIK3R5;CSF1R;COMP
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.08678073734055501,-0.6789166846199212,0.9166666666666666,0.938181123490131,1.0,14/36,23.08%,FGF8;SOX11;RUNX3;LMX1A;MAPT;FZD7;FGFR1;HEYL;EML1;RNF112;WNT16;SEMA3A;CX3CR1;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.12605370077386932,0.6787812043066519,0.8222222222222222,1.0,1.0,23/38,55.46%,CILP;CIDEA;IGF1;SFRP1;FGF19;CD28;SH3GL2;SFRP2;HAND2;IGFBP5;IFNG;PGR;GPNMB;IL10;RBMS3;FCGR2B;CCR1;ROBO1;MEF2C;MSR1;CD3E;SRGN;SYT11
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.15699969632553906,0.678229099494937,0.8974358974358975,1.0,1.0,21/21,84.40%,CCL19;THBS1;PTPRC;CCR2;IFNG;IL6;CD2;CLEC7A;IL33;AZU1;IL12B;LY96;HAVCR2;LILRA2;RASGRP1;WNT5A;LILRA5;SPN;LBP;TNFRSF8;TLR4
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.14942525783983254,0.6762639485208237,0.8313253012048193,1.0,1.0,18/22,71.15%,ADIPOQ;PTGIS;FPR2;GHSR;LRFN5;IL10;C1QTNF3;TNFAIP6;GHRL;SERPINE1;NLRP3;MEFV;TEK;IL13;FGF2;LILRA2;GPR31;NR1H4
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.17479891635931732,0.672966180876706,0.8292682926829268,1.0,1.0,8/15,44.87%,NRK;IGF1;LEP;CHRNA3;ADCY2;GHR;ANGPT1;ADCY5
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.16295475654425962,0.6723439306305764,0.8481012658227848,1.0,1.0,6/17,27.46%,CDH19;CADM3;NLGN4X;CDH8;CDH11;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.16900209218690704,0.6719399027983085,0.8266666666666667,1.0,1.0,6/16,29.60%,CCL19;THBS1;P2RY12;CCL21;SMOC2;CCR2
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.09381379002058128,0.6715178998674866,0.8888888888888888,1.0,1.0,79/118,64.63%,TCL1A;WT1;IGF1;VIP;GREM1;FGF10;IL2;SFRP1;FGF7;CCL14;SFRP4;FGF19;ADAMTS8;THBS1;ECRG4;CR1;FGF16;IL7R;GLP2R;FGF5;CYP1B1;PROK2;FOLR2;NR4A3;SFRP2;MYOCD;PROK1;SST;TGFB3;AGTR1;PODN;IFNG;AR;GPNMB;FLT3;INHBA;ELN;ALK;IL10;BMP5;PTGFR;WNT2;PTN;AVPR1A;IL6;GHRL;OPRM1;PDPN;CRLF2;HAS2;OSM;SLAMF1;ADAMTS1;CXCR2;SSTR4;CLEC7A;RERG;PRL;KIT;PDGFRA;CSF1R;CD86;GLI1;PKD2;ADORA3;ROR2;CXCL9;BCL2;PDGFC;ADRA1D;FGF2;S100B;HTR2B;FRZB;DLC1;F2R;ADRA1A;TNFSF4;S1PR3
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.11599560342186674,0.6703933002952694,0.8043478260869565,1.0,1.0,7/56,7.97%,TCL1A;WT1;IGF1;VIP;GREM1;IL2;SFRP1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.10135673574923473,0.6682730600193861,0.8842105263157894,1.0,1.0,60/89,64.03%,ADIPOQ;IGF1;FGF10;SFRP1;MYOC;FGF7;FGF19;THBS1;SEMA3D;FGF16;MYLK;FGF5;CYP1B1;NEXN;SFRP2;SLIT2;NGFR;SST;IGFBP5;THY1;PLXNA4;CCL7;PODN;HGF;DPYSL3;GPNMB;CCL11;CXCL12;SEMA3C;PTPRT;COL1A1;NAV3;CASS4;FERMT2;CCR1;TMEFF2;SULF1;PDPN;HAS2;CAMK2A;ROBO1;CCN1;RECK;CLEC7A;SERPINE1;KIT;PDGFRA;CSF1R;ADORA3;ROR2;MMP7;RET;CLIC4;TWIST2;PDGFC;FGF2;NKD1;DLC1;SNAI2;F2R
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.16245939595297568,0.6680110624676127,0.8780487804878049,1.0,1.0,17/20,72.12%,SLITRK3;MUSK;IL1RAPL1;IL1RAPL2;NRXN1;LRFN5;GHRL;NLGN1;MEF2C;PTPRD;SLITRK2;MDGA1;CLSTN2;SLITRK1;SRPX2;GPC6;CHRNB2
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.09365986428162687,0.6672072218858777,0.875,1.0,1.0,65/110,57.30%,TCL1A;CTSG;GREM2;CCL19;IL2;SFRP1;CCL14;F13A1;IL1RAPL1;IRGM;IL2RA;PTGIS;CCL17;HMHB1;CCL21;CCR5;CCL13;MMP2;CCR7;CNTFR;CCL7;CCR2;PYHIN1;HGF;DPYSL3;IL26;FLT3;CRHBP;CCL11;IL10;IRF4;FPR1;CXCL12;COL1A2;GHR;PTPRT;FCER2;CCL16;RIPOR2;ZEB1;ANKRD1;IL1R1;CCR1;IL6;LEPR;OPRM1;CCL25;CRLF2;IL5RA;SLA;HAS2;OSM;MNDA;CCL22;IL22RA2;CCL2;ADAMTS12;CCL8;KIT;CSF1R;PTPN5;CSF2RB;CD86;IL16;CD36
prerank,KEGG_2021_Human__HIF-1 signaling pathway,0.17371908566284064,0.6655915238710103,0.8875,1.0,1.0,11/15,61.65%,IGF1;EIF4E1B;PRKCB;IFNG;ANGPT1;IL6;CAMK2A;CYBB;SERPINE1;TEK;BCL2
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,-0.10761834114251986,-0.6652092949158892,0.9130434782608695,0.9479716532711088,1.0,23/24,82.38%,ITGA5;CTNNA2;ITGA1;LEF1;SLC8A3;ITGA9;SGCA;CACNB4;CACNA2D3;ITGB3;ITGA8;GJA1;CTNNA3;CDH2;CACNA2D1;ITGA11;CACNG5;ACTN3;ITGA4;SLC8A1;SGCG;LAMA2;SGCD
prerank,KEGG_2021_Human__Primary immunodeficiency,0.1674433328301051,0.6623592190728361,0.8767123287671232,1.0,1.0,11/16,57.85%,CD8B2;IL7R;PTPRC;TNFRSF13B;ICOS;CD8A;CD40LG;BTK;CD3E;CD79A;CD8B
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.13209271545692747,0.6615703686601422,0.8518518518518519,1.0,1.0,26/31,74.32%,CCL19;FGF10;IL2;LEP;CD28;PTPRC;GPR183;CD209;FCRL3;IL6;PDCD1LG2;CD40LG;MEF2C;NCKAP1L;CD3E;CD86;SASH3;CD38;BCL2;TNFSF4;IL12B;VCAM1;LILRB2;CHRNB2;CCL5;CD1D
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.14320733096382837,0.6601735014280693,0.8375,1.0,1.0,25/28,77.43%,IGF1;CCL19;FFAR1;CCR7;GHSR;TLR8;IFNG;PYHIN1;IL6;GHRL;MNDA;CLEC7A;CD36;NLRP3;MEFV;AZU1;F2R;GBP5;LILRA2;P2RX7;LILRB4;CD33;WNT5A;LILRA5;CX3CR1
prerank,KEGG_2021_Human__Olfactory transduction,0.16849959546345566,0.6586280557527744,0.8441558441558441,1.0,1.0,9/15,50.94%,OR2W3;OR52N4;OR3A2;SLC8A1;CNGA3;PDE1A;CAMK2A;CNGB1;SLC24A4
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.1251310193688162,-0.6583764235002918,0.9615384615384616,0.95038576994865,1.0,7/16,22.96%,ABCB1;SLC16A2;SLC16A12;SLCO2B1;SLC2A4;SLC1A3;SLC6A17
prerank,KEGG_2021_Human__Rap1 signaling pathway,0.1237874338722389,0.6548512861319433,0.9130434782608695,1.0,1.0,33/41,72.27%,IGF1;FGF10;FGF7;FGF19;THBS1;FGF16;FGF5;NGFR;PRKCB;HGF;CNR1;FPR1;ADCY2;ANGPT1;ADCY5;LPAR4;GNAO1;MRAS;KIT;PDGFRA;CSF1R;ITGAL;FYB1;TEK;PRKD1;PDGFC;FGF2;F2R;GRIN2B;PDGFRB;AKT3;LPAR1;ITGB3
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.15422051013158825,0.653853965437218,0.9186046511627907,1.0,1.0,15/16,79.93%,CCL19;FGF19;CCL21;CCR7;RASSF2;CCN2;FCGR2B;SLAMF1;DACT1;CD27;TGFBR3;RASGRP1;TNFRSF19;SEMA3A;WNT16
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.14796007591942345,0.653470477354045,0.8160919540229885,1.0,1.0,20/24,72.27%,VIP;THBS1;FGF16;LEP;THBS4;SPARC;CCL11;CNMD;SCG2;ANGPT1;GHRL;SULF1;PRL;TEK;PRKD1;FGF2;HTR2B;PPP1R16B;AKT3;ITGB3
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,0.13971411329435224,0.6534277734108495,0.9036144578313253,1.0,1.0,3/22,7.03%,CCR8;CCR4;GNG8
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.16179595684443887,0.6522014989048301,0.8518518518518519,1.0,1.0,15/18,69.01%,GREM1;DDR2;SLC8A1;OSR1;TGFB3;TMEM119;PTN;CCR1;MEF2C;CCN1;SRGN;GPM6B;FBN2;S1PR1;P2RX7
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.10009125403759728,-0.651916733832103,1.0,0.9536520220525289,1.0,18/26,49.91%,TREM2;FGFR1;NTRK3;PRKCQ;CD4;ROR1;CD200;IGF2;NTRK1;AXL;PDGFRB;RET;ROR2;TEK;CSF1R;PDGFRA;KIT;EPHA6
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.11350880129638283,-0.6464945993810014,0.9565217391304348,0.9535287952761943,1.0,15/21,52.14%,ATL1;CTNNA2;MAPT;SEMA5A;NREP;VASH2;NTNG1;S100B;SLITRK1;SLITRK5;MAP1B;SLITRK2;CNTN4;SLITRK4;MAP1A
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.1484519656943846,0.6441713452849323,0.8902439024390244,1.0,1.0,12/19,55.67%,IGF1;IL2;TNFSF18;IFNG;FLT3;GHR;IL6;OSM;GH1;IL22RA2;KIT;CSF1R
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.12183978486433175,0.644058457704515,0.8681318681318682,1.0,1.0,24/38,57.30%,IGF1;F13A1;THBS1;LEFTY2;SYT4;SYT10;TGFB3;SPARC;HGF;CRHBP;CPLX2;SYT6;TIMP3;SCG3;RIMS2;MMRN1;RAB31;PLEK;SERPINE1;SELP;SRGN;SYT1;SYT11;CD36
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.15877826950278925,0.6429413412262698,0.9154929577464789,1.0,1.0,8/15,47.62%,TCL1A;IRGM;NOS1;SFRP2;CALCR;RASSF2;IL6;OSM
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.11763362069162236,0.6356048456324332,0.8953488372093024,1.0,1.0,11/48,19.10%,CR2;COLEC12;TRIM58;RNASE3;S100A12;CR1;IRGM;PTX3;JCHAIN;MFAP4;KRT1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.12226718355553684,0.6334467993508036,0.8953488372093024,1.0,1.0,27/32,75.92%,CCL19;CXCL13;CCL14;S100A12;CCL17;CCL21;CCL13;CCL7;PF4V1;CCL11;CCL16;CCL25;PIK3CG;CCL22;CCL2;CXCR2;CCL8;NCKAP1L;JAML;CXCL9;CCL23;CCL4;TGFB2;PDE4B;CCL5;CCL18;CXCL10
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.14147966780747984,0.6333363501735443,0.8589743589743589,1.0,1.0,3/20,8.45%,IGF1;FGF10;GPR174
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.11562520732681053,0.6330755815604324,0.8636363636363636,1.0,1.0,13/39,29.87%,CCL19;IL2;S100A12;THBS1;P2RY12;FPR2;CCL21;TLR7;CCN4;AGTR1;CCR2;TLR8;IFNG
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.10018777101815703,0.6330088638149267,0.8762886597938144,1.0,1.0,41/82,48.64%,WT1;IGF1;FGF10;FGF7;SFRP4;TCF23;MUSK;FGF19;THBS1;FGF16;FGF5;CD28;ANK2;HAND2;CLEC6A;OSR1;VSTM2A;CLEC9A;SLC22A2;IFNG;AR;ACTG2;TMEM119;CALCR;IL26;INHBA;ELAVL4;IL10;ITK;C1QTNF3;ACTC1;ODAM;ANGPT1;CRTAM;RBMS3;STAP1;IL6;PIK3CG;RIMS2;ROBO1;MEF2C
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.14600736968661332,0.6312962719331512,0.891566265060241,1.0,1.0,17/19,77.28%,MYOC;GPR174;P2RY10;COL3A1;RIPOR2;F2RL2;LPAR4;ROBO1;HEG1;DLC1;F2R;GPR65;GPR55;LPAR1;GPR18;P2RY8;KANK2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.13131057767824325,0.6300427658228988,0.9156626506024096,1.0,1.0,9/25,31.74%,IGF1;CCL19;THBS1;CD28;CCL21;SMOC2;IFNG;AR;HGF
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.103208037772611,0.6253872070025365,0.8617021276595744,1.0,1.0,35/70,48.76%,WT1;IGF1;GREM1;FGF10;FGF7;SFRP4;TCF23;MUSK;FGF19;FGF16;FGF5;CD28;ANK2;HAND2;OSR1;VSTM2A;SLC22A2;IFNG;AR;SELE;ACTG2;TMEM119;CALCR;INHBA;ACTC1;ODAM;ANGPT1;RBMS3;STAP1;BVES;IL6;RIMS2;ROBO1;MEF2C;GH1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.13564409196385657,0.6248709630062227,0.8987341772151899,1.0,1.0,5/24,16.29%,RSPO3;SFRP1;SFRP4;RSPO1;RSPO2
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.09885302903299654,0.6223561728966731,0.8936170212765957,1.0,1.0,41/62,62.98%,LGI1;SLITRK3;SEMA3D;UNC5D;LAMA2;SLIT3;NEXN;EPHA5;GFRA1;SPTA1;SLIT2;EPHA3;NRXN1;CNTN2;NEFH;ACTBL2;DOK6;CXCL12;RELN;SEMA3C;TNR;PLPPR4;DOK5;NRXN3;GFRA2;MAP1A;ROBO1;KIF5A;EPHA6;NCAM1;SLITRK4;PALLD;DSCAM;CNTN4;SLITRK2;CNTN6;MAP1B;SLITRK5;SLITRK1;RET;S100B
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,0.1586290567182287,0.6214388611218905,0.8658536585365854,1.0,1.0,17/17,84.22%,GRIA1;PRPH;NOS1;PSMA8;NEFH;GRIA2;NEFL;KIF5A;BCL2;GRIN2B;NEFM;DNAH8;TUBB4A;RAB39B;KIF5C;TUBA1A;CASP12
prerank,KEGG_2021_Human__Gastric cancer,0.13553466361753738,0.6194875999094114,0.8289473684210527,1.0,1.0,10/24,38.20%,FGF10;FGF7;FGF19;FGF16;FGF5;WNT9B;TGFB3;HGF;WNT2;RXRG
prerank,KEGG_2021_Human__Intestinal immune network for IgA production,0.1512424662110539,0.6185177732102533,0.9014084507042254,1.0,1.0,11/20,47.37%,IL2;CD28;TNFRSF13B;ITGA4;TNFRSF17;ICOS;IL10;CXCL12;IL6;CCL25;CD40LG
prerank,KEGG_2021_Human__Pathways in cancer,-0.07127548050817065,-0.61633466610665,0.75,0.973960683209797,1.0,75/87,73.93%,FGF8;FOXO1;FASLG;PIK3R1;COL4A1;COL4A5;IL2RB;GNGT2;CTNNA2;LEF1;FZD7;FGFR1;HEYL;RASGRP4;LAMB4;FN1;RASGRP2;MAPK10;WNT16;SMO;GLI2;WNT5A;IGF2;COL4A4;RASGRP1;NTRK1;LPAR1;EDNRB;AKT3;CCNA1;TGFB2;PDGFRB;MITF;CSF2RA;IL12B;F2R;ESR1;FGF2;BCL2;RET;IL13;GNG2;GLI1;CTNNA3;CSF2RB;CSF1R;PDGFRA;KIT;RUNX1T1;GNB4;CAMK2A;IL5RA;GNG3;LPAR4;ADCY5;IL6;EDNRA;COL4A6;GLI3;GSTM5;ADCY2;RXRG;WNT2;CXCL12;ALK;FLT3;HGF;AR;PTGER3;IFNG;PRKCB;AGTR1;TGFB3;GSTT2;MMP2
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.13676698157452355,0.6144041558538075,0.9230769230769231,1.0,1.0,20/23,76.25%,CCL19;CCL14;CCL17;CCL21;CCL13;CCL7;CCL11;CCL16;CRTAM;CCL25;CCL22;CCL2;CCL8;RET;S1PR1;CCL23;CCL4;CCL5;CCL18;CCR6
prerank,KEGG_2021_Human__Coronavirus disease,-0.10082129904719528,-0.6130339386528283,0.9230769230769231,0.9714025239522222,1.0,25/28,74.35%,RPL3L;PIK3R1;C6;CSF2;TLR4;C1QB;MAPK10;C1QC;CXCL10;C5AR1;IL12B;NLRP3;FCGR2A;SELP;C1R;C3AR1;CCL2;CYBB;IL6;C1S;TLR8;PRKCB;MASP1;AGTR1;TLR7
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.11333197213198731,0.6108198590556417,0.925531914893617,1.0,1.0,33/37,80.27%,MYOT;SLITRK3;MUSK;NLGN4X;GPM6A;NRXN1;CNTN2;CHRNA1;LRFN5;LRRC4C;PPFIA2;CBLN2;UNC13C;NLGN1;LRRK2;DSCAM;PTPRD;SLITRK2;CDH2;CBLN1;SLITRK1;F2R;PCDHB3;NTNG1;GPC6;PDZRN3;CACNB4;C5AR1;CX3CR1;NLGN3;NRXN2;RAB39B;C1QC
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.14107324684370107,0.6068495844075832,0.9047619047619048,1.0,1.0,8/20,34.82%,CR2;IL2;LEP;PTPRC;MS4A1;ITGA4;FLT3;IL10
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.1277161647452244,0.599207530652764,0.8823529411764706,1.0,1.0,10/26,36.36%,PHOX2B;IGF1;TRIM58;RSPO1;PTPRC;HMHB1;SLC8A1;ALPK2;IL10;PEG3
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.11910575446630009,0.5972834862251198,0.9340659340659341,1.0,1.0,10/27,33.61%,SFRP1;IL1RAPL1;CYP1B1;SLIT3;NOS1;SLIT2;IGFBP5;CCR7;DPYSL3;FLT3
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.12441206861527243,0.5963433804037894,0.8488372093023255,1.0,1.0,18/32,51.72%,WT1;SFRP1;GABRG2;CYP1B1;P2RY12;NR4A3;ATP1A2;IGFBP5;RYR3;AR;CRHBP;DRD5;ADCY2;ADCY5;MEF2C;CCL2;LRRK2;PDE3A
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.14916659287835582,0.5943227496174529,0.8831168831168831,1.0,1.0,10/15,59.38%,ANGPTL7;IRGM;AGTR1;SPOCK1;PAPPA2;STON1;SLITRK4;SLITRK2;CD36;GFAP
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.10595520930495117,0.5929085384370808,0.9080459770114943,1.0,1.0,19/39,45.93%,IGF1;MYOC;COL10A1;COL19A1;VCAN;MATN3;FBN1;CDH11;TLL1;MMP16;BMP5;CNMD;COL1A2;PRELP;EVC;COL1A1;GHRL;SULF1;BMP3
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.14695584445682786,0.5925492723387088,0.9012345679012346,1.0,1.0,4/16,18.83%,GABRG2;GLRA1;GABRA1;GABRA5
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.1503142909017254,0.5798124570716865,0.9315068493150684,1.0,1.0,9/17,47.25%,WT1;FGF10;GDF6;OSR1;AGTR1;TCF21;PYGO1;SULF1;HAS2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.11136626135506715,0.5777160681326797,0.8953488372093024,1.0,1.0,19/34,54.01%,IAPP;SFRP1;SFRP4;NEUROD1;CYP1B1;SFRP2;SLIT2;NGFR;TGFB3;IFNG;RASSF2;FCER2;ANKRD1;IL6;MNDA;LRRK2;CLEC7A;CTLA4;ARHGEF6
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.08264466253164851,0.5774405543975313,0.9285714285714286,1.0,1.0,88/104,79.96%,ADIPOQ;IAPP;IGF1;CCL19;FGF10;MYOC;FGF7;FGF19;S100A12;THBS1;TRAT1;FGF16;LEP;FGF5;ADRB3;CD28;P2RX2;P2RY12;PTPRC;DCN;CLEC6A;CCL21;TLR7;CCR7;PRKCB;ICOS;HGF;CALCR;IL26;FLT3;RELN;FCRL3;ANGPT1;TNFAIP8L3;CASS4;FERMT2;IL6;PIK3CG;OSM;NLGN1;GH1;CLEC7A;KIT;PDGFRA;SELP;PIK3R5;CD86;LURAP1;CD27;TEK;ROR2;P2RX5;RET;BCL2;PRKD1;PDGFC;ADRA1D;FGF2;S100B;ESR1;HTR2B;F2R;ADRA1A;IL12B;CD19;GJA1;CCL4;PDGFRB;ADRB2;TGFB2;AXL;LPAR1;CCL5;NTRK1;IGF2;SOX2;HCLS1;WNT5A;LILRA5;CX3CR1;TNFRSF19;KL;ROR1;CD4;NTF3;TSPYL5;WNT16;CD80
prerank,KEGG_2021_Human__Complement and coagulation cascades,0.13442909391545577,0.5668787312719695,0.9452054794520548,1.0,1.0,4/21,13.64%,CR2;C7;F13A1;CR1
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,0.12315912868088918,0.5652695452763155,0.9047619047619048,1.0,1.0,12/21,52.26%,IL2;CLEC1B;CCL17;CLEC6A;CD209;IL10;EGR2;CLEC4D;IL6;MRAS;CCL22;CLEC7A
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.13237987555786046,0.5638676248950516,0.9518072289156626,1.0,1.0,11/18,55.67%,IGF1;IL2;TNFSF18;IFNG;FLT3;GHR;IL6;OSM;GH1;KIT;CSF1R
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.13475505644305386,0.559776636213051,0.9285714285714286,1.0,1.0,3/17,12.58%,AGTR2;GREM1;THBS1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.10097516083536281,0.5570324729584153,0.9642857142857143,1.0,1.0,22/33,63.67%,DES;CIDEA;GOLGA8Q;ABCD2;GOLGA8O;CCL13;THY1;CCL7;TSGA10IP;CCL11;GEM;GOLGA8M;CECR2;CCL2;RAB31;LRRK2;PALLD;PKD2;ATP8B4;PRKD1;ZNF135;CNTNAP1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.11484875598802234,-0.5492667853538508,1.0,0.9991681790683606,1.0,12/15,61.50%,MAPT;SLC8A3;SEMA3E;PKHD1;RAB39B;NLGN3;TGFB2;CBLN1;FLNC;FERMT2;CBLN2;PPFIA2
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.09973959848775935,0.5446422320341271,0.9438202247191011,1.0,1.0,27/40,64.24%,GREM1;FGF10;SFRP1;SFRP4;RSPO1;DKK2;SFRP2;PSMA8;DAAM2;PRICKLE1;COL1A1;GLI3;RBMS3;ADGRA2;ZEB2;DACT1;LRRK2;HECW1;BICC1;DACT3;GPC3;GLI1;DKK3;FRZB;NKD1;SNAI2;SHISA6
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,0.13573256008453574,0.543425026295724,0.974025974025974,1.0,1.0,5/15,28.91%,ATP1A4;PLN;SLCO1C1;ATP1A2;PRKCB
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.08412183260499599,0.5418888558451715,0.9247311827956989,1.0,1.0,18/60,30.18%,SCN7A;SCARA5;SCN2B;KCNA1;ATP1A4;SLC6A15;SLC30A8;KCNA2;KCNK2;ABCC9;LRRC55;KCNS2;SLC8A1;ATP1A2;KCND2;KCNA3;RYR3;KCNB1
prerank,KEGG_2021_Human__T cell receptor signaling pathway,-0.09921293150644574,-0.5288810355631243,1.0,0.9998143300408976,1.0,12/26,28.30%,PIK3R1;CSF2;ZAP70;PRKCQ;MAPK10;CD4;PDCD1;NFATC1;CD3D;LCP2;RASGRP1;AKT3
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.10527139753692559,-0.5259875586737026,1.0,0.9955926672105763,1.0,23/25,77.37%,AQP4;XCL2;AIF1;TLR4;GBP6;HLA-DPA1;WNT5A;CCL18;CCL5;CCL4;CCL23;GBP5;MEFV;CCL8;CCL2;CCL22;CCL25;CCL16;CCL11;CCL7;CCL13;CCL21;CCL17
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.0939421436309617,0.5223235317593726,0.9550561797752809,1.0,1.0,28/39,66.75%,KCNA1;ATP1A4;KCNA2;KCNK2;ABCC9;LRRC55;KCNS2;ATP1A2;KCND2;KCNA3;KCNB1;KCNE4;KCNQ5;LRRC38;SLC9A9;KCNT2;KCNH7;SLC24A4;KCNB2;SLC12A1;SLC24A2;PKD2;KCNS1;KCNE1;KCNJ15;KCNC1;NALCN;KCNQ2
prerank,KEGG_2021_Human__Focal adhesion,0.08723331395749744,0.5212253502539043,0.9444444444444444,1.0,1.0,20/46,43.09%,IGF1;COL6A6;THBS1;MYLK;LAMA2;COL6A5;ITGA4;COL6A3;TNC;PRKCB;THBS4;HGF;MYL2;THBS2;RELN;COL1A2;TNR;COL1A1;COL4A6;ITGA11
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.1262951789756477,0.5198961455746095,0.9759036144578314,1.0,1.0,11/20,50.09%,GDF6;THBS1;LEFTY2;TGFB3;INHBA;BMP5;GDF5;SULF1;BMP3;CCN1;ZEB2
prerank,KEGG_2021_Human__Measles,-0.1039842323213831,-0.5162366447694275,1.0,0.9922565033272838,1.0,19/20,82.05%,FASLG;PIK3R1;RAB9B;IL2RB;TLR4;MAPK10;CD3D;AKT3;IL12B;BCL2;CD3E;SLAMF1;IL6;FCGR2B;CD3G;CD209;TLR7;CD28;IL2RA
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.11465736458137113,0.5107639910507821,0.975609756097561,1.0,1.0,8/21,34.82%,SFRP1;MFAP5;PTPRC;SFRP2;TNFRSF13B;FLT3;INHBA;IL10
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.13643626023141558,0.5057312935910661,0.9710144927536232,1.0,1.0,3/16,13.64%,CR2;C7;CR1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.08044018578833514,0.5043688768452345,0.979381443298969,1.0,1.0,62/73,80.18%,IGF1;FGF10;FGF7;ANGPTL1;MUSK;FGF19;FGF16;FGF5;NR4A3;EPHA5;DDR2;EPHA3;NGFR;MMP2;CHRNA3;HGF;FLT3;ALK;CD8A;GHR;PTPRT;COL1A1;ANGPT1;COL4A6;CASS4;STAP1;GFRA2;SULF1;SLA;GH1;CYBB;EPHA6;KIT;PDGFRA;NCKAP1L;CD3E;FLRT2;CSF1R;CD8B;TEK;SORBS1;ROR2;RET;PRKD1;PDGFC;FGF2;GRIN2B;SHC4;EFS;PDGFRB;ADRB2;AXL;ITGB3;NTRK1;LCP2;IGF2;KL;PLAT;ROR1;CD4;NTF3;SDC2
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.11635565908146306,0.5001427061700572,0.987012987012987,1.0,1.0,11/16,64.21%,ADIPOQ;ADCYAP1;TLR7;IFNG;DEFB124;IL6;CLEC7A;IL33;CSF1R;AZU1;TNFSF4
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.08764125489543105,0.483450174733101,0.9885057471264368,1.0,1.0,27/38,66.75%,KCNA1;ATP1A4;KCNA2;KCNK2;ABCC9;LRRC55;KCNS2;ATP1A2;KCND2;KCNA3;KCNB1;KCNMB2;KCNQ5;LRRC38;SLC9A9;KCNH7;SLC24A4;KCNB2;SLC24A2;KCNMB1;PKD2;KCNS1;KCNE1;KCNJ15;KCNC1;NALCN;KCNQ2
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.07726855052507717,0.48282066410120145,1.0,1.0,1.0,32/48,65.54%,SOX10;AGTR2;ECRG4;CCIN;VCAN;IL1RAPL2;SH3GL2;CA10;SNTG2;DCX;DCLK1;SPOCK1;EOMES;RELN;EGR2;TAGLN3;PCDH18;ADAM23;MOG;VIT;ADGRA2;CNTN4;CDH2;CNTN6;PKD2;ADAM22;MDGA1;PDGFC;S100B;NPTX1;GRIN2B;APOD
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.10663905252715165,0.47911963702330695,0.9873417721518988,1.0,1.0,15/23,61.77%,ADIPOQ;IL1RAPL1;COL3A1;CCR7;SELE;DPYSL3;FLT3;IL1R1;TIMP3;SELP;CSF1R;PTPN5;MEFV;BCL2;AFF3
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.09822316103439421,0.47281224111761366,0.9655172413793104,1.0,1.0,6/27,21.06%,IGF1;CCL19;IL2;LEP;CD28;PTPRC
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.07891190166318082,0.46553801164572556,0.9587628865979382,1.0,1.0,43/66,63.64%,CLEC4C;CTSG;RNASE3;S100A12;FCAR;CR1;FOLR3;PTX3;ADGRE3;KRT1;PTPRC;FPR2;FCN1;GLIPR1;CRISPLD2;FGL2;FPR1;FCGR3B;OLR1;MPO;CLEC4D;TNFAIP6;IL6;SIGLEC5;MNDA;CYBB;CHIT1;RAB31;CXCR2;C3AR1;RNASE2;NCKAP1L;DOCK2;FCGR2A;CD36;ITGAL;BPI;ATP8B4;SERPINB10;AZU1;RAB44;CD53;CLEC5A
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.08917777891146778,0.4643275054853745,0.9883720930232558,1.0,1.0,12/35,34.82%,CLC;CCL19;CR1;LEP;IL27;CD28;PTPRC;TNFSF18;TNFSF8;CD209;GPNMB;IL10
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.07012461843240855,0.4568617833479642,0.9690721649484536,1.0,1.0,23/69,35.33%,OGN;WT1;VIP;GREM1;SFRP1;SFRP4;ADAMTS8;CYP1B1;SFRP2;MYOCD;SST;TGFB3;FBLN1;IGFBP5;PODN;IFNG;AR;IL26;GPNMB;INHBA;IL10;BMP5;GDF5
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.06454723137409482,0.45448984676017257,0.9897959183673469,1.0,1.0,23/119,20.79%,TCL1A;LGI1;IGF1;VIP;GREM1;FGF10;IL2;SFRP1;COLEC12;FGF7;CCL14;FGF19;THBS1;CR1;FGF16;IL7R;GLP2R;NEUROD1;FGF5;HPR;PROK2;P2RX2;FOLR2
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.07539705854899965,0.4529969337237688,0.9591836734693877,1.0,1.0,54/67,77.04%,CLEC4C;CTSG;RNASE3;S100A12;FCAR;CR1;FOLR3;PTX3;ADGRE3;KRT1;PTPRC;FPR2;FCN1;GLIPR1;CRISPLD2;FGL2;FPR1;FCGR3B;OLR1;MPO;CLEC4D;TNFAIP6;SIGLEC5;MNDA;CYBB;CHIT1;RAB31;CXCR2;C3AR1;RNASE2;DNASE1L3;NCKAP1L;DOCK2;FCGR2A;CD36;ITGAL;BPI;ATP8B4;SERPINB10;AZU1;RAB44;CD53;CLEC5A;ADA2;LILRA2;CD93;SELL;LAIR1;LILRB2;CLEC12A;CD33;C5AR1;MCEMP1;SIGLEC9
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,0.08146912789648236,0.4482445744443288,0.978494623655914,1.0,1.0,7/40,17.26%,CHRM2;FGF10;FGF7;FGF19;FGF16;MYLK;FGF5
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.07438025736969704,0.4426949507953483,0.9591836734693877,1.0,1.0,42/65,63.64%,CLEC4C;CTSG;RNASE3;S100A12;FCAR;CR1;FOLR3;PTX3;ADGRE3;KRT1;PTPRC;FPR2;FCN1;GLIPR1;CRISPLD2;FGL2;FPR1;FCGR3B;OLR1;MPO;CLEC4D;TNFAIP6;SIGLEC5;MNDA;CYBB;CHIT1;RAB31;CXCR2;C3AR1;RNASE2;NCKAP1L;DOCK2;FCGR2A;CD36;ITGAL;BPI;ATP8B4;SERPINB10;AZU1;RAB44;CD53;CLEC5A
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.10711850095383785,0.4407706078317942,1.0,0.9985557933841206,1.0,5/18,25.35%,SFRP1;SFRP4;SFRP2;WNT9B;PSMA8
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.0793292410042904,0.42955806689243814,0.9880952380952381,0.9977208878231528,1.0,12/39,31.59%,SCN7A;KCNA1;ATP1A4;KCNA2;ABCC9;KCNS2;SLC8A1;ATP1A2;KCNA3;SLC22A2;CNGA3;KCNMB2
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.058961992359709066,0.4156568339799023,0.98989898989899,0.9967756035697695,1.0,41/129,34.82%,CILP;PHOX2B;WT1;IGF1;FGF10;SFRP1;ZNF536;FGF7;SFRP4;TCF23;MUSK;TRIM58;FGF19;ZNF98;ZNF492;FGF16;BNC2;FGF5;ZNF727;CD28;SH3GL2;PTPRC;ANK2;SFRP2;HMHB1;EFEMP1;HAND2;SLC8A1;OSR1;VSTM2A;CCN4;SLC22A2;IFNG;AR;PGR;ACTG2;TMEM119;CALCR;INHBA;ALPK2;IL10
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.0344137539562623,0.26062513816245514,1.0,1.0,1.0,122/200,64.67%,SOX10;ZNF728;ADIPOQ;PHOX2B;WT1;SUPT20HL1;IGF1;FOXD3;SFRP1;ZNF536;FGF7;ZNF157;TCF23;ZSCAN23;ZNF98;PHOX2A;GDF6;ZNF492;ZNF80;BNC2;NEUROD1;ZNF727;KLF17;VGLL3;NOS1;NR4A3;NKX6-3;MYT1L;SFRP2;EBF2;SUPT20HL2;EFEMP1;HAND2;MYOCD;HAND1;OSR1;CDK15;DACH2;GATA1;TGFB3;ZFHX4;ZFPM2;ZNF521;PRKCB;IFNG;EOMES;FOSB;ZNF208;AR;PYHIN1;TCEAL7;BHLHE22;TCF21;PRRX1;PGR;DBX2;INHBA;IL10;IRF4;ZNF99;PEG3;RXRG;PRICKLE1;RFX6;RFPL4AL1;ZNF676;IGSF1;COL1A1;ZEB1;GLI3;EGR2;MEOX2;FOXI2;RORB;ANKRD1;IKZF1;IL6;MAGEL2;TCF4;MEF2C;ZEB2;EBF3;MIXL1;RFPL4A;RUNX1T1;ZNF518B;ZNF454;ZNF835;KIT;ZNF257;ACTA2;SAMD11;CD86;ACTL6B;ZNF366;GLI1;DMRT3;ZNF423;DKK3;PURG;MEOX1;FOXF1;TFEC;CD38;NKX2-3;RET;ZNF154;ERG;CEBPE;TWIST2;FLI1;IRX6;HLF;FGF2;ESR1;ZNF135;HSF5;SNAI2;F2R;TNFSF4;ZNF354C;ZIM2
